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Abstract 
Abstract 
Metal complex-DNA interaction is gaining considerable attention owing to their utility in 
the design of conformational- specific probes for biomolecule structure, development of 
selective DNA cleaving agents for mapping or foot printing as well as for rational drug 
design. Metal- based chemotherapeutics which include anticancer, lymphoma, viral HIV 
are attractive from medicinal inorganic point of view as many metal-based drugs are 
entering fast in human clinical trials. Besides platinum based drugs, other metals such as 
gold, ruthenium, titanium, vanadium and copper are also appealing. This has opened up 
research in the field of proteomics for treating cancer or other diseases. 
DNA is the molecular target for many small molecules and metal complexes. A novel 
DNA binding metal complex with antitumour activity and clinical efficacy must fulfill 
the requirements as, (i) good intrinsic properties, including saline solubility and enough 
stability to arrive intact at the cellular target (ii) efficient transport properties in blood and 
through membranes (iii) efficient DNA binding properties (iv) the ability to differentiate 
between cancerous and normal cells (v) activity against tumours that are, or have become 
resistant to cisplatin and its derivatives. There are number of modes through which metal 
complexes can interact with DNA. These binding modes are external binding by 
electrostatic attraction, intercalation of planar aromatic molecules between the base pairs 
of the DNA helix, major/minor groove binding and phosphate backbone interaction. 
Intercalation is driven by hydrophobic effects, which are widely used in biological 
systems to increase nonspecific binding while specific and selective binding is a feature 
of covaient interaction of the metal complex to the nucleobases of DNA helix. 
Among the various factors governing the binding modes, the most significant is the 
ligand design due to its potential to fine tune the reactivity of metal complexes into the 
biological system. In this regard, introduction of chiral auxiliaries in the complexes is an 
attractive prospect because it modulates the reactivity of compounds towards DNA. 
Synthesis of transition metal complexes by incorporating chiral tridentate ligand is a 
dynamic approach, which yields in an enantiosclectivc manner robust complexes capable 
of binding to the molecular target site. In designing chiral compounds, amino acids are 
often employed as a source of stereogenic carbon center because of their simple 
molecular structure, compatibility in biological system and good metal complexing 
ability. The utility of chiral probe for DNA handedness is limited not only by the 
sensitivity with which the DNA binding may be detected but also by the sensitivity with 
which the probe may distinguish the enantiomer. 
To rationalize these findings, we have synthesized and characterized four series of novel 
chiral complexes with first row transition metal ions viz. Co(Il), Ni(II), Cu(ll) and Zn(I]). 
In the last two series, the heterobimetallic complexes Cu-Sn2 and Cu-Zr2 were isolated 
with tin/zirconium tetra chlorides. The interaction studies of copper complexes with 
calf- thymus DNA have been studied by UV/vis, fluorescence, circular dichroism 
spectroscopy, cyclic voltammetry and viscosity measurements. 
A new series of chiral complexes [l,2-Bis(lH-benzimidazole-2yl)- ethane-1,2-diol 
(ethylenediamine) metal (II)] chloride, [l,2-Bis(lH-benzimidazole-2yl)- ethane-1,2-diol 
(1, 10 phenanthroline) metal (II)] chloride and [l,2-Bis(lH-benzimidazole-2yl)- ethane-
1,2-diol (L-tryptophanato) metal (II)] chloride M - Co (II), Ni(ll), Cu(II) have been 
synthesized and characterized. The benzimidazole ligand L exhibits coordination mode 
with an oxygen atom of alcohol group directed towards the metal and another -OH group 
having different molecular axis hence directed away from the metal center. The 
complexes [C,8H2iN602Cu]CI, [C,8H2iN602Ni]CI, [C28H2iN602Cu]Cl, 
fC28l'2iN602Ni]CI and |C28H2iN602Co]CI are ionic in nature while IC27H22N6O4CU] and 
[C27H22N604Ni] are non-electrolyte. The donor sets involved in coordination with metal 
ions are -0- atom of alcohol group together with two -N- atoms of benzimidazole groups, 
and two -N- of 1,10 phenanthroline or ethylenediamine, while L tryptophan coordinate in 
a bidentate manner through amino and carboxylate group. On the basis of analysis and 
spectral studies, the proposed geometry of the complexes is five-coordinate. The ball and 
stick model of the proposed structure of the complexes was constructed which shows 
apparently no strain on any bond and angle. The interaction of complexes 
[Ci8H2iN602Cu]Cl, [C28r2iN602Cu]CI and [C27H22N6O4CU] with calf-thymus DNA 
have been carried out by UV/vis titration, circular dichroism, electrochemical methods 
and viscometry. The intrinsic binding constant Kb values of the complexes 
[Ci8H2iN602Cu]Cl, [C28H2iN602Cu]Cl and [C27H22N6O4CU] were found to be 1.57 x lO" 
M'', 1.51 x \(f M'' and 1.3 x 10^  M"', respectively suggesting that the complexes bind 
III 
strongly to the calf-thymus DNA by covalent interaction. Covaient mode of binding was 
further authenticated by the interaction studies of these complexes with DNA bases, 
guanine, adenine and thymine using absorption spectroscopy. There is substantial blue 
shift and large hyperchromism on addition of guanine to the copper complexes while 
adenine and thymine exhibited relatively small hyperchromic changes in absorbance 
intensity. These spectral changes clearly indicate preferential covalent binding of copper 
complexes to guanine. 
The chiral macrocyclic complexes [1,2 bis(IH-benzimidazol-2yl)l-(l,8 
dihydrol,3,6,8,10,l3 hexaazacyclotetradecane) 2-hydroxy ethanolate copper (II)/nickel 
(11)] perchlorate were synthesized by che interaction of 1,2 bis(lH-benzimidazol-2yl) -
1,2 ethanediol ligand L and fl,8 dihydro 1,3,6,8,10,13 hexaazacyclotetradecane copper 
(lI)/nicl<el(II)] diperchlorate complexes. All the complexes were characterized by various 
spectroscopic techniques. Molar conductance measurements showed that all the 
complexes are ionic in nature. Metal center is encapsulated by the ligand L in 
pentacoordinated environment in chiral complexes. The optical rotation [ajo values of 
[1,2 bis(lH-benzimidazol-2yl)l-(l,8 dihydro 1,3,6,8,10,13 hexaazacyclotetradecane) 2-
hydroxy ethanolate copper (II)/nickel (11)] perchlorate at 25 °C indicate that the 
complexes are chiral in nature. Absorption and fluorescence spectral studies, cyclic 
voltammetry and viscosity measurements have been carried out to assess the comparative 
binding of achiral [1,8 dihydro 1,3,6,8,10,13 hexaazacyclotetradecane copper (II)] 
diperchlorate and chiral [1,2 bis(lH-benzimidazol-2yl)l-(l,8 dihydro 1,3,6,8,10,13 
IV 
hexaazacvclotetradecanc) 2-hydroxy ethanolate copper (II)] perchlorate with CT DNA. 
Anahsis of the results suggests that new chiral complex binds to CT DNA through a 
partial intercalation mode that is different from the binding mode of parent achiral 
complex. The binding constants for the achiral and chiral complexes bound to CT DNA 
were determined to be Kb of 2.7 x 10'' M"' and 6.6 x 10'' M'', respectively. Circular 
dichoric studies ha\e been further employed to ascertain the binding mode of chiral 
complex, which is consistent with the other spectral studies. 
The novel chiral trinuclear complexes [C26H36N806CuSn2]Cl2, [C28H4oN806CuSn2]Cl2 
[C;pH-,:Ns04NiSn;]CI: and fC28H%N804NiSn2]Cl2 were synthesized by employing a well-
designed three-step pathway under anhydrous conditions and characterized by various 
spectroscopic techniques. Interaction of the complexes [C26H36N806CuSn2]Cl2 and 
[C:>;H4nN80pCuSn2]Cl2 with calf-thymus DNA were studied by spectrophotometry, cyclic 
voltammetr\ and \ iscosit\ measurements. The kinetic studies of calf-thymus DNA and 
guanine were carried out at 260nm (?Mn,^^ of calf thymus DNA) and 273nm, respectively 
under pseudo-first order conditions. The rate constants, kobs were evaluated by the linear 
least square regression method. The absorption spectra of the complexes with 
calf- thymus DNA show hyperchromism with red shift of 2-4 nm. The electrochemical 
beha\ior of the complexes were studied in DMSO/H2O (5:95) solution and showed a 
quasireversible Cu(ll)/(1) redox couple. The voltammetric studies of the complexes in the 
absence and in the presence of DNA exhibit a shift in the formal potential E" and ratio of 
cathodic to anodic peak currents Ipa/lpc, indicating strong binding of the complexes to 
calf- linmus DNA. The decrease in viscosity of DNA was also observed with increasing 
concentration of the complexes. Interaction of [C26H36N806CuSn2jCl2 and 
[C2sH^ ,NsO:,CuSn:]Cl2 complexes with CT DNA and guanine indicate that the tin(IV) 
atom binds to the phosphate backbone of the DNA helix while the copper(II) center 
preferential!) attacks at the N? position of guanine, and shows structural and 
conformational changes in DNA. 
Another series of chiral trinuclear complexes [C23H3iN606CuSn2Cl4]CI, 
[C23H;,N,OXuZr:Ci4]Cl. [C23H3iN606ZnSn2Cl4]CI and [C23H3iN606ZnZr2Cl4]CI were 
synthesized and characterized by spectroscopic (IR. 'H, ' ' 'C, 2D cosy and ' S^n NMR, 
EPR. LA' vis. ESI-MS) and analytical methods. In all complexes, the geometry of copper 
and zinc metal ions were described as square pyramidal with L- tryptophan coordinated 
to copper/zinc via carboxyiate group while Sn/Zr was present in hexacoordinate 
environment. The interaction of complexes [C23H3iN606CuSn2Cl4]Ci and 
lC23H;,N,,0.,CuZr:Cl4]Cl with calf-thymus DNA in tris buffer were studied by electronic 
absorption titration, fluorescence titration, cyclic voltammetry, circular dichroism and 
\'iscometric measurements. The emission quenching of these complexes by [FeCCNje]"^  
depressed greatly w hen bound to DNA. Observed changes in the circular dichoric spectra 
of DN.A in presence of copper complexes support the strong binding of complexes with 
DNA. The relative specific viscosity of DNA bound to complexes decreased indicating 
that the complexes bind to DNA via covalent binding. To further confirm the mode of 
binding, the interaction of complexes [C23H3)N606CuSn2Ci4]Cl and 
VI 
|C:3H-. N(,0-,CuZr:Cl4]CI ha\e also been earned out with guanine, adenine and thymine 
at their characteristic d-d bands in the visible region. The results reveal that the extent of 
DNA binding of complex [CiBH-iiNdOfiCuSn^ CUlCI was slightly greater than that of 
complex [C::H3iNt,0(,CuZr:Cl4]C[ and in both the complexes Sn(fV)/Zr(fV) metal ions 
bind to the phosphate backbone of the DNA helix, while the copper (II) ion preferentially 
auackj. al the Ni position of guanine. To evaluate the mechanistic pathway of DNA 
inhibition, counting experiments and MTT assay were employed to assess the induction 
of apoptosis b\ complex fC23H3|N606CuSn2Cl4]CI. Western blot analysis of whole cell 
lysatev and mitochondrial fractions with Bcl-2 and p-53 family proteins and caspase-3 
colorimetr\ assa\ were also carried out on a human neuioblastoma cell line SY5Y. 
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Abstract 
Abstract 
Metal complex-DNA interaction is gaining considerable attention owing to their utility in 
the design of conformational- specific probes for biomolecule structure, development of 
selective DNA cleaving agents for mapping or foot printing as well as for rational drug 
design. Metal- based chemotherapeutics which include anticancer, lymphoma, viral HIV 
are attractive from medicinal inorganic point of view as many metal-based drugs are 
entering fast in human clinical trials. Besides platinum based drugs, other metals such as 
gold, ruthenium, titanium, vanadium and copper are also appealing. This has opened up 
research in the field of proteomics for treating cancer or other diseases. 
DNA is the molecular target for many small molecules and metal complexes. A novel 
DNA binding metal complex with antitumour activity and clinical efficacy must fulfill 
the requirements as, (i) good intrinsic properties, including saline solubility and enough 
stability to arrive intact at the cellular target (ii) efficient transport properties in blood and 
through membranes (iii) efficient DNA binding properties (iv) the ability to differentiate 
between cancerous and normal cells (v) activity against tumours that are, or have become 
resistant to cisplatin and its derivatives. There are number of modes through which metal 
complexes can interact with DNA. These binding modes are external binding by 
electrostatic attraction, intercalation of planar aromatic molecules between the base pairs 
of the DNA helix, major/minor groove binding and phosphate backbone interaction. 
Intercalation is driven by hydrophobic effects, which are widely used in biological 
systems to increase nonspecific binding while specific and selective binding is a feature 
of coxalent interaction of the metal complex to the nucleobases of DNA helix. 
Among the various factors governing the binding modes, the most significant is the 
ligand design due to its potential to fine tune the reactivity of metal complexes into the 
biological system. In this regard, introduction of chiral auxiliaries in the complexes is an 
attractive prospect because it modulates the reactivity of compounds towards DNA. 
Synthesis of transition metal complexes by incorporating chiral tridentate ligand is a 
dynamic approach, which yields in an enantioselective manner robust complexes capable 
of binding to the molecular target site. In designing chiral compounds, amino acids are 
often employed as a source of stereogenic carbon center because of their simple 
molecular structure, compatibility in biological system and good metal complexing 
ability. The utility of chiral probe for DNA handedness is limited not only by the 
sensitivity with which the DNA binding may be detected but also by the sensitivity with 
which the probe may distinguish the enantiomer. 
To rationalize these findings, we have synthesized and characterized four series of novel 
chiral complexes with first row transition metal ions viz. Co(ll), Ni(I[), Cu(ll) and Zn(II). 
In the last two series, the heterobimetallic complexes Cu-Sn^ and Cu-Zr2 were isolated 
with tin/zirconium tetra chlorides. The interaction studies of copper complexes with 
calf- thymus DNA have been studied by UV/vis, f]uorescence, circular dichroism 
spectroscopy, cyclic voltammetry and viscosity measurements. 
A new series of chiral complexes [l,2-Bis(lH-benzimidazole-2yl)- ethane-1,2-dioi 
(ethylenediamine) metal (II)] chloride, [l,2-Bis(lH-benzimidazole-2yl)- ethane-1,2-diol 
(1, 10 phenanthroline) metal (II)] chloride and [l,2-.Bis(lH-benzimidazole-2yl)- ethane-
1,2-diol (L-tryptophanato) metal (II)] chloride M = Co (II), Ni(II), Cu(II) have been 
synthesized and characterized. The benzimidazole ligand L exhibits coordination mode 
with an oxygen atom of alcohol group directed towards the metal and another -OH group 
having different molecular axis hence directed away from the metal center. The 
complexes [Ci8H2iN602Cu]Cl, [C,,sH2iN602Ni]Cl, [C2xH2iN602Cu]CI, 
[C28H2iN602Ni]Cl and [C28H2iN602Co^ ,Cl are ionic in nature while [C27H22N6O4CU] and 
[C27H22N604Ni] are non-electrolyte. The donor sets involved in coordination with metal 
ions are -0- atom of alcohol group together with two -N- atoms of benzimidazole groups, 
and two -N- of 1,10 phenanthroline or ethylenediamine, while L tryptophan coordinate in 
a bidentate manner through amino and carboxylate group. On the basis of analysis and 
spectral studies, the proposed geometry of the complexes is five-coordinate. The ball and 
stick model of the proposed structure of the complexes was constructed which shows 
apparently no strain on any bond and angle. The interaction of complexes 
[Ci8H2iN602Cu]Cl, [C28H2iN602Cu]CI and [C27H22N6O4CU] with calf-thymus DNA 
have been carried out by UV/vis titration, circular dichroism, electrochemical methods 
and viscometry. The intrinsic binding constant Kb values of the complexes 
[Ci8H2iN602Cu]CI, [C28H2iN602Cu]Cl and [C27H22N6O4CU] were found to be 1.57 x lO" 
M"', 1.51 x 10"* M"' and 1.3 x 10^  M"', respectively suggesting that the complexes bind 
\u 
strongly to the calf-thymus DNA by covalent interaction. Covalent mode of binding was 
further authenticated by the interaction studies of these complexes with DNA bases, 
guanine, adenine and thymine using absorption spectroscopy. There is substantial blue 
shift and large hyperchromism on addition of guanine to the copper complexes while 
adenine and thymine exhibited relatively small hyperchromic changes in absorbance 
intensity. These spectral changes clearly indicate preferential covalent binding of copper 
complexes to guanine. 
The chiral macrocyclic complexes [1,2 bis(lH-benzimidazol-2yl)l-(l,8 
dihydrol,3,6,8,10,13 hexaazacyclotetradecane) 2-hydroxy ethanolate copper (II)/nickel 
(II)] perchlorate were synthesized by the interaction of 1,2 bis(lH-benzimidazol-2yl) -
1,2 ethanediol ligand L and [1,8 dihydro 1,3,6,8,10,13 hexaazacyclotetradecane copper 
(II)/nickel(n)] diperchlorate complexes. All the complexes were characterized by various 
spectroscopic techniques. Molar conductance measurements showed that all the 
complexes are ionic in nature. Metal center is encapsulated by the ligand L in 
pentacoordinated environment in chiral complexes. The optical rotation [a]D values of 
[1,2 bis(lH-benzimidazol-2yl)l-(l,8 dihydro 1,3,6,8,10,13 hexaazacyclotetradecane) 2-
hydroxy ethanolate copper (II)/nickel (II)] perchlorate at 25 °C indicate that the 
complexes are chiral in nature. Absorption and fluorescence spectral studies, cyclic 
voltammetry and viscosity measurements have been carried out to assess the comparative 
binding of achiral [1,8 dihydro 1,3,6,8,10,13 hexaazacyclotetradecane copper (II)] 
diperchlorate and chiral [1,2 bis(IH-benzimidazol-2yl)l-(l,8 dihydro 1,3,6,8,10,13 
IV 
hexa.izac>clotetradecane) 2-hydroxy etiianolate copper (II)] perchlorate with CT DNA. 
•XnalNsis of the results suggests that new chiral complex binds to CT DNA through a 
partial intercalation mode that is different from the binding mode of parent achiral 
complex. The binding constants for the achiral and chiral complexes bound to CT DNA 
were determined to be Kh of 2.7 x lO" M'' and 6.6 x lO'' M"', respectively. Circular 
dichonc studies have been further employed to ascertain the binding mode of chiral 
complex, which is consistent with the other spectral studies. 
The novel chiral trinuclear complexes [C26H36N806CuSn2]Cl2 [C28H4oN806CuSn2]Cl2, 
fC26H -;Ns04NiSn2]Cl2 and [C2sH36N804NiSn2]Ci2 were synthesized by employing a well-
designed three-step pathway under anhydrous conditions and characterized by various 
spectroscopic techniques. Interaction of the complexes [C26H36N806CuSn2]Cl2 and 
[C28H. iN806CuSn2]Cl:\\ith calf-thymus DNA were studied by spectrophotometry, cyclic 
voltammetrN and \iscosit\ measurements. The kinetic studies of calf-thymus DNA and 
guanine were carried out at 260nm (>^ nid\ of calf thymus DNA) and 273nm, respectively 
under pseudo-first order conditions. The rate constants, kobsWere evaluated by the linear 
least square regression method. The absorption spectra of the complexes with 
calf- thymus DNA show hyperchromism with red shift of 2-4 nm. The electrochemical 
behaMor of the complexes were studied in DMSO/H2O (5:95) solution and showed a 
quasireversible Cu(n)/(l) redox couple. The voltammetric studies of the complexes in the 
absence and in the presence of DNA exhibit a shift in the formal potential E° and ratio of 
cathodic to anodic peak currents Ipa/Ipc, indicating strong binding of the complexes to 
calf- thvmus DNA. The decrease in viscosity of DNA was also observed with increasing 
concentration of the complexes. Interaction of |C26H:,6N806CuSn2]Cl2 and 
[C28H .^)N«OoCuSn;]Cl2 complexes with CT DNA and guanine indicate that the tin(IV) 
atom binds to the phosphate backbone of the DNA helix while the copper(ll) center 
preferentiallv attacks at the N? position of guanine, and shows structural and 
confomiational changes in DNA. 
Another series of chirai trinuclear complexes [C23H3|N606CuSn2Cl4]Cl, 
[C23H.;,N60,CuZr;Cl4]Cl. [C23H3iN606ZnSn2Cl4]Cl and [C23H3iN606ZnZr2Cl4]CI were 
synthesized and characterized by spectroscopic (IR, 'H. ' ' C , 2D cosy and "^Sn NK4R, 
EPR. L'VAis. ESI-MS) and analytical methods. In all complexes, the geometry of copper 
and zinc metal ions were described as square pyramidal with L- tryptophan coordinated 
to copper/zinc via carboxylate group while Sn/Zr was present in hexacoordinate 
environment. The interaction of complexes [C23H3iN606CuSn2Cl4]CI and 
[C23H:iN(,Ot,CuZr2Cl4]CI with calf-thymus DNA in trts buffer were studied by electronic 
absorption titration, fluorescence titration, cyclic voltammetry, circular dichroism and 
viscometric measurements. The emission quenching of these complexes by [Fe(CN)6]''' 
depressed greatly when bound to DNA. Observed changes in the circular dichoric spectra 
of DN.^ in presence of copper complexes support the strong binding of complexes with 
DNA. The relative specify viscosity of DNA bound to complexes decreased indicating 
that the complexes bind to DNA via covalent binding. To further confirm the mode of 
binding, the interaction of complexes [C23H3iN606CuSn2Cl4]Cl and 
VI 
iC;;H. \(,0^CuZi;Cl4]Cl ha\e also been carried out with guanine, adenine and thymine 
Ji the!- characteristic d-d bands in the visible region. The results reveal that the extent of 
DNA binding of complex |C23H3iN606CuSn2Cl4]CI was slightly greater than that of 
complex [C;_;H.;iNc.06CuZr2Cl4]CI and in both the complexes Sn(IV)/Zr(lV) metal ions 
bind to the phosphate backbone of the DNA helix, while the copper (II) ion preferentially 
attacks at the N7 position of guanine. To evaluate the mechanistic pathway of DNA 
inhibition, counting experiments and MTT assay were employed to assess the induction 
of apoptosis b\ complex [C2;H3iN606CuSn2Cl4]CI. Western blot analysis of whole cell 
Ksates and mitochondria! fractions with BcI-2 and p-53 family proteins and caspase-3 
colori"ieir\ assax were also carried out on a human neuroblastoma cell line SY5Y. 
VM 
Abbreviations 
BCA 
CD 
CT DNA 
CV 
cyto c 
DMLiM 
DMF 
DMSO 
ECL 
EDTA 
EthBr 
EtOH 
FBS 
FHS 
5-Fu 
IL 
LMCT 
LNT 
MDM2 
MeOH 
MTT 
/;NA 
PBS 
PC-12 
PMSF 
PVDF 
bicinchoninic acid 
circular dichroism 
calf-thymus DNA 
cyclic voitammetry 
cytociirome c 
Dulhecco's modified Eagle modiiini 
dimethylformamide 
dimetiiylsuifoxide 
enhanced chemiluminescence 
etiiyienediaminetetraacetic acid 
ethidium bromide 
ethanol 
fetal bovine serum 
foetal horse serum 
5-tluorouracil 
intra Jigand 
ligand to metal charge transfer 
Liquid nitrogen temperature 
murine double minute 2 
methanol 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyU2//-tetrazolium 
bromide 
/>nitroanilide 
phosphate buffered saline 
rat pheochromocytoma cancer cells 
phenylmethylsulfonyl fluoride 
polyvinylidene fluoride 
SDS sodium dodecyl sulphate 
SY5Y human neuroblastoma cancer cells 
TBS tris buffered saline 
tris tris(hydroxymethyl)aminomethane 
TCNE tetracyanoethylene 
UV ultra-violet 
CHAPTER I 
Introduction 
Introduction 
Rational design of inorganic compounds for therapeutic applications has opened up a new 
research area in bioinorganic chemistry i.e. medicinal inorganic chemistry. It is at the 
interface between medicine and inorganic chemistry, and includes metal-based drugs, 
metal sequestering or mobilizing agents, metal diagnostic aids, and the medicinal 
recruitment of endogenous metal ions [1-6]. This Held gained momentum with the advent 
of cis-platin (cis-diaminedichloro-platinum (II))- archetypical inorganic anticancer drug 
[7]. Besides cis-platin and its direct derivatives carboplatin (diamine [1,1-
cyclobutanedicarboxylato(2-)]-0,0'-platinum(II)) and other Pt (II) complexes were 
routinely used as anticancer drugs (Figure 1). The dominance of platinum based 
anticancer drugs has surpassed over three decades. However, these drugs show activity 
against a limited number of tumours, in addition cause serious side effects and have 
failed primarily due to high toxicity, acquired drug resistance and possibly also due to 
lack of action at the molecular target site [8]. 
H3N. ,ci H3N yO~< . r-'N^V / % ^ 
PI \pf X > /""^  1 
Figure 1. Platinum (II) complexes in worldwide clinical use, cisphilin (left), carhoplalin 
(middle), oxaliplatin (right) 
Metal ion and metal coordination compounds are i<novvn to affect cellular natural 
processes viz. cell division, gene expression and non natural process such as toxicity, 
carcinogenicity and antitumour chemistry in a drastic way [9,10]. Metal ions exist as 
electron deficient cation (Lewis acids) in the biological system and hence are attracted to 
electron rich (Lewis bases) biological molecules such as proteins and DNA [11]. 
Pharmacological target of the antitumour drugs is cellular DNA and N7 atoms of the 
imidazole rings of guanine and adenine located in the major groove of the double helix 
are the most accessible and reactive nucleophilic sites for binding to DNA in a majority 
of antitumour drugs having cis-platin type of mechanism of action [12-17]. DNA, an 
inherently chiral molecule has a polymorphic structure with polyanionic nucleotide 
chains and sugar phosphate backbones. Double helix DNA can adopt a variety of 
sequence dependent secondary structures i.e. right handed B form to left handed Z 
conformation. All of these conformations play important role in gene expression [18]. 
Targeting DNA at the molecular level with specificity will lead not only to novel 
chemothcrapeutic agents but aLso search for DNA probes and to develop highly sensitive 
diagnostic agents. Specific recognition can be engineered into metal complex-DNA 
system by matching the "molecular shape", symmetry and functionalities of the metal 
complex to that of DNA target [19-20]. Metallointercalators have A (right handed) and A 
(left handed) symmetry that can be recognized by the DNA helix (I'igure 2). Chiralily can 
cause subtle changes in electronic properties as well as molecular specificity [21]. 
A A 
Figure 2. A schematic representation of right-handed Delta (A) and left-handed Lambda 
(A) transition metal complexes 
An understanding of the orientation and interaction due to chiral structure of the 
molecules in the biomimetic and biomolecular systems can be helpful in designing drugs 
in a more effective way [22]. The structure-function relationship in nature is so powerful 
that when a functional disorder manifests in the form of a disease, it can be cured only by 
using a molecule of a specific chiral structure, because chiral receptor sites in human 
body interacts only with drug molecules having the proper absolute configuration, which 
results in marked differences in the pharmacological activities of enantiomers [23]. The 
interaction of two enantiomers of chiral transition metal complexes with the DNA helical 
structure provides a level of specificity. 
The first demonstration of the effect of the leaving group chirality on biological activity 
was introduced by N. Farrel et al [24] in the cationic complexes of the type [PtCI 
(diamine) (RR'SO)]"^ where RR'SO is unsymmetrically substituted sulfoxides [25]. They 
demonstrated that introducing chirality enhances cytotoxicity in cisplatin resistant cell 
lines, which was attributed to change in reactivity and cellular uptake. This was perhaps 
also due to hydrolytic behaviour of Pt-S band and stereochemical requirement of the 
sulphur ligand. In another effort, chiral and achiral Pt(II) complexes having general 
formula [Pt(acylthiourea)CI (RR'SO)] (Figure 3) where RR'SO is sulfoxide ligand were 
prepared 
R R' SO = DMSO, R- MTSO, S- MTSO 
CH2CH3 
^ CH2CH3 
•N 'X^N 
Figure 3. Structure of [Pt(acylthioureato)Cl (RR 'SO)] 
The complexes were chiral or achiral according to the variation of sulfoxide ligand. If the 
sulfoxide ligand were DMSO or methyl phenyl sulfoxide (MPSO), then the complexes 
formed would be achrial. If chiral sulfoxides such as (R)-methyl(p-tolyl)sulfoxide (R-
MTSO) and (S)-methyl(p-tolyl)sulfoxide (S-MTSO) were used, then complexes formed 
would be chiral. Cytotoxic studies of these complexes against HeLa cancer cell line 
support that acylthiourea ligand showed cytotoxic behaviour with antiproliferative effects 
dependent on the nature/type of substituent [26]. 
A rationally designed metal complex prepared from a trivalent cobalt ion and a 
tetradentate ligand (Figure 4) capable of binding natural amino acids with high and 
predictable regio- and stereospecificity appeared in "Nature [27]. 
(a) 
H00Gx^NH2 H3Q^^CH3 
(b) 
Figure 4. Structure of (a) tetradentate ligand{h) its Co(III) complex 
The fundamental concepts used in this report were to develop the chiral metal complex 
for regiospecific and stereospecific recognition of amino acid, which could be applicable 
for other bidentate a-H amino acids. In order to explore the possibility, new receptor 
metal complex in enantiomerically pure R-form was reacted with glycine, L and D forms 
of alanine, phenylalanine and tryptophan. The X-ray crystallography and NMR data 
revealed the coordination of amino acids to the receptor took place with unprecedented 
regiospecificity and stereospecificity. 
Zacharias et al have reported first structurally characterized chiral homotrinuclear 
[Zn3L(n-OAc)](CI04)2.3CHCl3.H20, [Zn3L(p-OAc)]C104.PF6.5CH30H.H20 and 
heterotrinuclear [Zn2CuL(|i-OAc)](C104)2.3CHC!3.H20 complexes of optically active 
3+3 macrocyclic hexaaminotriphenolic ligand [28]. This ligand ensured the facilitation of 
three metals in close proximity, despite the proportional variation of metals. The 
molecular structure of these complexes were established crystallographically. The cation 
[Znj L'(|.i-Oac)]^ structure of homotrinuclear complexes closely resembles the trinuclear 
Zn (11) active site of PI nuclease. Complex [Zn3L(^-OAc)]C104.PF6.5CH30H.H20 and 
[Zn2CuL()j.-OAc)](C104)2.3CHCl3.H20 were found to be effective in the cleavage of CT 
DNA. 
Incorporating chiral auxiliary in a transition metal complexes influences the cell response 
and contributes to understanding the process that are crucial for antitumour activity. In 
this regard, amino acids, which are naturally occurring chiral compounds, have been 
extensively used as chiral auxiliaries to create / induce a quaternary stereogenic carbon 
center. The relevance of amino acids lies in their biological importance, not only as they 
form the building block of peptides and proteins but also cellular tissues in fluid in living 
organism which contains a reservoir of free amino acids. They take part in important 
metabolic reactions, including the biosynthesis of polypeptides and proteins and the 
synthesis of nucleotides. High biological importance, chirality and amphiphility 
combined with a low molecular weight and relative simplicity of molecular structures 
make amino acids the most suitable candidates for drugs scaffold representing typical 
features of natural bioactive substances [29-32], 
Metal complexes of amino acids are involved in exchange and transport mechanism of 
trace metal ions in human body. Such systems provide models of protein-DNA and 
peptide derived antitumour agent-DNA interaction. Various side groups of amino acid are 
found to have a potential to recognize the specific base sequence through hydrogen bond 
formation with the nucleic bases in DNA [33-34]. The physiologically interesting mixed 
ligand complexes of amino acids are tiie most studied class of this field. Two copper 
complexes (Figure 5) of the type [CU(L')(L")] (where L' = tryptophanate or 
phenylahininatc, L" = cystoinethiokitc) were prepared, ch;irac(crizcd and their 
spectrophotometric and voltammetric behaviour was investigated [35]. 
HO,C-CH--J^ O HO,C-CH->^ ^ < 5 -
,c=o 
Figure 5. Structure of[Cu{L')(L')J 
Mixed ligand ternary metal complexes of amino acids and nucleic acid constituents play 
an important role in biochemical processes, for example genetics and molecular biology 
[36] as nucleic acids and proteins recognize each other by very specific and selective 
interactions through amino acid side chain and nucleic acid constituents [37]. Mixed 
ligand ternary complexes of nucleic acid bases and nucleotides such as thymine, cytidine, 
2- thiouracil and amino acids viz. L-alanine, L-phenylalanine and L-tryptophan (Figure 
6) were synthesized and characterized by various spectroscopic techniques [38-39]. 
A. R. Chakravarty et al have demonstrated the ternary copper (II) complexes [Cu(L-
lysine)B(C104)](C104) and [Cu (L-methionine)B(C104)](CI04) where B is a heterocyclic 
base viz. 2,2'-bipyridine (bpy), 1,10 phenanthroline (phen), dipyriclo[3,2-d:2',3'-
f]quinoxaline (dpq) and dipyrido[3,2-a:2',3'-c]phenazene (dppz). Complexes of 1,10 
phenanthroline were characterized by X-ray crystallography. 
HjO- I 
HN 
0 
OH2 
O 
- ^ 0 H 3 . 
H2O 
H2O Na 
.0 -1 
H2O 
M = Cu(II), Ni(II), Co(II) 
Figure 6. Structure of few ternary complexes of thymine and cytid'me 
These complexes contain bioessential a amino acids, L-lysine [40] and L-methionine [41] 
as potential photosensitizers in metal bound form and N, N' donor heterocyclic bases as 
DNA groove binder. They have probed the effect of transition metals like copper(II) ion 
on the photoexcitation wavelength in a ternary structure "A-Cu(II)-B" having the amino 
acid (A) and the DNA binder (B) covalently bound to the metal (Figure 7). 
-N 
Solv 
.NH, 
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OCIO, 
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-N 
- bpy, phen, dpq, dppz 
N^ 
Figure 7. Structure of [Cu(L-methiomne)B(Soh)] (CIO4) and [Cu(L-lysine) B(C104)] 
Amino acid Schiff base complexes of first low transition metals such as Co(II), Ni(n), 
Cu(II) etc were reported to exhibit fungicidal, bactericidal, antiviral and antitubercular 
activity [42-45]. Several Schiff base complexes were found to inhibit tumour growth 
[46]. A few structurally characterized amino acid derived Schiff bases and their metal 
complexes were reported [42,47-50]. 
Wang el al [51] have reported copper (II) and cobalt (II) complexes of valine derived 
Schiff base (Scheme 1). These complexes were characterized by elemental analysis FTIR 
and X-ray diffraction. Biological studies of the complexes were carried out in vitro for 
antimicrobial activity against Gram-positive, Gram-negative bacteria and human 
pathogenic fungi. Copper complex proved to be a broad spectrum agent showing 
significant inhibition of the_ Gram-positive bacteria. The in vitro cytotoxicity of this 
compound revealed that it was nontoxic to human erythrocytes even at a concentration of 
500 ^ ig/ml. 
Q/^> N , ^ ^ ^ L-vali.je, Co(C104)2, ^ ^ N J ^ L-valrne,Cu(C104K 0'^ " 
Q-^Y ^ ~ *™' ^'•'""' '^""' ^ V ^ ^ KOH, MeOH, ret lux 0^ f' '^' 
Scheme 1. Synthetic route of copper (II) and cobalt (II) complexes of valine derived 
Schiff base 
Vittal et al were interested to study the reduced Schiff bases of amino acids and their 
metal complexes [52]. Four copper (II) complexes containing the reduced Schiff base 
ligands, namely, N-(2-hydroxybenzyl)-glycinamide (Hsglym) and N-(2-hydroxybenzyl)-
L-aianinamide (Hsalam) have been synthesized and characterized (Figure 8). The crystal 
structures of [Cu2(sglym)2Cl2], [Cu2(salam)2(N03)2].H20, 
[Cu2(salam)2(lM03)(H20)](N03).1.5H20 and [Cu2(salam)2](CI04)2.2H20 show that the 
Cu(ll) atoms are bridged by two phenolato oxygen atoms in the dimers. 
H,N 
V^ 
Figure 8. Schematic diagrams ofligands (left) and the dicopper complexes (right) where 
R = H or Me, L = aniorj or water 
The sgiym iigand was bound to Cu(II) in facial manner while saiam ligand prefered to 
bind to Cu(II) in meridonal geometry. Another example of reduced Schiff base ligands of 
amino acid is N-(2 hydroxybenzyl)-a-amino acid (Figure 9) where a-amino acid are 
glycine, L-alanine and L-valine. Ternary Cu(ll) complexes of glycine, alanine and valine 
with phenanthroline were isolated and characterized [53], Copper (11) complex containing 
an axial Cu(ll)—O bond was explored to explain the nature of substrate binding at the 
active site of tyrosinase 
R = H,CH, ,CH(CH3)2 
Figure 9. Structure of reduced Schiff base ligands 
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The choice of metal ions and its oxidation state can be decisive in regulating the 
immediate in vivo response to metal- based chemotherapeutic agents. Transition metal 
ions are site selective at physiological pH and generally bind to the most accessible N7 
position of guanine in the DNA helix. They are compatible in the biological system in 
contrast to platinum based anticancer agents, which are non-specific, resulting in 
significant toxicity [54] The oxidation state of metal ion dictates particular coordination 
geometries, hence limiting appropriate binding for different ligand sets [55J. 
Among first row transition metal ions, titanium complexes viz. titanocenedichloride 
CpiTiCb, (Figure 10) which entered in phase II clinical trial show pronounced 
antitumour properties and low toxic side effects [56-57]. It was observed that this 
complex showed effectiveness against platinum resistant cell lines indicating that a new 
therapeutic option was available against ovarian cancers (Platinum based drugs were 
resistant to ovarian cancer cell lines) [58-59]. However, the complex binds only weakly 
to DNA bases and more strongly to phosphate backbone. 
Figure 10. Structure ofTilanocene dichloride 
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Cp2TiCl2 inhibits DNA synliicsis ratiier than R"NA and protein synthesis and titanium 
accumulates in nucleic acid rich regions in tumour cells after in vivo or in vitro 
administration [60-62]. 
Budotitane, which was the first nonplatinum transition metal anticancer agent to be tested 
in clinical trials, (Figure 11) is quite effective against a number of ascites tumours and 
induced colorectal tumours in animals [63]. Clinical trials indicate that it was fairly well 
tolerated by patients with the dose limiting side effects being cardiac arrhythmia [64]. In 
vitro and in vivo experiments with budotitane revealed no significant DNA damage [65], 
however, diaquo complex bind strongly to DNA [66]. 
H CH, 
Figure 11. Structure of Budotitane 
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Meta! complexes of vanadium exhibit anticancer activity tiirougii oxidative DNA damage 
or by inhibiting enzymes involved in DNA metabolism. Vanadyl sulfate and sodium 
ortho vanadate inhibit the growth of proliferative tumour cells but have little effect on 
nonproliferative cells. The cytotoxicity was enhanced when H2O2 was added [67]. 
Activity against the L12I0 murine leukemia cell line has been observed for the peroxo 
compounds (NH4)4[0(0(02):V)2], M3fO(02)2(C204)V] (M - K^ NH4^ and 
NH4[0(02)(malato)V]. Vanadyl bleomycine in the presence of H2O2 preferentially 
cleaves G-A sites in DNA by the mechanism different from that of Fe-bleomycine [68]. 
A vanadium (III) complex of cystein has also shown significant antitumour activity in 
mice [69-70], 
Iron is capable of binding to the many biological targets including DNA and to catalyze 
free radical reaction that will lead to a site-specific dam.age [71]. Iron chelated to DNA 
plays an important role in DNA damage induced by xenobiotic- derived electrophiles. 
The structural analysis of iron bound DNA complexes has major biochemical importance 
in view of the important role of iron in the oxidative stress and due to its strong affinity 
towards complexation with cell components, particularly those of nucleic acids and their 
nucleobases. 
Iron (11) complexes of phenanthroline and its derivatives are useful for construction and 
characterization of DNA binding molecules owing to their relative ease of preparation 
and their intense optical absorption [72]. DNA binding of iron (11) mixed ligand 
complexes containing phenanthroline and DIP i.e. [Fe(phen)2(DIP)] and [Fe(phen) 
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(DIP):]*^" where plien =1,10 phenanthroline and DIP = 4,7-diphcnyI-l,10-phenanthroline 
has been examined by various techniques [73J (Figure 12). The CD spectral profiles 
indicated that A enantiomer of iron (11) complex preferentially binds to DMA. The 
binding constant, hypochromicity and thermodynamic parameters of DNA binding were 
also determined. 
(a) (b) 
Ph///,, 
2+ 
Figure 12. Structure of complexes (a) [Fe(phen)2(DIP)]^' (b) [Fe(phen) (DIP)}]*' 
DNA binding and cleaving properties of the ortho, meta and para (bishydroxy) salen-Fe 
complexes were studied in view of their use as chemical nucleases (Figure 13). The para 
hydroxy salen Fe complex has been used to detect sequence specific drug-DNA 
interaction. Specific binding of Hoechst 33258 to AT sequence and chromomycin to GC 
sequence were illustrated [74]. 
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OH HO HO OH 
H0-{>O._0-HpKOH 
\ / 
Figure 13. Structure ofsalen-Fe complexes 
Cobalt complexes have received less attention in comparison to other transition metal 
complexes [75-78] although they exhibit interesting metallointercalation and DNA 
cleavage properties [79-801. Besides this, cobalt containing complexes offer an exciting 
possibility for oral delivery of a wide variety of peptide based drugs-most eftlcient 
chemotherapeutics. Currently, these peptide-based drugs arc given intravenously because 
of digestion degradation and poor absorption. They covalently bind lo the cobalt 
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containing coenzymes vitamin B12 and are readily transported from the digestive system 
to circulation via vitamin B12 transport system [81]. 
iJan-Nian Ji et al [82-84] have shown that fCo(L)2(L')r^ where L - 1,10 phenanthroline 
or 2, 2'-bipyridine, L' == 2(2-chloro-5-nitrophenyle)imidazo-[4,5-f|-1.10 phenanthroline 
(C'NOIP), 2-phcnylimida/o-[4,5-ri-l,10 phenanthroline (PIP) or 2-(2-hydroxy-5-
nitrophenyl) imidazo-[4,5-f]-l,10 phenanthroline (HNOIP) bind to DNA through an 
intercalation mode and promote photocleavage of plasmid DNA. A similar type of 
complex of dipyrido [3,2-a2, 3'c) phenazine (DPPZ) induces single strand scission of 
DNA upon irradiation at 254 nm [85]. 
Three new cobalt (II) complexes containing asymmetric ligands, [Co(bpy)2(pdtb)]^^, 
[Co(bpy)2(pdta)]^ "*" and [CofbpyjiCpdtp)]^ "" where bpy = 2,2'-bipyridine, pdtb = 3-
(pyridine-2-yl)-5,6-diphenyl-as-trizine), pdta = 3-(pyridine-2-yl)-as-trizino[5,6-fl-
acenaphthyiene) and pdtp = 3-(pyridine-2-yl)-as-trizino[5,6-f|phenanthroline) were 
synthesized and characterized [86] (Figure 14). In these complexes, bpys are used as co-
complexation ligands because they are minimally efficient to induce intercalative binding 
with DNA, which allow determination of the influence of asy^nmetric ligands on the 
interaction. The DNA binding studies indicate that size and shape of intercalating ligand 
have a marked effect on the binding affinity of the complexes involving CT DNA. 
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(a) 
- \ / ^ 
(b) 
(c) 
•3 + 7J + Figure 14. Chemical structure of (a) [Co(bpy)^(pdlb)] (b) [Co(bpy)i(pdta)] and 
(c) fCo{hpy):(pdfp)f' 
Recently, the DNA binding properties of the Co(I]I) complex of 1,3 bis (2-pyridylimino) 
isoindoline with extended aromatic ring system and 1,4,7-triazacyclononane (tacn) ligand 
were investigated (Figure 15). These complexes bind to the DNA surface with no partial 
intercalation. The difference in ligand architecture of the complexes causes different 
binding behaviour towards DNA. The intrinsic binding constant reveal that monopositive 
complex ion exhibits a DNA binding affinity lower than the tripositive complex 
+3 [Co(tacn)2] ' [87]. 
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(a) .Us. // (b) 
Figure 15. Structure of (a) 1,3 bis (2-pyridylimmo) isoindoline (b) tacn 
Copper complexes are attractive scaffold for metal based drug research as they possess 
biologically accessible redox potentials with relevant oxidation state +1 and +2. Due to 
the plasticity and participation of copper as an integral part of the active site of 
metalloproteins familiarize its coordination with the human body's functions. 
Furthermore, the copper (II) has relatively high nucleobase affinity, which enables it to 
distinguish between different forms of DNA by coordination to the electron-rich 
nucleobases. Copper (II) complexes coordinate to the N7 position of guanine [88-90] and 
are therefore, selective at the molecular target site. Thus, they have the potential for 
application in vivo as chemotherapeutic agents. This target selection and interaction can 
be further modulated by the increasing copper nuclearity and ligand structure [91-93]. 
A novel trinuclear complex CU3-L ( L = N, N, N', N, N", N"-hexak.is(2-pyridyl) 1-3,5-tris 
(aminomcthyl benzene) demonstrated a moderate binding ability for DNA. CU3-L is more 
efficient than its mononuclear analogue Cu-DPA (DPA = 2,2' - dipyridylamine) at the 
same concentration (Figure 16) [94]. Incorporation of more than one Cu(II) in a single 
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complex produced enhanced electrostatic interactions to the anionic DNA phosphate 
backbone and facilitate its binding to DNA [95-96]. The studies revealed that potential 
synergistic effect between the three or at least two Cii(ll) centers in CU3-L contributes to 
its relatively high nucleolytic efficiency . 
n 
t/? ^ . / ^ 
Cut, N ^ ^ ^ HN '-Cu" 
•N=< I V - N ' 
N ,N 
Vu 
Figure 16. Structure ofCus-L andCu-DPA 
To explore the relationship between structure and DNA binding ability of complexes a 
series of [Cu(imda)(diimine)] where Hjimda = iminodiacetic acid and diimine =1 ,10 
phenanthroline (phen), 5,6 dimethyl-1,10 phenanthroiine (5,6 dmp) and dipyrido-[3,2-
d:2',3'-f]-quinoxaline (dpq) were synthesized and characterized [97]. fCu(imda)(dpq)] 
and [Cu(imda)(phen)(H20)] are bound to DNA through partial intercalation, while 5,6 
dmp complex were involved in groove binding. The carboxylate group of Hiimda 
interacted with sugar hydroxyl groups of DNA and provided the recognition elements 
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like amine and carboxylate group of amino acids and protein moieties, tiius leading to the 
selective control of metal chelate nucleobase recognition [98]. 
J. Z. Wii et al [99] have reported the synthesis of biniiclear copper complexes [(phen)Cu 
(^ -bipp)CLi (phen)](C104)4 where phen = 1,10 phenanthroline and bipp = 2,9-bis (2-
imidazo[4,5-f][l,10] phenanthroline)-1,10-phenanthroiine (Figure 17) and its interaction 
with CT DNA by means of electronic absorption titration, luminescence studies and 
viscosity measurements were studied. The emission band of the complex decreased 
remarkably in presence of DNA and hypochromism was observed upto 18% indicating 
that complex binds to CT DNA by intercalation of the two phenanthroline copper 
terminals. 
n 4+ 
^-^ XT) 
Figure 17. Structure of [(phen)Cu(/u-bipp)Cu(phen)J 4^ 
Copper (II) complexes of tridentate ligands are limited [lOO-IOl] and they have certain 
advantages over bidentate ligands [102]. An example of tridentate ligand is imidazole 
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terpyridine (Itpy) (Figure 18). Its copper (II) complex [Cu(ltpy)2](CI04)2 is an avid 
binder and shows interaction due to the presence of extended aromatic ring system in Itpy 
1103]. 
^ ^ 
' ^ Z l^*^^:^ 
Figure 18. Structure of imidazole terpyridine (Itpy) 
Copper based reactions of DNA are particularly appealing since copper accumulates in 
tumours due to selective permeability of cancer cell membranes to copper compounds. A 
number of copper complexes have been screened for anticancer activity and some of 
them were found active both in vivo and in vitro. An antitumour copper salycylaldoxime 
(CuSAL) complex (Figure 19) induces topoisomerase (II) to form single strand nicks in 
DNA and poisoned its activity, which is a potential cellular target for a number of 
anticancer drugs [104]. 
OH 
Figure 19. Structure of CuSAL -
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Recently, A. H. Jr. et al have synthesized a new mononuclear copper (II) complex 
[Cu(HPCINOL)(CI)]Cl.MeOH of tripodal N3O ligand where HPCINOL = [l-(bis-
pyridine-2-ylmethyl-amino)-3-ciiloropropan-2-olJ, and its in vilro anlitiiinour activity 
towards human myeloid leukemia cell line has been checked. This complex promotes the 
death of THP-1 a human leukemia cells m vi/ro, inducing cell death by apoptosis 
(programmed cell death) [105], which was further confirmed by fluorescence 
microscopy, cell morphology and DNA degradation experiments. 
Zinc is the most abundant trace intracellular element and plays an important role in both 
genetic stability and function [106]. Mechanistically, zinc has a significant impact on 
DNA as a component of chromatin structure, DNA replication and transcription and 
DNA repair [107]. Zinc (II) complexes of p-isopropylbenzaldehyde and methyl 2-pyridyl 
ketone thiosemicarbazones show potent cytotoxic activity and induction of apoptosis in 
cells resistant to cisplatin [108]. 
B. Spingler et al have reported the zinc complex of l5-fluoro-l,4,7,10,13-
pentaazacyclohexadecan-14,16-dione (15-fluoro Cumac) and copper complexes of (15-
fluoro Cumac) and l5-fluoro-15methyl-l,4,7,10,13-pentaazacyclohexadecan-l4,16-dione 
(15-nuoro-15methyl-Cumac) (Figure 20). The ligand binds to metal center by triple 
coordination of secondary amine in zinc complex. The interaction of the complex with 
poly d(GC) was studied by circular dichroism, which exhibited change exclusively in the 
positive band of the spectrum while the negative band remained unaffected. These results 
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indicate tiiat the zinc complex binds to B-DNA but does not promote the transition from 
BtoZ-DNA[109]. 
R, 
Ri 
,0 
NH 
O 
NH 
.M. 
NH I NH 
NH 
2+ 
M = Zn, R|= F, R2 = H 
M =--Cii, R,= F, R: - 11 
M = Cu, R|= F, R2 = Me 
Figure 20. Structure of zinc and copper complexes of(15-fluoro Citmac) and 
(15-jhoro-1 Smethyl-Cumac) 
In another report, the interaction of genomic DMA with zinc hydroxybenzoite [Zn(H20)6] 
(p-HO-C(,H4(COO)2 2H2O) was studied by gel electrophorosis. The remarkable changes 
in intensities, brightness and mobility of the bands indicated the covalent binding mode 
of the complexes with DNA [110]. 
Twelve new amino acid derivatives of Zn(II) complexes were prepared by the reaction of 
ZnS04 and nine tetradentate ligands, glycine, alanine, valine, leucine, serine and histidine 
derivatives (Figure 21) [111]. Several Zn(I]) complexes exhibit in vitro insulinomimctic 
activity which were estimated by the inhibition of free fatty acid release in isolated rat 
adipocytes treated with epinephrine [112-113]. 
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Figure 21. Structure of teradcntate ligands derived from amino acids 
In the second transition metal series, a vast majority of DNA binding studies was 
focused primarily on ruthenium complexes due to their unique spectroscopic and 
electrochemical signature [114-116]. The ruthenium complexes have a larger impact on 
the biodistribution, the pharmacokinetics and the mechanism of action is also faster but 
these complexes are barely soluble in aqueous solution which is pre- requisite condition 
for both efficient administration and transport of the drug through living organism. 
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Figure 22. Structural scheme of the chiral Ru(II) complexes [Ru(phen):L]. L = (a) 
MCMIP (b) DZDFic) DMI1BT{(\) PHEHAT{c) 6-0HDPPZ{f) 6-NO2 DPPZ 
Nevertheless, great number of experimental and theoretical researches have been carried 
out on ruthenium complexes, in particular the chiral complexes [Ru(phen)2 L] [117-121] 
where phen =1,10 phenanlhroline and L = 2-(6-methyl-3-chromonyle imidazo [4,-5-f] 
lMO]-phenanthroline) (MCMIP), 9-diazo-4,5-diazafiuorene (DZDF), 1 !,13-dimethyl-
13H-4,5,9,l l,14-hexaaza-benzo[b]triphenylene-10,i2-dione) (DMHBT), 1,10-
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phenanthroline [5,6-b] 1,4,5,8,9,12-hexaazatriphenylene (PHEHAT), 6-hydroxyl-
dipyido [3,3-a:2\3'-c] phenazine (6-OH DPPZ), 6-nitro- dipyido [3,3-a:2',3'-c] 
phenazine (G-NOT DPPZ) as they have diverse applications e.g. DNA-structural probes, 
molecular switch, DNA-photocleavage regents [122-124] (Figure 22). Thus, modifying 
the ligand, changing substitutive group or substituent position on the intercalating ligand 
can create some interesting differences in the DNA binding properties as well as in 
physical properties, viz. solubility, crystalline nature of the complexes etc [125-126], 
The most successful ruthenium-based anticancer compound trans-[RuCl4-
(DMSO)lm][ImH] (NAMI-A) where Im = Imidazole ligands entered clinical trials [127] 
and has been rendered water soluble by using dialkyi sulfoxides [128] (Figure 23). The 
mechanism of action of this compound is not related to DNA binding; rather, it is 
antimelaslatic agents [129]. NAMl-A is active against lung metastasis in vivo and tumour 
cell invasion in vitro [130]. The solution chemistry of NAMl-A involves both loss of CI 
and DMSO. 
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Figure 23. Structure of potential ruthenium based antimetastatic agents, NAMI-A 
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Tin and organotin compounds containing electronegative atoms such as halogen atoms 
show Lewis acid character and the tin atom increases its coordination number from four 
or five, six or seven upon addition of neutral organic donor ligands [131-132]. Many 
organotin complexes exhibit excellent antitumour activity against several cancer cell lines 
[133-138]. To seek a correlation between antitumour activity and structure, it is generally 
accepted that the coordination of organic ligands facilitates transport across membrane, 
while the antitumour activity is exerted by diorganotin (IV) moiety, dissociated from the 
complexes [139-140]. Most of the antitumour drugs are DNA targeted, so the interaction 
of tin compounds with DNA and mononucleotide were extensively investigated. The 
binding ability of organotin compounds toward DNA depends on coordination number 
and nature of groups bonded to central tin atom. The phosphate group of DNA sugar 
backbones usually acts as an anchoring site and nitrogen of DNA base binding is 
extremely effective (Figure 24). 
Figure 24. Possible structure ofSn sites in phosphate bound R2Sn(IV)-DNA 
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This often results in the stabilization of the tin center as an octahedral stable species. 
Evidences for the coordination of dimethyltin (IV) cation to phosphate group of DNA or 
DNA fragments has been found both in solution and in solid state [141-142]. 
Tin complexes of amino acids and their derivatives (N protected and peptides) containing 
the carboxylic 0-Sn (IV) bond have been extensively studied because of their antitumour 
activity, enhanced reactivity and stereochemical non-rigidity [143-145], In solid state, the 
di and triorganotin (IV) amino acid compounds are readily formed in the reaction 
between the free ligand and an organotin oxide or hydroxide. FTIR and mossbauer data 
showed that organotin (IV) derivatives of glycine are N-bridged polymer. This structure 
has been confirmed crystallographically [146]. Stable six-coordinated BuiSnLA (LA = 
substituted N-phthaloyI amino acid) type complexes were prepared by the heterocyclic p-
diketones and N-phthaloyle amino acids (Figure 25). These complexes were 
characterized by various spectroscopic techniques and crytallographically. Some of these 
complexes were tested for their antimicrobial activities [147]. 
R 
H.C \ 
Bu 
\ 
SvC /,C~CH-N 
•^ N Bu 
Figure 25. Structure ofBu2SnLA. R = -4-F-C6Hr, •4-Cl-C6H4-,-4-Br-C6H4-, -CF3, R'=-
H, -CH3, -CH(Cth)2 
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A. Linden et al have reported [148] in vitro cytotoxic activity of complex 
{["Bu2Sn(LH)l20}2 where LH - p-{[(E)-l-(2hydroxyphenyl)ethylidene]amino} 
propionate, (Figure 26) which is centrosymmetric tetranuciear 
bis(dicarboxylatotetrabutyldistannoxane) complex containing a planar Sn402 core. The 
compound {["Bu2Sn(LH)]20}2 has shown pronounced cytotoxic activity against WIDR, 
M19 MEL, A498, IGROV, H226, MCF7 and EVSA-T human cell lines in comparison to 
cisplatin. These observations may be predictive of w vivo antitumour activity. 
OH 
Figure 26. Structure of LH 
A novel antitumour agents triphenyl tin benzimidazolethiol (TPT) (Figure 27a) has been 
developed by our group [149], which was far more potent than cisplatin in inducing 
apoptosis in HeLa cells. Several experiments were carried out for diagnosing the 
signaling pathway, which suggested that apoptotic effects of TPT on tumour cells were 
mediated through p-53 pathway. The up-regulation of Bak at the transcriptional level 
resulted in the release of cyto c from mitochondria to cytosol and subsequently, the 
activation of procaspases 9,3 suggested that TPT induced apoptosis signaling proceeds by 
an intrinsic mitochondrial pathway (Figure 27 b). 
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Figure 27. (a) Structure of triphenyj tin benzimidazolethiol (TPT) (b) The dose 
dependent response of HeLa cells towards different molar concentration of TPT or 
cisplatin after 24 hours of treatment was measurement by MTT assay 
In another report, the compounds [C2H5Sn(TAML )^C5H5N] and 
[C2H5Sn(TAML'')C5H5N] where TAML = tetraazamacrocycl ic ligand (Figure 28) were 
synthesized and characterized by IR, 'H, '^C, "^Sn NMR and X-ray crystal data. These 
complexes displayed effective antitumour activity [150]. 
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Figure 28. Proposed structure of the complexes X = 1, 2, 3 or 4, R = CH3/C2H5 
32 
Beyond choosing the correct metal ions for particular applications, the key to synthesize 
metal-based pharmaceutical agents is searching a suitable ligand. Ligand modification in 
geometry size, hydrophobicity, planarity and the charge and hydrogen bonding ability of 
the complexes may lead to spectacular changes in binding modes, location, affinity and 
provide the chance to explore various valuable conformations or site specific DNA 
probes and potential chemotherapeutic agents [151]. Ligands can ensure protection of 
tissues from toxic metal ion or in a contrasting strategy, enhance uptake of 
pharmacological beneficial metal ion [152]. Ligands also serve in a traditional 
coordination chemistry capacities of modifying reactivity and/or substitutional inertness. 
Transition metal complexes of macrocyclic ligands are found to be very versatile 
complexes due to their potenfial medicinal application [153], cancer diagnosis and 
treatment of tumours [154]. The preference for the macrocyclic complexes over other 
ligand metal system is motivated by some exceptional features [155] viz. ease of 
synthesis, relatively small size, excellent kinetic and thermodynamic stability of their 
metal complexes and biocompatibility in living system. Direct synthesis of macrocycles 
often results in very low yield of the desired product so, many synthetic routes of 
macrocyclic ligands involve the use of the metal ion template to orient the reacting 
groups of linear substrate in the desired conformation for the ring to close [156]. 
Pendant groups in macrocycles are used to tune the selectively of the metal complexes, 
enforcing specific oxidation states and coordination geometry [157]. Assembling 
architecture bearing chiral functionality constitutes a de novo synthetic strategy as it 
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enhances selective binding of the complexes to molecular target [158]. The use of 
optically active amino acids in metal template reactions was also reported [159] as not 
only Ihcy impart chirality into the molecules but also they are effective in the cleavage of 
DNA in the presence of ascorbate and hydrogen peroxide. G.A. Lawrance et al [160] 
iiave reported metal directed synthesis of a chiral pendant arm hcxaamine macrocyle 
derived from an amino acid. 1,3-phenyl propane-1,2 diamine (dapp) was prepared by a 
three step synthesis based on L-phenylalanine and characterized. 
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NH N H ; K 
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Scheme 2. Synthetic route of macrocyclic (2,10-diphenyl-6,]3-dimethyl-6,13-dinitro-
1,4,8,1 l-tetraazacyclotetradecane)copper(Il) complex and acyclic (5-methyl-5-mtro-l,9-
diphenyl-3,7-diazanonane-l,9-diamine) copper (II) complex 
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The reaction of [Cu(dapp)2] with formaldehyde and nitroethane in basic condition 
yields small amount of the macrocyclic complex ion (2,10-diphenyl-6,13-dimethyl-6,13-
dinitro-1,4,8,1 l-tetraazacyclotetradecane)copper(ll) (Scheme 2). However, acyclic (5-
methyl-5-nitro-l,9-diphenyl-3,7-diazanonane-l,9-diamine) copper (II) complex was also 
obtained as major product due to the presence of cis/trans isomer of bis (diamine) copper 
complex. Macrocyclic and acyclic product were separated by cation exchange 
chromatography. 
The macrocyclic Cu (II) complexes of the formula [Cu(L')]Cl2, [Cu(L^)]Cl2, [Cu(L^)]Cl2, 
[Cu(L )^]Cl2 and [Cu(L )^](C104)2 where (L' = 3,10-bis(2-methylpyridine)-l,3,5,8,10,12-
hexaazacyclotetradecane,L = 3,10-bis(2-propionitrile)-l,3,5,8,10,12 hexaazacyclotetra-
decane, L'' = 3,10-bis(2-hydroxyethyl)-l,3,5,8,10,12 hexaazacyclotetradecane, h^ = 3,10-
bis(2-benzyl)-l,3,5,8,10,13-hexaazacyclotetradecane and L^  = 2,6,9,13 tetraparacyclopha-
ne) (Figure 30) interacted with DNA in different binding modes and exhibited effective 
nuclease activities [161-162]. The functional groups on the side chain of macrocycles 
play a key role in deciding the mode and extent of binding of Cu complexes to DNA. 
Therefore, extensive studies using different structural macrocycles to evaluate and 
understand the factors that determine mode and mechanism of the binding interaction of 
macrocyclic transition metal complexes with DNA are neccassary. Absorption and 
fluorescence spectroscopic studies, cyclic voltammetry and viscosity measurements were 
used for the interaction of these macrocycles with CT DNA [161-162]. 
35 
^V-cn , -
H/ \ H 
-N N V 
. a ( ^ N — C H j — / N 
-N N ^ 
ICULV"^ 
H/ \ H 
"^ ^ / 
ICuL^I-" 
'CN 
H/ \ H 
- N N 
- N N ^ 
'OH 
ICULY"" 
U>-^2C-
H O H -
N - C H 2 - < 0 
ICuL'p^ 
[CntT 
Figure 30. Chemical strucliires of the macrocydic copper (II) complexes 
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On addition of CT DNA, all the macrocyclic complexes except lCu(L-^ )] Cb show 
decrease in molar absorptivity (hypochromism) oYthe LMCT absorption band as well as 
red shift (Figure 31). The complex [Cu(L )^]Cl2 exhibits an increase in molar absorptivity 
(hyperchromism) with no shift. 
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Figure 31. Absorption spectra of (a) fCuL'jCh (b) fCuL-JCh (c) [CuL^JCh in the 
absence (...) and presence (—) of increasing amounts of DNA 
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These observations suggest that copper complexes of L' , L'* and L^  ligand bind to DNA 
through partial intercalation by providing an aromatic moiety present in the side chain 
attached to macrocycle or within the macrocycle to overlap with the stacking base pairs 
of DNA helix. On the other hand, complexes [Cu(L )^]Cl2 and [Cu(L^)]Cl2 lack any fused 
aromatic ring to facilitate intercalation rather they possess -NH and OH groups, which 
form hydrogen bonding with the base pairs of DNA. 
Furthermore, binding constant (Kb) were also determined for copper complexes of L , L 
and L^  as 2.1 x 10^  M'', 4 x 10^  M"' and 7.8 x 10^  M"', respectively. The difference in 
binding constants of the three complexes to DNA further support that the functional 
groups on the side chains of macrocycle play a key role in deciding the mode and extent 
of binding of complexes to DNA. 
Competitive ethidium bromide binding study was employed to understand the mode of 
DNA interaction of [Cu(L')]Cl2, [Cu(L )^]Cl2 and [Cu(L )^]Cl2 complexes. The addition of 
the complexes to DNA pretreated with EthBr causes appreciable reduction in emission 
intensity, indicating that the complexes compete with EthBr in binding to DNA (Figure 
32). The quenching constants Ksv were determined by Stern-Volmer equation. The 
values for the copper complexes L , L and L are 1.34, 0.74 and 0.39, respectively. 
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Figure 32. Emmision spectra of EB bound to DNA in the absence (...) and presence (—) 
of the (a) fCuL'jCh(b) [CuL'JCh (c) [CuL^JCh 
Cyclic voltammetry is the most effective and versatile electroanalytical technique 
available for the mechanistic study of redox systems [163]. Complexes [Cu(L )]Cl2, 
[CLI(L'')]C12 show irreversible redox behaviours with low Ipc/Ipa values while [Cu(L )^]Cl2 
exhibits reversible CV. Redox potential of the complex follow the trend [Cu(L')]Cl2 
>[Cu(L^)|Cl2 >[Cu(L^)]Cl2 illustrating the ability of the hexaazamacrocycles to stabilize 
the CLi(l) state. The more decrease of the peak current for complex [Cu(L^)]Cl2 than that 
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of [Cii(L )^]Cl2 suggest the stronger binding affinity complex [Cu(L')]Cl2to DNA (Figure 
33). 
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Figure 33. Cyclic voltammogram of [CuLJCU in the absence (—) and in presence (inner 
line) of DNA 
Viscosity measurements were also carried out to understand the binding mode of the 
complexes [Cu(L')]Cl2, [Cu(L )^]Cl2 and [Cu(L )^]Cl2 with CT DNA. In presence of 
[Cu(L'^ )]Cl2 there is no obvious effect on the relative specific viscosity CT DNA whereas 
complexes fCu(L )]Cl2 and [Cu(L")]Cl2 decrease the viscosity of DNA. The decrease in 
viscosity may be explained by a binding mode, which produced bends or kinks in DNA 
(Figure 34). 
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Figure 34. Effect of increasing amounts oflCul'jCh (J^) [CuL^JCh (o) [CuL^JCh (*)on 
the relative specific viscosity ofCTDNA 
Circular dichroism is an extremely appropriate technique to monitor the DNA structure 
and its modification upon interaction with metal complexes in solution. The CD spectrum 
of CT DNA exhibits a positive band at 275 nm due to base stacking, and a negative band 
at 245 nm due to the helicity of B DNA. CD titration poly d(GC) with copper complexes 
[87] of 15-fluoro-15-methyl-l,4,7,10,13, pentaazacyclohexadecan-14,16-dione (15 
fluoro-15 methyl Cumac) and 15 fluoro-1,4,7,10,13-pentaazacyclohexadecan-14,16-
dione (15 fluoro-Cumac) induced a complete B-Z DNA transition (Figure 13). The 
degree of cooperativity of 15 fluoro-15 methyl Cumac and 15 fluoro Cumac was found to 
be 7.3 and 3.4, respectively. 
Figure 35. Circular dichroism spectra of poly d(GC) after the addition of (15 fluoro-15 
methyl Citmac) (—) and (15 fluoro-Cumac) (--) 
This remarkable difference was due to additional methyl group of 15 fluoro-15 methyl 
Cumac, which involved in a hydrophobic interaction with the DNA (Figure 35). 
Metal complexes that have ability to bind DNA effectively under physiological 
conditions are suitable candidates to be investigated both in vitro and in vivo against 
cancer cells. Based on the excellent DNA binding behaviour, a new designer bimetallic 
compound triphenyl tin benzimidazolethiol copper chloride (TPT-CuCb) (Figure 36) 
have been studied for its effect on the regulation of apoptosis in HeLa cells, MCF-7 cells 
and in vivo Wister rat model [164]. Treatment of HeLa cells with TPT-CuCh rescued the 
accumulation of p-53 from the suppression of human papilloma virus E6, resulting in a 
dramatic up- regulation of Bax and Bak and down-regulation of antiapoptotic factor 
shown to mediate in a p-53 dependent manner. Moreover, TPT-CuCN induced apoptosis 
was also mediated through an intrinsic mitochondrial pathway (Figure 37). Furthermore, 
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caspase-3 was found to be indispensable in TPT-CuCia triggered apoptosis signaling 
pathway. 
H .CI, 
Figure 36. Structure ofTPT-CuCh 
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Figure 37. 7b/a/ cellular proteins were prepared for analysis ofp53, p21/WAF,Bax and 
Dak by Wastern blotting. Tubulin was used as an internal control to ensure the equal 
loading 
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Present Work 
The design of small molecules that can interact with DNA represents a tremendously 
important area of bioinorganic chemistry. The introduction of chirality in such small 
molecules leads to the targeting of specific DNA sites by matching the shape, symmetry 
and functionalities of transition metal complexes to that of the DNA target. The present 
work stems from the potential use of chiral complexes in the field of genomics, drug 
design/delivery and DNA probes. 
The ligand framework plays significant role in muting the toxicity of the metallodrug as 
well tailored multifunctional ligands offer exciting possibilities by providing appropriate 
anchoring sites for the metal ion, matching the structural motif at the molecular target and 
restricting the geometry. A biologically significant benzimidazole derivative 1, 2-Bis(lH-
benzimidazole-2yl)- ethane-1,2-diol, which acts as chiral facially tridentate ligand has 
been tethered to ethylenediamine, 1,10 phenanthroline and L - tryptophan in presence of 
metal chlorides to achieve novel chiral metal complexes. The binding of copper 
complexes with CT DNA have been studied by UV/vis, cyclic voltammetry, circular 
dichroism and viscosity measurements. The results suggest that complexes bind to DNA 
covalently, which was further confirmed by the interaction studies of copper complex 
with DNA bases viz. guanine, adenine and thymine. 
Chiral metallated macrocycles are of interest owing to their importance in biological 
system and their utility as novel probes of nucleic acid structure and sites. To study the 
influence of chirality in hexaazamacrocycles, chiral facially coordinating tridentate ligand 
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was capped to the [1, 8-dihydro-l, 3, 6, 8, 10, 13-hexaazacyclotetradecane Cu(ll)/Ni(ll)] 
diperchlorate. This approach is unique as it restricts the geometry to pentacoordinate and 
provides stereoselective specific interaction at the target site. Besides this, it also helps to 
induce chirality in achiral macrocyclic moiety. Comparative DNA binding studies of 
chiral and achiral copper complexes by various techniques viz. absorption titration, 
fluorescence spectral studies, cyclic voltammetry, viscosity measurements and circular 
dichroism have been performed. 
The binding of the heterobimetallic complexes with DNA increases manifold in 
comparison to monometallic complexes. The discriminating power of transition and 
nontransition metal ions Cu/Sn and Cu/Zr have been utilized in the synthetic strategy as 
literature supports that copper has a tendency to bind covalently to N7 of guanine 
nucleobase while Sn/Zr prefers te bind to phosphate backbone of DNA helix. Based on 
the rationale of dual effect metal pair, a novel series of chiral trinuclear complexes [Bis 
(aquodiaminotryptophanato) Cu(ll)-Sn2(lV)]chloride and their Ni analogues were 
synthesized and characterized by various spectroscopic techniques. The kinetic, 
viscometric and electrochemical behaviour of representative copper complexes 
LC26H36NK06CuSn2]Cl2 and [C28H4oN806CuSn2]Cl2 towards guanine and CT DNA were 
studied to understand the mechanistic approach of binding to a target molecules. 
Another set of chiral trinuclear complexes were synthesized by the reaction of [Bis(l,2-
diaminobenzene)copper/zinc(ll)] chloride and tin/zirconium tetrachloride followed by the 
addition of L-tryptophan. DNA binding studies of copper complexes were carried out by 
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electronic absorption titration, fluorescence titration, cyclic voltammetry, circular 
dichroism and viscometric measurements. Complex [C23H3iN606CuSn2Cl4]CI, which 
exhibits high binding alTinily under physiological condition, is a suitable candidate to be 
investigated in against cancer cells. Thus, in vitro antitumour studies of complex 
|C2iM3iN(,()6CuSn2Cl.i]Cl have been carried out on SY5Y cells. Western blot analysis of 
whole cell lysates and mitochondrial fractions with Bcl-2 and p-53 family proteins and 
caspase-3 colorimetry assay were also carried out on a human neuroblastoma cell line 
SY5Y. 
CHAPTER II 
Experimental 
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CHAPTER II 
EXPERIMENTAL METHODS 
The following techniques were employed: 
1. Characterization techniques 
1.1 Infrared spectroscopy 
1.2 Ultra-violet and visible spectroscopy 
1.3 Nuclear magnetic resonance spectroscopy 
1.4 Electron paramagnetic resonance spectroscopy 
1.5 Mass spectroscopy 
1.6 Molar conductance measurements 
1.7 Polarimetry 
2. DNA binding studies 
2.1 Cyclic voltammetry 
2.2 Absorption spectral studies 
2.3 Fluorescence spectral studies 
2.4 Circular dichoric spectral studies 
2.5 Viscometry studies 
3. In vitro antitumour studies 
3.1 Cell counting 
3.2 MTT assay for cell viability 
3.3 Western blot analysis 
3.4 Caspaso-3 colorimetric assay 
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1. Characterization techniques 
1.1 Infrared spectroscopy 
The infrared spectroscopy is a useful technique to characterize a compound. It results 
from transition between vibrational and rotational energy levels. IR region of the 
electromagnetic spectrum covers a wide range of wavelength from 200 to 4000 cm' . It 
has been found that in IR absorption, some of the vibrational frequencies are associated 
with specific groups of atoms and remain same irrespective of the molecules in which the 
group is present. These are called characteristic frequencies |I65J and their constancy 
results from the constancy of bond force constants from molecule to molecule. The 
important observation that the IR spectrum of a complex molecule consists of 
characteristic group frequencies makes IR spectroscopy, unique and powerful tool in 
structural analysis. 
1.2 Ultraviolet and visible spectroscopy 
When a molecule absorbs radiation, its energy is increased. This increased energy is 
equal to the energy of the incident photon expressed by the relation 
E = hv 
E = he / ^ 
where h is Planck's constant, v is the frequency, X is the wavelength of the radiation and 
c is the velocity of light. Most of the compounds absorb light in the spectral region 
between 200 and 800 nm resulting in the excitation of electrons of the molecules from 
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ground state to higher electronic states. In transition metals, all the five'd' orbitals viz. 
dxy, dyz, dxz, dz and dx'^ -y^  are degenerate. However, in coordination compounds due to the 
presence of ligands, this degeneracy is destroyed and d orbitals split into two groups tjg 
(dxy, dyz and dxz) and Cg (dz' and dx^ -y") in an octahedral complex and t and e in a 
tetrahedral complex. The set of tjg orbitals goes below the original level of degenerate 
orbitals in octahedral complexes and the case is reversed in tetrahedral complexes (Figure 
38 a, b). At energy higher than the ligand field absorption bands, 
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Figure 38 (b). Ligand field splitting of a tetrahedral complex, 'g' subscript is omitted in 
Tj symmetry 
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we commonly observe one or more very intense bands that go off scale unless log s is 
plotted. These are the charge transfer bands, corresponding to electron transfer processes 
that might be either ligand -^ metal (L -> M) or metal -> ligand (M -^ L). M -^ L 
transitions occur for metal ion complexes that have filled, or nearly filled, t^ g orbitals with 
ligands that have low lying empty orbitals. These empty orbitals are ligand n* orbitals in 
complexes such as those of pyridine, bipyridine, 1,10-phenanthroline, CN", CO and NO. 
Figure 39 shows overlap of a tig metal orbital and ;:* of CO. 
Ni — C = 0 : Ni = C = 0 
Valence bond representation 
(u) (b) 
= 0 C = 0 
Molecular orbital 
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(0 
Figure 39 Melal carbon double bonding 
The L —> M charge-transfer (C-T) spectra have been studied more thoroughly. The 
intense bands are for Laporte-al lowed transitions commonly of the/? (ligand) -^ f^ '(metal) 
type. The ionization energy for the ligand (or its ease of oxidation) as well as the 
oxidation state and electron configuration of the metal (or its ease of reduction) 
determines the energy of the transition. No net oxidation-reduction usually occurs, 
because of the short lifetime of the excited stale [166]. 
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1.3 Nuclear magnetic resonance spectroscopy 
The nuclei of certain isotopes possess a mechanical spin or angular momentum. The 
NMR spectroscopy is concerned with nuclei having nuclear spin quantum number 
I = 1/2, example of which include 'H, '^C, ^ 'P, "^Sn and ''^ F. 
For a nucleus with I = 1/2, there are two values for the nuclear spin angular momentum 
quantum number mi = ±1/2 which are degenerate in the absence of a magnetic field. 
However, in the presence of the magnetic field, this degeneracy is destroyed such that the 
positive value of mi corresponds to the lower energy state and negative value to higher 
energy state separated by AE. 
In an NMR experiment, one applies strong homogeneous magnetic field causing the 
nuclei to presses. Radiation of energy comparable to AE is then imposed with radio 
frequency transmitter equal to precision or Larmor frequency and the two are said to be 
in resonance. The energy can be transferred from the source to the sample. The NMR 
signal is obtained when a nucleus is excited from low energy to high energy state. 
1.4 Electron paramagnetic resonance spectroscopy 
EPR spectroscopy [167] is the branch of absorption spectroscopy in which radiation 
having frequency in the microwave region is absorbed by energy levels of electrons with 
unpaired spins. The magnetic energy splitting is done by applying a static magnetic field. 
For an electron of spin S = 1/2, the spin angular momentum quantum number will have 
values of Ills = ±1/2. In absence of magnetic field, the two values of nis i.e. +1/2 and -1/2 
5! 
will give rise to a doubly degenerate spin energy state. If a magnetic field is applied, this 
degeneracy is lifted and leads to the non-degenerate energy levels. The low energy level 
will have the spin magnetic moment aligned with the field and correspond to the quantum 
number ms = -1/2. On the other hand, the high energy state will have the spin magnetic 
moment opposed to the field and correspond to the quantum number m^  = +1/2. 
1.5 Mass spectroscopy 
At electron beam energy of about 9 to 15 electron volts, depending on the molecule 
involved, a molecular ion is formed by interaction with the beam electrons. Recognition 
of the parent ion (actually a radical ion) is of great importance because it gives the 
molecular weight of the sample [168]. At this point, the molecular weight is an exact 
numerical molecular weight not the approximation obtained by the all other molecular 
weight procedures. Mass spectra is usually obtained at an electron beam energy of 70 
electron volts and under these conditions numerous fragment ions (including the parent 
ions) versus their relative concentrations constitutes the mass spectrum of the samples. 
The fragmentations occur on the basis of mass/charge (m/z). The largest peak in the 
spectrum is called base peak and assigned a value of 100%. The other peaks are reported 
as percentage of the base peak. 
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1.6 Conductance measurements 
The conductivity measurement is one of the simplest and easily available techniques used 
to study the nature of the complexes. It gives direct information regarding whether a 
given compound is ionic or covalent. For this purpose, the measurement of molar 
conductance (Am), which is related to the conductance value in Ihe following manner is 
made. 
cell constant x conductance 
An 
concentration of solute expressed in mol cm"'' 
Conventionally, solutions of 1x10" M strength are used for the conductance 
measurements. Molar conductance values of different types of electrolytes in a few 
solvents are given as, 1:1 electrolyte has a value of 80-115 ohm"' cm^ mol'' in MeOH, 
65-90 ohm"' cm^ mol"' in DMF, 78-80, 50-70 ohm"' cm^ mol"' DMSO and 35-45 ohm"' 
cm^ mol' in EtOH [169- 170]. Similarly a solution of 2:1 electrolyte has a value of 
160-220 ohm"' cm^ mol"' in MeOH, 130-170 ohm"' cm^ mol"' in DMF and 70-90 ohm"' 
cm" mol"' in EtOH. 
1,7 Poiarimetry 
Optical isomerism manifests itself by the rotation that certain molecules impart to the 
plane of polarized light when in gaseous, liquid or molten state or in solution (Figure 40). 
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This rotation is observed and measured by a rather simple instrument, known as 
polarimeter. The specific rotation [a] of a dissolved substance is given by the expression 
a [a] = 
Ixc 
where a is the observed rotation in degrees 
1 is the path length of the sample in decimeters 
c is the concentration in grams per milliliter 
The dependence on wavelength and temperature is indicated by subscripts and 
superscripts respectively. Thus [ajo^^ means the specific rotation at 25° C measured at 
the wavelength of the sodium D line. 
Optical rotation is generally measured using light Irom a sodium-vapour lamp, which 
gives essentially monochromatic radiation (the yellow sodium D line is a doublet at 5890 
and 5896 A**). A beam of light is polarized by passage through nicol prism (the polarizer), 
PDiarizcci 
V ^ 
Koteted 
polari/w) lighl 
Figure 40. Rotation of plane of polarized light by optically active compounds 
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which consists of two calcite prisms cemented together so that only one of the two rays 
formed by double refraction is transmitted. The beam of polarized light passes through 
the solution and then through a second nicol prism. When no optically active material is 
placed between the prisms (O" rotation), the prisms are positioned at right angles so that 
no light is transmitted. When an optically active material is placed between the prisms, 
the analyzer must be turned in order to maintain the darkness in the field of view. The 
optical rotation is the angle by which the analyzer is turned in order to reach darkness. It 
is very difficult to determine by eye the setting for complete darkness, because positions 
near the completely dark position are very dark. Therefore, many instruments are 
constructed such that the field of view is divided into two equal parts, and the analyzer is 
adjusted so as to equalize the light intensity in each half of the field. 
2. DNA binding studies 
CT DNA was procured from Sigma Chemical Company and tris base was obtained from 
E. Merck. All the experiments involving interaction of the complexes with CT DNA were 
conducted in buffer containing tris (0.01 M) adjusted to pH 7.2 with hydrochloric acid. 
The CT DNA was dissolved in tris-HCl buffer and was dialyzed against the same buffer 
overnight. Solutions of CT DNA gave ratios of UV absorbance at 260 and 280 nm above 
1.8, indicating that the DNA was sufficiently free of protein [171]. DNA concentration 
per nucleotide was determined by absorption spectroscopy using the molar absorption 
coefficient 6600 dm^ mof' cm'' at 260 nm [172], The stock solution was stored at 4°C. 
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2.1 Cyclic voltammetry 
Cyclic voltammetry involves the measurement of current-voltage curves under diffusion 
controlled, mass transfer conditions at a stationary electrode, utilizing symmetrical 
triangular scan rates ranging from a few millivolts per second to hundred volts per 
second. The triangle returns at the same speed and permits the display of a complete 
polarogram with cathodic (reduction) and anodic (oxidation) waveforms one above the 
other. Two seconds or less is required to record a complete polarogram [173]. 
Consider the reaction 
0 + ne • R (i) 
Assuming semi-infinite linear diffusion and a solution containing initially only species O. 
With the electron held at a potential Ei where no electrode reaction occurs. The potential 
is swept linearly at v v/sec so that the potential at any time is 
E(t) = Ei-vt 
or Epeak = E°-0.0285 
The rate of electron transfer is so rapid at the electrode surface that species 0 and R 
immediately adjust to the ratio according to the Nernst equation, which is as follows., 
Co(0,t) = Co* - [nFA(7rDo)''']-' J I(7r)(t-T)-"' dx (ii) 
1 = nFACo*(7rDoCT)''- x (a t) (iii) 
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Redox (electron-transfer) reactions of metal complexes can be investigated by cyclic 
voitammctry. An electrode is immersed in a solution of the complex and voltage is swept 
while current flow is monitored. No current flows until oxidation or reduction occurs. 
After the voltage is swept over a set range in one direction, the direction is reversed and 
swept back to the original potential. The cycle may be repeated as often as desired. 
Figure 41 shows the cyclic voltammograms (CV) for a reversible one-electron redox 
reaction such as, 
CpFe(CO)LMe • CpFe(CO)LMe^ + e' 
Sweeping the potential in an increasing direction oxidize the complex as the anodic 
current f, flows; reversible reduction of CpFe(CO)LMe'^  generates cathodic current Ic on 
the reverse sweep. The magnitude of the current is proportional to the concentration of 
the species being oxidized or reduced. 
The measured parameters of interest on these cyclic voltammograms are Ipa/Ipc the ratio 
of peak currents, Epa - Epc the separation of peak potentials and the formal electrode 
potential E". For a Nernstian wave with stable product, the ratio Ipjlpc = I regardless of 
scan rate, E" and diffusion coefficient, when Ipa is measured from the decaying current as 
a base line. The difference between Epa and Epc (AEp) is a useful diagnostic test of a 
Nernstian reaction. Although AEp is slightly a function of E", it is always close to 
2.3RT/ nF. 
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Figure 41. (a) Cyclic potential sweep (b) Resulting cyclic voltammogratn 
The technique yields information about reaction reversibilities and also offers a rapid 
means of analysis for suitable systems. The method is particularly valuable to study 
interaction of metal ions to DNA as it provides a useful compliment to other methods of 
investigation, such as UV/vis spectroscopy. Cyclic voltammetric studies were 
accomplished on a CH Instrument Electrochemical analyzer using a three-electrode 
configuration comprised of a Pt wire as the auxiliary electrode, a platinum micro-cylinder 
as the working electrode and Ag/AgCl as the reference electrode. Supporting electrolyte 
for the experiments was 0.4 KNO3. Electrochemical measurements were made under 
nitrogen atmosphere. All electrochemical data were collected at 298 K and are 
uncorrected for junction potentials. 
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2.2 Absorption spectral studies 
In a closed constant volume system, the rate of a chemical reaction is defined as the rate 
of change of the concentration of any of the reactants and products with time. The 
concentration can be expressed in any units of quantity per unit volume e.g. moles per 
liter, moles per cuhic centimeter. The rate will he defined as positive quantity regardless 
of the component whose concentration change is measured. 
The rate of a chemical reaction is not measured directly instead the concentration of one 
of the reactants or products is determined as a function of time. A common procedure for 
determining the reaction order is to compare the experimental results with integrated rate 
equations for reactions of different orders. For a first order rate equation, integrating by 
separate variables using integration limits such that at t = 0, c ^ CQ and at t = t, c = c. 
[174]. 
-dc/dt = kc 
or In (CQ/C) = kt 
The intrinsic binding constant Kb of the complex to CT DNA was determined from Eqn. 
(1), through a plot of [DNA]/ea-Sf vs. [DNAJ, where [DNA] represents the concentration 
of DNA, and Ea, £f, and Cb the apparent extinction coefficient (Aobb/[M]), the extinction 
coefficient for free metal complex (M), and the extinction coefficient for the free metal 
complex (M) in the fully bound form, respectively. In plots of [DNA]/ea-Sf vs. [DNA], 
Kb is given by the ratio of slope to intercept [175]. These absorption spectral studies were 
performed on USB 2000 Ocean Optics spectrometer. 
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[DNAI ^ [DNA] , _ ! (1) 
Ea-Sf Sb-sr Kb(eb-ef) 
2.3 Fluorescence spectral studies 
When molecules that have absorbed light are in a higher electronic state, they must lose 
their excess energy to return back to the ground state. If the excited molecule returns to 
the ground state by emitting light, it exhibits fluorescence and spectrum thus obtained is 
called emission spectrum, This phenomenon is generally seen at moderate temperature in 
liquid solution. The emission spectrum is obtained by setting the excitation 
monochromator at the maximum excitation wavelength and scanning with emission 
monochromator. Often an excitation spectrum is first made in order to confirm the 
identity of the substance and to select the optimum excitation wavelength. Further 
experiments were carried out to gain support for the mode of binding of complexes with 
CT DNA. Non fluorescent or weakly fluorescent compounds can often be reacted with 
strong fluorophores enabling them to be determined quantitatively. On this basis 
molecular fluorophore EthBr was used which emits fluorescence in presence of CT DNA 
due to its strong intercalation. Quenching of the fluorescence of EthBr bound to DNA 
were measured with increasing amount of metal complexes as a second molecule and 
Stern-Volmer quenching constant K was obtained from the following Eqn. [176] 
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lo/I = l+Kr (2) 
where r is the ratio of total concentration of complex to that of DNA and lo and 1 are the 
fluorescence intensities of EthBr in the absence and presence of complex. Emission 
intensity measurements were carried out using Hitachi F-2500 spectrofluorometer at 
room temperature. 
2.4 Circular dichoric spectral studies 
Circularly polarized light represents a wave in which the electrical component spirals 
around the direction of propagation of the ray, either clockwise or counterclockwise. 
Within the absorption band, the molar absorptivity for right and left handed circularly 
polarized light is different, that is (Ed-Si) 7^  0. This effect changes linearly polarized light 
into elliptically polarized light and is known as circular dichroism. 
When a substance near an absorption band absorbs left circularly polarized light, the 1 
component, more strongly than the right circularly polarized light, the d component, i.e. 
£i > Ed then the amplitude of d component will be greater than the 1 furthermore, if £d > E| 
then the d component will be retarded more than the 1 component (Figure 42). 
The ellipticity, that is the angle whose tangent is ratio of minor axis of the ellipse OB to 
the major axis OA, is denoted by 0. The molecular ellipticity [0j can be shown by the 
relationship [177]. 
[6] = 3305 (£, - Ed) 
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Figure 42. Elliptically polarized light produced when rjip-rji and ei>£d 
Circular dichroism graphs are plots of [0] against wavelength. Circular dichoric spectra 
were obtained on JASCO J-715/J-710 CD spectropolarimeter at 25*^ C. 
2.5 Viscometry studies 
The hydrodynamic changes are the consequence of the change in length of the molecule, 
the diminished bending between layers and the diminished length-specific mass. 
Viscosity measurements were carried out using Ostwald's viscometer at 29±0.01°C. Flow 
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time was measured with a digital stopwatch. Each sample was measured three times and 
an average flow time was calculated. Data were presented as (ri/rio) versus binding ratio 
([M1/[DNA1), [178-179] where T) is a viscosity of DNA in the presence of complex and 
r)() is the viscosity of DNA alone. Viscosity values were calculated from the 
observed flow time of DNA containing solution (t >100s) corrected for the flow time of 
buffer alone (to), r| = t- to 
3. In vitro antitumour studies 
Cell Culture 
SH-SY5Y human neuroblastoma cell line 
SH-SY5Y cells were obtained from the American Type Culture, collection was 
maintained in DMEM supplemented with 10% FBS, antibiotic-antimycotic (1 ml/100ml), 
non-essential amino acid (Iml/lOOml) and glutamine (2.5ml/100ml). Incubation was 
performed at 37''C in a humidified atmosphere, with 5% CO2 in the air. 
PC-12 rat pheochromocytoma cell line 
PC-12 cells were maintained in DMEM supplemented with 10% horse serum, 5% fetal 
calf serum, and antibiotic-atimycotic (Iml/IOOml). Incubation was performed at 37° C in 
a humidified atmosphere, with 5% CO2 in the air. 
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3.1 Cell counting 
The cells were plated in a 24 well plate at a density of 2.5 x 10^  ceils per well. 
Approximately 800|j,l of medium was added to each well and the plate was kept in the 
incubator. After about 24 hours the cells were serum starved for 12 hours and various 
concentrations of complex were added in duplicates to the plate. After 24 hours of 
incubation the cells were counted with haemocytometer. A graph of the number of live 
cells vs. compound concentration was plotted [180]. 
3.2 MTT assay for cell viability 
The internal environment of proliferating cells is more reduced than that of non-
proliferating cells. This reduced state can be measured using tetrazolium salts. Most 
frequently used salt is MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoiium), 
which is a water soluble tetrazolium salt and has been used in models for screening 
cytocidal chemical agents. MTT is converted to an insoluble purple formazan by 
cleavage of the tetrazolium ring by the dehydrogenase enzymes (Figure 43). This water 
insoluble formazan can be solubilized with DMSO or HCl/ isopropanol and the dissolved 
material is measured spectrophotometrically yielding absorbance as a function of 
concentration of converted dye. The cleavage and conversion of the soluble yellow dye to 
the insoluble purple formazan is used as an assay for the measurement of cell 
proliferation. Active mitochondrial dehydrogenases of the living cells will cause this 
conversion. Dead cells do not cause this change [181]. 
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Figure 43. Molecular structures of MTT and its reaction product Formazan 
Preparation of whole cell lysates and mitochondrial fraction 
Preparation of total cell lysates and mitochondrial fractionation of cells into membrane 
and cytosolic fractions used for detection of cyto c were performed according to the 
methods described earlier [164,182,183]. 
Protein estimation 
Quantitative determination of the protein content in each well was estimated by Pierce 
BCA protein assay, which is a highly sensitive method of determination of total protein 
content in dilute aqueous solutions. In this method, the lysates diluted with corresponding 
lysis buffer were treated with 50|.d of Reagent A and l|.d of Reagent B for 30 minutes. 
Then the optical density at 570 nm was monitored, which is proportional to the total 
protein content and the number of cells in each well. This reagent system utilizes BCA as 
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a detection reagent for Cu ,^ which is formed when Cu ^ is reduced by protein in alkaline 
environment. The purple coloured reaction product is formed by chelation of two 
molecules of BCA with one cuprous ion. This water soluble complex exhibits strong 
absorbance at 570 nm that is linear with increasing protein concentrations. 
Protein + Cu'* • Tetradentate-Cu* complex 
Cu"^  complex + BCA • BCA-Cu"*^  complex 
(Purple colour) 
3.3 Western blot analysis 
The method of transferring or blotting a pattern of separated proteins from the gel onto a 
sheet of PVDF membrane is called western blotting. Transfer of proteins from the gel to 
PVDF can be achieved either by capillary blotting or by electroblotting [184]. The 
transferred proteins are bound to the surface of the membrane, providing access for 
reaction with immunodetection reagents. This involves probing the blot, usually using an 
antibody to detect the specitic protein. For this an indirect detection method is used in 
which the blot is first incubated with a primary antibody added first to bind to the 
antigen, will block all remaining hydrophobic binding sites on the PDVF membrane. The 
blot is then incubated in a dilution of a labeled secondary antibody that is directed against 
the primary antibody (Figure. 44). 
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Figure 44. A. In the direct detection method, labeled primary antibody binds to antigen 
on the membrane and reacts with substrate creating a detectable signal. B. In the indirect 
detection method, unlabeled primary antibody binds to the antigen. Thus a labeled 
secondary antibody binds to the primary antibody and reacts with the substrate 
This IGg molecule will bind to the blot if it detects the antigen, thus identifying the 
protein of interest. The primary antibody is conjugated with the enzyme horseradish 
peroxidase, which uses H2O2 as its substrate. The detection of horseradish peroxidase 
oxidizes the luminol with concomitant production of light, the intensity of which is 
increased 1000 fold by the presence of a chemical enhancer. The light emission can be 
detected by exposing the blot to a photographic film. 
3.4 Caspase-3 colorimetric assay 
Activation of caspases initiates apoptosis in mammalian cells [185]. The assay is based 
on spectrophotometric detection of the chromophore p-nitroanilide (pNA) after cleavage 
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from the labeled substrate DEVD-/?NA. The/7NA light emission can be quantified using 
a microtiter plate reader at 405 nm. Comparison of the absorbance ofjcNA from an 
apoptotic sample with an uninduced control allows determination of the increase in 
CPP32 activity. 
CHAPTER III 
Binding Studies of Asymmetric Pentacoordinate 
Copper(ll) Complexes Containing Phenanthroline, 
Ethylenedlamine and L-Tryptophan Ligands with 
Adenine, Thymine, Guanine and Calf-Thymus DNA 
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C H A P T E R III 
Experimental 
Reagent grade chemicals were used without further purification for all synthesis. 
NiCii.61120, CUCI2.2H2O, cthylenediamine, adenine, tartaric acid (E. Merck), 
C0CI2.2H2O (BDH), 1,10 phenanthroline monohydrate (CDH), thymine, guanine (Sigma 
Chemical Co.), i, 2-diamino benzene (Loba Chemie) and L-tryptophan (Lancaster), were 
used as received. IR spectra (KBr pellets) were recorded on an Interspec 2020 FTIR 
spectrometer. The 'H and '^ C NMR spectra were obtained at 300 MHz on a Bruker DRX-
300 spectrometer. Microanalyses were performed on Carlo Erba analyzer model 1108. 
UV/vis spectra were recorded on a USB 2000 Ocean Optics spectrometer in methanol 
and the data were reported as A-max/nm. Specific rotations [a]D of the complexes were 
measured on a polarimeter Rudolf Autopol III at 20 °C at the sodium D line in a 1 dm 
tube containing methanolic solution. EPR spectra of the copper complexes were recorded 
on a Varian E 112 spectrometer at X-band frequency (9.1GHz) at room temperature and 
liquid nitrogen temperature. Molar conductances were measured at room temperature on 
a Digisun electronic conductivity bridge. All voltammetric experiments were performed 
in single compartmental cells at 25 °C with H20/MeOH (95:5) and 0.4M KNO3 as a 
supporting electrolyte. Solutions of adenine and thymine were prepared in double 
distilled water (pH 5.2) while the solution of guanine was prepared in phosphate buffer 
(pH2). 
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Synthesis of I, 2-Bis(lH-benzimidazole-2yl)- ethane-1, 2-diof 
[C,f, H,4N402l (L) 
The ligand L was prepared according to the procedure reported earlier [186], which is 
described below (Scheme 3). 
1, 2-diaiTiinobenzene (4.32 g, 40 mmol) and L (+) tartaric acid (3.00 g, 20 mmol) were 
dissolved in 50 ml of 4M hydrochloric acid. The solution was refluxed for 24 hours. 
After cooling a brown compound (the chloride salt of the protonated ligand) crystallized 
from the dark brown solution. The crystals were filtered and redissolved in 150 ml water 
and 150 ml ethanol. After adding active carbon, the solution was heated to reflux for 2 
hours. The colourless solution was neutralized with concentrated ammonia and white 
precipitate was filtered. 
QC .NH2 COOH -OH + H-C 4MHC1 NH2 H O - i - H 
COOH 
1,2-diamino benzene L (+) Tartaric acid 
Scheme 3 
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Synthesis of [l,2-Bis(lH-benzimidazole-2yl)- ethane-l,2-diol (ethylenediamine) 
metal (11)1 chloride 
[C,8H2,N602CU]C1 
To a soiution of copper chloride dihydratc (1.71 g, 10 mmol) in MeOH (50 ml), 
ethylenediamine (0.67 ml, 10 mmol) was added slowly in 1:1 molar ratio. A blue product 
was obtained in solution and to the above product in solution was added a solution of L 
(2.94 g, 10 mmol) dissolved in the mixture of EtOH (40 ml) and water (10 ml) dropwise 
under stirring at room temperature until complete dissolution. A blue solution resulted, 
that was slowly evaporated. After 5 days amorphous green product was obtained, that 
was washed thoroughly with n-hexane, filtered and dried in vacuo , 
(C,8H2,N602NilCI 
To a solution of nickel chloride hexahydrate (2.37 g, 10 mmol), ethylenediamine (0.67 
ml, 10 mmol) was added slowly in 1:1 molar ratio. A blue solution was obtained and to 
the above solution, ligand L (2.94 g, 10 mmol) dissolved in the mixture of EtOH (40 ml) 
and water (10 ml) was added dropwise under stirring at room temperature. A deep blue 
solution resulted and the pH of solution was adjusted to 8-9 with aqueous NaOH solution. 
The colour of the solution turned to green and was left at room temperature for slow 
evaporation. After 6 days amorphous light green product was obtained, which was 
washed thoroughly with n-hexane, filtered and dried in vacuo. 
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Synthesis of [l,2-Bis(lH-benziniidazole-2yl)- ethane-l,2-dio! (1, 10 phenanthroline) 
metaJ (II)] chloride 
[C28H2,N602CU]CI 
1,10 phenanthroline (1.98 g, 10 mmol) dissolved in methanol was treated with copper 
chloride dihydrate (1.71 g, 10 mmol). A green product was obtained. The ligand L (2.94 
g, 10 mmol) dissolved in EtOH (40 ml) and water (10 ml) was added to the above 
reaction mixture at room temperature and stirred until complete dissolution. The green 
coloured solution was left for slow evaporation. After 4 days light green product was 
isolated which was washed with hexane and dried in vacuo . 
[CzsHi.NeOjCoJCl 
To a methanolic solution of cobalt chloride dihydrate (2.37 g, 10 mmol) was added 1,10 
phenanthroline (1.98 g, 10 mmol). The solution was stirred and ligand L (2.94 g, 10 
mmol) dissolved in EtOH (40 ml) and water (10 ml) was added with constant stirring. 
The dark pink solution was allowed to slow evaporation. After 3 days brown precipitate 
was formed, which was filtered, washed with hexane and dried in vacuo. 
ICisHz.NfiOzNilCl 
To a solution of nickel chloride hexahydrate (2.37 g, 10 mmol), I. 10 phenanthroline 
(1.98 g, 10 mmol) was added slowly in 1:1 molar ratio. The ligand L (2.94 g, 10 mmol) 
dissolved in the mixture of EtOH (40 ml) and water (10 ml) was added to resulting blue 
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solution dropwise under stirring at room temperature. The pH of solution was adjusted to 
8-9 with aqueous NaOH solution. The colour of the solution turned to green and was left 
at room temperature for slow evaporation. After 4 days amorphous light green product 
was obtained, which was washed thoroughly with n-hexane, filtered and dried over fused 
CaClz. 
Synthesis of [l,2-Bis(lH-benzimidazole-2yl)- ethane-l,2-diol (L-tryptophanato) 
metal (II)] chloride 
(C27H22N6O4CU] 
Copper chloride dihydrate (1.70 g, 10 mmol) and L-tryptophan (2.04 g, lOmmol) were 
dissolved in 100 ml of methanol. The pH of reaction mixture was adjusted 8-9 by adding 
NaOH. A solution of ligand (2.94 g, 10 mmol) in the mixture of water and ethanol (1:4) 
was added to the above reaction mixture. The green coloured solution was heated for 2 
hours and left for slow evaporation. After 4 days dark green amorphous product was 
obtained, which was filtered, washed with hexane and dried in vacuo. 
[C27H22Nf,04Ni] 
To a methanolic solution of nickel chloride hexahydrate (2.37 g, 10 mmol) was added 
L-tryptophan (2.04 g, 10 mmol) dissolved in methanol. The resulting blue solution was 
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treated with aqueous NaOH until pH 8-9 was reached. A solution of ligand (2.94 g, 10 
mmol) in EtOH (40 ml) and H2O (10 ml) was added to the green coloured solution. The 
reaction mixture was heated for 4 hours and left for slow evaporation at room 
temperature. After 5 days light green compound was isolated, washed with hexane and 
dried in vacuo. 
Results and discussion 
The synthesis of the ligand was a straightforward Phillips condensation reaction and the 
complexes were prepared by the coordination of ligands to the central metal ion via 
nitrogen and oxygen donor atom. Nitrogen atoms participate through the coordinate 
linkages, while oxygen atom is involved in coordination under release of HCI. The 
complexes conform to the composition LML' where L = l,2-Bis(]H-benzimidazole-2yl)-
1,2-ethanediol, M = Co(II), Ni(II), Cu(II) and L' = 1,10 phenanthroline or 
ethylenediamine or L-tryptophan as proposed in the structure (Scheme 4) and shown in 
the ball and stick, model (Figure 45). Evidently, the central metal ion acquires square 
pyramidal geometry in all the complexes. The complexes [Ci8H2iN602Cu]CI, 
|C,gH2iN602Ni]CI, [C28H2iN602Cu]CI, [C2sH2iN602Ni]Cl and [C2sH2iN602Co]Cl are 
ionic in nature while [C27H22N6O4CU] and [C27H22N604Ni] are non-electrolyte. All the 
complexes are optically active as established by their circular dichoric spectra and 
polarimetry. The important properties and physical data of the complexes are shown in 
Table-1. 
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(a) 
n^aciiSis^sc'-^^ 
(b) 
P ^ 
(c) 
Figure 45. Ball stick models of complexes (a) [C18H21N6O2MJCI (b) [C28H2iN602M]Cl 
(C) [C27H22N6O4M] 
76 
IR spectra 
IR spectrum of the free ligand L displays a characteristic 'D(O-H) band at 3497 cm"' 
|i87|. A medium intensity band at 1585 cm"' lias been assiyncd to u(C^N) of the 
imidazole ring [188] and a characteristics \)(N-H) stretching vibration appears at 3180 
cm"'. Other frequencies D{C-N) and i)(C-0) appear at 1317 cm ' and 1267 cm"', 
respectively. In all the complexes u(O-H) stretching vibration disappears with the 
emergence of a new peak in the region of 3479-3491 cm"' confirming the coordination of 
the metal ion through oxygen of one of the alcohol group of the ligand while other is 
uncoordinated. Furthermore, ^(C^N) of imidazole group undergoes a negative shift of 
8 cm"'. The shift in IR frequencies after the coordination of metal ion indicates the 
involvement of nitrogen atom in the formation of complexes. These data also support the 
contention that the ligand is tridentate with N, O, N donor sets. The IR spectra of 
complexes [CigHiiNeOzCuJCI, [CigHjiNfANiJCl, [C27H22N6O4CU] and [C27H22N604Ni] 
show T)(NH2) at 3275-3285 cm''. Symmetric and antisymmetric t)(COO) vibrations at 
1610 and 1395 cm'', respectively were also observed for complexes of L-tryptophan 
[189]. The bands observed due to \)CNH2) and •u(COO) in complexes [C27H22N6O4CU] and 
[C27H22N604Ni] are lower in comparison to free amino acid suggesting that amino acid 
binds to metal ion in bidentate manner. Other medium intensity bands have been assigned 
to D(C-C) and D(C-N) at 1300-1400 cm"' and u(Ar) at 700 cm"'. The far IR spectra of the 
complexes reveal \)(M-0) and \)(M-'N) stretching vibration in the range of 420-432 cm" 
\ / 
and 525-534 cm' , respectively confirming the square pyramidal environment around the 
metal ion (Table 2). 
EPR spectra 
The solid state X-band EPR spectra of copper complexes acquired at room temperature 
and LNT have been found to be anisotropic exhibiting two peaks (Figure 46). The EPR 
signals of [C,8H2iN602Cu]Cl, [C28H2iN602Cu]CI and [C27H22N6O4CU] at room 
temperature with gi = 2.02-2.04, g||= 1.96-1.98 exhibit an inverse gi >g||~ge pattern with 
unresolved hyperfme coupling indicating a {dz'}' ground state for the complexes 
implying trigonal bipyramidal geometry around the Cu(Il ) ion [190]. This is inconsistent 
with the results of other spectral studies. 
JL 
2000 3000 
HG 
4000 
Figure 46. X-band EPR spectra of complex [C2SH21N6O2CUJCI at room temperature 
(curve a), at LNT(curve b) 
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Upon exposure to LNT, the EPR spectra of complexes [Ci8H2iN602Cu]Cl, 
[C28H2iN602Cu]Cl and [C27H22Nf,04Cu] result a large change in coordination geometry, 
as reflected by the 'g' values g (|= 2.16-2.21, gi = 2.02-2.06 and ge = 2.0023 , which are 
different from the 'g' values observed at room temperature. Since g||>g_L^ge is indicative 
of a {dx^ -y^ }' or {dz^}' Cu(II) ion, this pattern is consistent with Cu(Il) ion in a distorted 
square pyramidal geometry [191]. Such transformations in EPR spectral features on 
changing the recording condition, with variations in g values suggest that they are crystal 
spectra rather than a true molecular spectra [192]. 
NMR spectra 
The ligand L and complexes [Ci8H2iN602Ni]CI, [C28H2iN602Ni]Cl and [C27H22N604Ni] 
were further characterized by 'H NMR and '^ C NMR spectroscopy. 'H NMR spectrum of 
the ligand L recorded at 300 MHz at room temperature reveals (0-H) protons at 6.1 ppm 
and aromatic proton signals at ca. 7.1-7.2 ppm respectively. '^ C NMR spectrum of the 
ligand exhibits 5c (C=N). Ar-C and (C-H) at 154, 129-134 and 66.2 ppm, respectively. 
'H NMR of [Ci8H2iN602Ni]CI, [C28H2iN602Ni]Cl and [C27H22N604Ni] complexes have 
several interesting features compared to that of free ligand (Table 3). 'H NMR spectrum 
of the ligand exhibits a characteristic signal at ~ 6.1 ppm, [193] which is ascribed to the 
free OH group. On complexation, this signal disappears suggesting that OH group is 
coordinated to metal center by the elimination of one molecule of HCI, However, another 
signal appears at 5.8 ppm, which shifts slightly in the complexes indicating that one of 
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the OH group is uncoordinated and is involved in iiydrogen bonding with the anions and 
solvents. Other resonances in metal complexes appear at -8.5, 4.8 and 7.1 - 7.5 ppm for 
(N-H), (C-H) and Ar protons, respectively. There is a slight shift in these resonances in 
complexes to the resonances in comparison to those of the free ligand recorded under the 
same conditions. The 'H N M R spectra of complexes [CixH2iN602Ni]Cl, and 
[C27H22N604Ni] also exhibit a signal at -5.2 ppm due to the presence of primary amine. 
"C NMR spectra is in well agreement with 'H NMR spectra and show the signals at 
130-136, 50.7 and 156.5 ppm for (Ar-C), (C-H) and (C=N) groups respectively. The low 
field signal for C=N indicates the coordination of nitrogen to metal center. In addition 
complex [C27H22N604Ni] also shows the (COO) carbon at 170 ppm (Table 4). 
Electronic spectra 
Electronic spectra for complexes [Ci8H2iN602Cu]Cl, [C28H2iN602Cu]Cl and 
IC27H22N6O4CU] recorded in ethanol at 25 '^ C show prominent broad band at 589 nm, 
720 nm and 690 nm, respectively ascribed to d-d transition, which are followed by strong 
bands at 232-278 nm in UV region assigned to intraligand transitions. These results are 
typical of square pyramidal copper (II) complexes [105, 194, 195J with nitrogen donors, 
which generally exhibit a single band between 585 to 750 nm (dxz, dyz-* dx2-y2)- In 
contrast, trigonal bipyramidal copper (II) complexes usually show a maximum at > 800 
nm (dxy, dx2-y2 ~^dz') with a higher energy shoulder(dx2, dy^^dz"). The broad band at 589 
nm, 720 nm and 690 nm in the complexes [Ci8H2iN602Cu]Cl, [C2sH2iN602Cu]Cl and 
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[C27H22N6O4CL1], respectively further confirm the square pyramidal geometry as deduced 
by EPR spectral studies at LNT. The complex [C27H22N6O4CU] shows an additional band 
at 362 nm, which is attributed to ligand to metal charge transfer transition. 
The UV/vis spectrum of [C28H2iN602Co]Cl recorded in ethanol displays a similar d-d 
transition at ca. 505 nm and strong bands in UV region at 256 and 371 nm, which is in 
good agreement with square pyramidal environment of the Co(II) ion [196]. 
The complexes [Ci8H2iN602Ni]Cl, [C28H2!N502Ni]Cl and [C27H22N604Ni] exhibit d-d 
band at 600 nm, 630 nm and 620 nm, respectively assigned to ^Bi(F) -^ E^ (F) and 
B|(F) -^ A2, E(P) transition [197]. The X^ax values are consistent with a 
pentacoordinate environment around Ni(II) ion. The spectra also show strong LMCT 
bands in 320-360 nm region. 
Electrochemistry 
The cyclic voltammogram of copper complexes were recorded in MeOH/H20 (5:95) at 
298 K at a scan rate of 0.2 Vs'' in the potential range 1.6 to -1.2 V. The CV of complex 
[C|gH2iN602Cu]Cl in absence of CT DNA exhibits a quasireversible redox wave for one 
electron transfer process corresponding to Cu(II)/(I) redox couple with E = -54 mV and 
AEp value of 61 mV. The AEp value is slightly larger than Nernstian value observed for 
one electron transfer couple. Large peak width for one electron couple Cu(Il)—>Cu(I) in 
these complexes is a common observation [173]. This clearly indicates considerable 
reorganization of the coordination spheres during electron transfer regardless of the 
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precise mechanism. The ratio of the anodic and cathodic peal< currents Ipa /Ipc is ~1 
implying qiiasireversible electron transfer. At different scan rates, the voltammogram 
does not show any major change. Keeping all the parameters constant (T = 298 K, scan 
rate 0.2 Vs'', potential rangel.6 to -1.2) CT DNA of 6 x 10'' M concentration was added 
to complex [Ci8H2iN(j02Cii]CI (c = 0.1 x 10'^  M) which experiences a shift in E1/2 value 
as well as in AEp value (Figure 47). The ratio of Ipa/Ipc^ ^ 1-35 for the CT DNA bound 
complex, which suggests that the adsorption of the Cu(l) product tends to be suppressed 
in the presence of CT DNA [197]. 
0.8 O.i 0 
Potentiol/V 
-0.4 -1,2 
Figure 47. Cyclic voltammogram at a scan rale 0.2 Vs' in MeOH/H20 (5:95) of free 
complex [CisH2/Nc02Cu]Cl (ciir\>e a) and complex [CisHiiNiOjCujCl in presence of 
CT DNA (curve h) 
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lairlliciilhc shift in E"aiid AE,, values with increase in \^J\^,^ values suggest that complex 
fCi8H2iN602Cu]Cl is strongly bound to DNA. 
The CV of complex [C28H2iN602Cu]CI reveals one electron quasireversible redox wave 
Cu(ll)/Cu(]) with E"=-53 mV and AEp= 54 mV values. The ratio of anodic to cathodic 
current is ~1 suggesting the reversibility of the process. On addition of CT DNA of 
c = 6 X 10"^  M, the CV of complex [C28H2iN602Cu]CI shows a shift in yi^^ ratio 
(Ipa/lpc =0.684, a shift of 0.32) AEp= 56 mV (Figure 48) at the same parameters [198]. 
0.8 0.4 
Potenl io l /V 
Figure 48. Cyclic voltammogram at a scan rate 0.2 Vs' in MeOH/H^O (5:95) (a) the 
complex fC2sH2jN602CuJCl (b) the CT DNA bound complex [C2dhiN602Cu]Cl 
The complex [C27H22N6O4CU] display a quasireversible cyclic voltammetric response 
assigned to the Cu(II)/Cu(l) couple at AEp= 44 mV and E° = 52 mV (Figure 49). On 
addition of CT DNA, complex exhibit large shift in AEp (37 mV) and E" (53 mV) values 
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in comparison to complex [Ci8H2iN602Cu]Cl and [C28H2iN602Cu]Cl. The decrease in 
0 in the presence of CT DNA suggest that the adsorption of CLI(I) is enhanced in 
the presence of CT DNA. The Ipa/Ipc ratio of complex [C28H2iN602Cu]CI is in contrast 
to the Ipa/lpc ratio of the complex [CisHoiNeOoCuJCI and [C27H22N6O4CU] which 
increases in the latter case however, all the copper complexes bind strongly to CT DNA 
either by stabilization of Cu(ll) species over Cu(l) or Cu(I) species over Cu(II) species. 
Our interpretation is in fairly good agreement with observation of Palaniandavar et al 
[199] 
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Figure 49. Cyclic voltammogram at a scan rate 0.2 Vs'' in MeOH/H^O (5:95) of the 
complex [C27H22N6O4CU] (curve a) and the CT DNA bound complex fC27H2jN604CuJ 
(curve b) 
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Interaction studies with DNA 
The interaction of copper complexes with CT DNA was investigated using absorption 
spectra. The absorption spectra of copper complexes exhibit IL n-^ n* transition at 232-
278 nm. Fixed amounts (0.83 x 10"^  M) of complexes were titrated with the increasing 
amount ol'CT DNA (1.6-4.1 x 10"^  M) and the electronic spectral Uaces of complexes are 
shown in Figure 50-52. 
300 too 500 
Wavelength t nm) 
600 
Figure 50. Absorption spectral traces of complex [C18H21N6O2CUJCI in Tris HCl buffer 
upon addition ofCTDNA. Inset: Plots of [DNA]/ Sa-Sfvs. [DNA] for the titration ofCT 
DNA with complexes •, experimental data points; full lines, linear fitting of the data 
On addition of CT DNA, the absorption spectra of complexes [Ci8H2iN602Cu]CI, 
[C28H2iN602Cu]CI and [C27H22N6O4CU] exhibit hyperchromism [94, 200] with a red 
shift of 2-6 nm in IL transitions. The hyperchromic effect and hypochromic effect are the 
spectral features of DNA concerning its double-hetix structure [201]. Therefore, the 
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observed hyperchromicities on addition of these complexes reflect strong structural 
damage, which is probably due to strong binding of the complexes to DNA nitrogen 
bases through covalent bond formation by utilizing the sixth vacant position of the 
coordination sphere of the metal ion [202]. 
^•^r K(3 = 1 5 1 X 1 0 ' ' M - 1 
1 2 -
2 3 4 
CDNADXIO"5M 
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Figure 51. Absorption spectral traces of complex [C2sH2iN602Cii]Cl in Tris HCl buffer 
upon addition of CT DNA. Inset: Plots of [DNA]/ Sa-Sfvs. [DNA] for the titration of CT 
DNA with complexes •, experimental data points; full lines, linear fitting of the data 
To study the binding affinity of the copper complexes with CT DNA, the intrinsic 
binding constants Kb of complexes were determined using Eq. 1 [175] by monitoring the 
changes in absorbance in IL bands with increasing concentration of DNA. The intrinsic 
binding constant Kb of complexes [CigHiiNeOaCujCl, [C28H2iN602Cu]Cl and 
[C27H22N6O4CU] were obtained as 1,57 x lO'' M"', 1.51 x 10^  M"' and 1.3 x 10^  M'', 
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respectively [203]. The Kb values indicate that the complexes [Ci8H2iN602Cu]CI and 
[C28H2iNfi02Cu]CI moderately bind to CT DNA with almost same affinity while complex 
[C27H22N6O4CU] unambiguously reveal the strong association with CT DNA due to the 
presence of L-tryptophan moiety (Figure 52). 
0 0 
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Figure 52. Absorption spectral traces of complex [C27H22N0O4CU] in Tris HCl buffer 
upon addition ofCTDNA. Inset: Plots of [DNA]/ Sa-Sj vs. [DNA] for the titration ofCT 
DNA with complexes •, experimental data points; full lines, linear fitting of the data 
The side chains of amino acid have a potential to recognize the specific base sequence 
through hydrogen bond formation with the nucleic bases in DNA and facilitate the 
binding of complex with DNA [33, 204]. However, Kb values are smaller than classical 
intercalators and metallointercalators whose binding constants were in order of 
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10^  M'' [205]. Therefore, it is proposed that complexes bind to CT DNA through covalent 
bond formation. 
In order to gain support for the covalent binding of the copper complexes involving 
possibly Nv guanine coordination, the interaction of complexes [Ci8H2iN602Cu]CI, 
[C28H2iN602Cu]CI and [C27H22N6O4CU] with DNA bases guanine, adenine and thymine 
were investigated using electronic absorption spectral technique. Addition of guanine to 
the complex [C27H22N6O4CUI results in an increase in absorbance at 690 nm (d-d band) 
with a blue shift of 40 nm (Figure 53). 
5.0 r 
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Figure 53. Absorption spectra of complex [C27H22N6O4CU] (6 x 10" M) (curve a), on 
interaction with adenine (curve b), thymine (curve c), guanine (curve d) and CT DNA 
(curve e) 
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Figure 54. Absorption spectra of complex [C1SH21N6O2CUJCI (6 x 10''' M) (curve a), on 
interaction with adenine (curve b), thymine (curve c), guanine (curve d) and CT DNA 
(curve e) 
Q.20 
500 600 700 
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Figure 55. Absorption spectra of complex [C2sH2iN602Cu]Cl (6 x 10''' M) (curve a), on 
interaction with adenine (curve b), thymine (curve c), guanine (curve d) and CT DNA 
(ciin'e e) 
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However, on addition of guanine to the complexes [Ci8H2iN602Cu]Cl and 
[C28H2iN602Cu]CI, a red shift of 10 nm with hyperchromism at 589 nm and 720 nm, 
respectively was observed (Figure 54 and 55). The interaction of copper complexes with 
adenine and thymine exhibited relatively small hyperchromic changes in absorbance 
intensity with 2-4 nm shift in wavelength. These spectral changes reveal that the 
complexes have stronger binding affinity towards guanine in comparison to thymine and 
adenine. This preference for guanine is substantially large and display specificity of the 
copper complex to bind to N7 position of guanine [206, 207], which is purine nucleobase. 
The complexes show preference for guanine due to two effects. When adenine binds, 
only a weak hydrogen bond is formed between the chloride ligand of the complex and 
NH2-C6 group of adenine; secondly, a significant stronger molecular orbital interaction is 
identified in guanine in comparison to adenine. The presence of electron withdrawing 
0x0 group at the Ce position of the purine ring lowers the energy of the lone-pair orbital 
at N7 of purine base. Our results are consistent with earlier reports by Lippard et al on 
preferencial binding to N7 position of guanine in the cisplatin type of complexes [207]. 
Further, it is remarkable that the changes in the intensity and wavelength of the d-d 
transition observed for all the copper complexes bound CT DNA and its bases follows the 
trend [C27H22N6O4CU] > [Ci8H2iN602Cu]Cl ~ [C28H2iN602Cu]Cl indicating that 
[C27H22N6O4CU] complex binds strongly to CT DNA in comparison to 
[C,8H7,N602Cu]Cl and [C28H2iN602Cu]CI complexes. 
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Circular dichroism 
The circular dichoric spectra of complexes [Ci8H2iN602Cu]CI and [C27H22N6O4CU] in 
MeOH at room temperature exhibit a strong positive cotton effect around 254 nm (Figure 
56 a and c). On the other hand, the complex [C28H2iN602Cu]Cl, shows a positive rise at 
287 nm and negative band at 298 nm in UV region as shown in Figure 56 b, while in 
visible region complex [C28H2iN602Cu]CI shows a strong positive cotton effect around 
650 nm. A positive signal at 287 nm is also observed in complex [C27H22N6O4CU]. 
To study the binding behaviour of the complexes with CT DNA, particularly the 
structural and conformational changes occurring in DNA on addition of chiral complexes, 
the CD technique is extremely appropriate. The circular dichoric spectrum of CT DNA in 
the UV region exhibits a positive band at 273 nm due to base stacking and negative band 
239 nm due to helicity of DNA [199] (Figure 57). Addition of copper complexes causes 
significant and distinct spectral perturbation of the CD spectrum of CT DNA. In presence 
of complex [Ci8H2iN602Cu]Cl, the peak position shifts from 273 to 282 nm with a 
decrease in positive ellipticity, while the intensity of negative ellipticity band decreases 
remarkably with no shift (Figure 58 a). For complex [C28H2iN602Cu]CI, the CD 
spectrum undergoes a shift in peak position similar to complex [Ci8H2iN602Cu]CI with a 
decrease in positive and negative ellipticity bands (Figure 58 b). 
(a) 
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Figure 56. Circular dichoric spectra of complexes (a) [CisH2iN602Cu]Cl (b) 
[C2sH2iNr,02Cii]Cl (c) [C27H22N6O4CU] 
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Figure 57. Circular dichoric spectra ofCTDNA alone 
When the CD response was obtained for CT DNA bound to complex [C27H22N6O4CU], 
highest decrease in positive ellipticity with shift in band position from 273 to 284 
complex was observed in comparison to complex [CisH2iN602Cu]CI and 
[C28H2iN602Cu]Cl, which is consistent with the highest DNA binding constant observed 
for it (Kb = 1.3 X 10') (Figure 58 c). These results support that significant Cu(ll) 
complex-CT DNA interaction takes place [208] and the binding of complexes with CT 
DNA induces certain conformational conversions within the DNA molecule [209]. 
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Figqre 58. Circular dichoric spectra of (a) CT DNA in presence of complex 
[CISH.JNGOJCUJCI (b) CTDNA in presence of complex [Cj&H.iI^eOjCuJCl (c) CX TMk 
in presence Q{lC2iU22^b04Cii]. [DNA] ^3x 10"'M 
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Viscosity studies 
To support the binding mode of metal-DNA interaction, viscosity measurements are quite 
useful and more accurate [210]. Satyanarayana et al have elucidated vividly that in 
classical intercalation model DNA helix lengthens as base pairs are separated to 
accommodate the bound ligand leading to increased viscosity values of DNA. In contrast, 
a partial non-classical intercalation of ligand causes a kink in the DNA helix and reduces 
the length and its viscosity [210, 211]. 
The interaction of complex [Ci8H2iN602Cu]Cl, [C28H2iN602Cu]Cl and [C27H22N6O4CU] 
with CT DNA decreases the relative viscosity of CT DNA with increasing concentration 
of the copper complexes (Figure 59). However, the extent of decrease for complex 
[C27H22N6O4CU] is more in comparison to [Ci8H2iN602Cu]Cl and [C28H2iN602Cu]CI 
These results support that all the copper complexes bind to CT DNA covalently but with 
different affinity [212]. 
0.05 0.15 
l/R(=[Cu]/[DNA]) 
0.25 
Figure 59. Effects of increasing amount of complex [CisH2iN60iCiiJCl ( '), complex 
[CjsHjjN^OjCuJCl (A) and [C27H_vN60^CiiJ (m) on the relative viscosity of CT DNA at 
29 ± 0. l"C. [DNA]=5 x 10'^ M. 
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Conclusions 
In summary new chiral transition metal complexes were synthesized and characterized by 
various physicochemical techniques. Tethering two biologically significant DNA 
moieties, ethylenediamine / 1,10 phananthroline/ L-tryptophan with benzimidazole ligand 
complements and tunes the DNA-binding affinity of copper complexes by providing 
unique structural similarity to the biological target at the molecular level. The complexes 
display significant selectivity for binding with N? guanine bases of DNA, facilitated by 
H-bonding between NH2 group of ethylenediamine and exocyclic oxygen of guanine. 
Similarly, in case of tryptophan the possibility of the complex coordinating through 
covalent mode increases significance due to the molecular specificity. The intrinsic 
binding constants Kb for complex [C27H22N6O4CU] is higher than other analogous 
complexes [Ci8H2iN602Cu]Cl and [C28H2iN602Cu]Cl, revealing the strong binding 
affinity of complex containing L-tryptophan. There was significant perturbation in the 
CD spectrum of CT DNA in presence of copper complexes suggesting the strong 
conformational changes in the DNA helix. Higher binding affinity together with strong 
conformational changes reasonably support the transformation of B-DNA into A-like 
conformation. 
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CHAPTER IV 
Chiral and Achiral Macrocyclic Copper (II) Complexes: 
Synthesis, Characterization and Comparative Binding 
Studies with Calf-Thymus DNA 
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CHAPTER IV 
Experimental 
Nickel chloride hexaiiydrate, copper chloride dihydrate, ethylenediamine, tris-base, L (+) 
tartaric acid, formaldehyde (E. Merck) and 1,2-diaminobenzene (Loba Chemie) were 
used as received. All reagents grade compounds were used without further purification. 
Specific rotations [ajo of the complexes were obtained on a Rudolf Autopol HI 
polarimeter at 20 C at the sodium D line in a 1-dm tube containing the complex 
dissolved in DMSO. Molar conductance was measured at room temperature on a Digisun 
Electronic Conductivity Bridge. Fourier-transform IR (FTIR) spectra were recorded on 
an Interspec 2020 FTIR spectrometer, as KBr pellets. The NMR spectra were obtained on 
a Bruker DRX-300 spectrometer. The solid state EPR spectra of the copper complexes 
were acquired on a Varian E 112 spectrometer using X-band frequency (9.1GHz) at 
liquid nitrogen temperature. Carbon, hydrogen and nitrogen contents were analyzed on a 
Carlo Erba Analyzer Model 1108. UV/vis spectra were recorded on a USB 2000 Ocean 
Optics spectrometer and the data were reported as X a^x/nm. All voltammetric experiments 
were performed in single compartmental cells at 25*^ 0 with H2O/DMSO (95:5) and 0.4 M 
KNO3 as a supporting electrolyte in the potential range of 1.6 to -1.2 V. 
Synthesis of 1, 2-Bis(lH-benzimidazole-2yl)- ethane-l,2-diol [C|6 H14N4O2J (L) 
The ligaiid L was prepared according to the procedure reported earlier [186], which is 
described in scheme 3. 
Synthesis of [l,8-dihydro-l,3,6,8,10,13-hexaazacyclotetradecane metal (II)] 
diperchlorate 
[C8H22N(,CU](CI04)2 
The synthesis was carried out by the method reported earlier [213] (Scheme 5). 
To a stirred methanolic solution (50 ml) of CUCI2.2H2O (1.70 g. 10 mmol) were slowly 
added ethylenediamine (1.34 ml, 20 mmol), 37% formaldehyde (3.00 ml, 40 mmol) and 
25% ammonia (1.00 ml, 20 mmol). The resulting mixture was relluxed for ca. 24 hours 
until a dark blue solution appeared. This solution was cooled at room temperature and 
filtered under vacuum. Excess pci'chloric acid in methanol was added to the filtrate and 
the mixture was kept in refrigerator for 24 hours. The purple-red crystals were separated, 
washed thoroughly with methanol, dried in vacuo and recrystallized from acetonitrile. 
IC8H22Nr,Ni](CI04)2 
Ethylenediamine (1.34 ml, 20 mmol) was added to the stirred methanolic solution of 
nickel chloride hexahydrate (2.37 g, 10 mmol) followed by the addition of 37% 
fornialdchyde (3.00 ml, 40 mmol) and 25% ammonia (1.00 ml, 20 mmol). The resulting 
mixture was refluxed for ca. 24 hours until a dark orange solution resulted. The solution 
was cooled at room temperature and filtered under vacuum to remove nickel hydroxide. 
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Excess perchloric acid in methanol was added to the filtrate and the mixture was kept in 
the refrigerator. The yellow crystals, which separated out, were washed thoroughly with 
methanol and dried in vacuo. The crystals were recrystallised from acetonitrile. 
Synthesis of [1,2 Bis (lH-benzimidazol-2yl) 1-(1, 8 dihydro 1,3,6,8,10,13 
hexaazacyclotetradecane) 2-hydroxy ethanolate metal (II)] perchlorate 
IC24 H35N,„02CuIC104 
The ligand L (2.94 g, 10 mmol) dissolved in the 50 ml methanol was mixed to an 
aqueous solution of complex [C8H22N608Cu](C104)2 (4.63 g, 10 mmol) in 1:1 molar 
ratio. To the resulting deep blue solution was added aqueous NaOH (0.40 g, 10 mmol) 
drop wise with constant stirring and the reaction mixture was heated to reflux for 1 hour. 
A dark green amorphous product was obtained in a solution, which was filtered, washed 
with hexane and dried in vacuo (Scheme 6). 
[C24H35N,o02Ni]C104 
Macrocyclic complex [C8H22N608]Mi](C104)2 (4.58 g, 10 mmol) was added to the ligand 
L (2.94 g, 10 mmol) dissolved in the mixture of water and ethanol in 1:1 molar ratio. To 
the resulting yellow solution was added aqueous NaOH (0.40 g, 10 mmol) dropwise with 
constant stirring and the reaction mixture was heated to reflux for I hour. A light green 
precipitate was isolated after filtration, washed with hexane and dried in vacuo. 
103 
y 
H2 H, 
IVI 
N 
H2 
\ N 
H2 
lVI=CLi(II),Ni(II) 
Scheme 5. 
4HCH0, 2NH3 
-4H2O H 
H / \.h] 
H 
M=Cu(Il),Ni(II) 
(CI04)2 
H ^ H H ,H 
NH 
N 
lA / " -(^04)2 
M=Cu(lI),Ni(II) 
NaOH 
HO H H 
HVJ-H CD4 
Scheme 6. 
M=Cii(Il)NKII) 
104 
Results and discussion 
The ligand L was synthesized by Phillips condensation of the I. (+) tartaric acid with the 
I ,?-(liaiiiinohcn/ciie (Sclicnic 3). i'lirlhcij new cliiial nuKiocyclic complexes 
[C24H35Nio02Cu]CI04 and [C24H35Nio02Ni]CI04 were prepared by the reaction of 
|CxH22N6Cu](CI04)2 and [QH22N6Ni](CI04)2 with 1,2 Bis(IH-benzimidazol-2yl) -1,2 
ethanediol ligand L, respectively (Scheme 5 and 6). The isolated chiral complexes are 
soluble in DMSO but insoluble in other common organic solvents. All the complexes 
were ionic in nature and the molar conductance of the complex [C24fh5Nio02Cu]C104 
and [C2iH^sNin02Ni]C104 in DMSO were observed in the range 50-60 a ' cm^ M"' 
correspond to 1:1 electrolyte, indicating that one CIO4 ion is present in the outer sphere, 
which was further authenticated by the elemental analysis and IR spectral bands. The 
optical rotation [ajo +103, +106 for complexes [C24H35N|o02Cu]C104 and 
[C24H35Nio02Ni]C104, respectively indicate that complexes are optically active (Table 5). 
In chiral complexes, ligand coordinates to metal ion via deprotonation of one of the 
alcohol functions while the other remains uncoordinated because the two alcohol 
functions are mutually trans and involved in hydrogen boding with the anion and 
solvents. Thus, the coordination geometry of the central metal ion is square pyramidal in 
chiral complexes, which is proposed on the basis of spectroscopic studies. The ball and 
stick model of the chiral complexes was constructed which indicates no strain on any 
bond or any angle (Figure 60). Comparative DNA binding studies were performed using 
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copper complexes and analogous nickel complexes were synthesized only for NMR 
studies. 
V ^ d p 
Figure 60. Ball and stick model ofchiral complexes 
IR spectra 
The IR spectrum of free ligand L displayed u(O-H) bands at 3497 cm . A medium 
intensity band at 1585 cm"' has been assigned to t»(C=N) of imidazole ring [188, 214] and 
a characteristics D(N-H) stretching band appeared at 3180 cm''. Other frequencies v(C-
N) and t)(C-0) appeared at 1317 cm"' and 1267 cm"', respectively. 
In complexes [C24H35Nio02Cu]C104 and [C24H35Nio02Ni]C104,u(0-H) stretching bands 
disappeared with the emergence of new peaic at ca. 3400 cm"' [187, 215] confirming the 
coordination of the metal ion through oxygen of one of the alcohol group of ligand while 
other remains uncoordinated. The potentiometric titrations of the ligand reveal that the 
first deprotonation takes place at the alcohol function around pH 6-8. However the 
second deprotonation was not observed before pH 10, which accounts for the 
stabilization of second alcohol proton and probability of hydrogen bonding with the 
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anions [186]. Coupled with these observations the \)(C-0) stretching band is slightly 
shifted to higher frequencies region in the spectra of complexes [C24H35Nio02Cu]C104 
and [C24H35Nio02Ni]C104 due to coordination of one of the oxygen atom of ligand. The 
band at ca.l592 cm'' arising due to u(C=N) group of ligand was observed at almost the 
same position in the spectra of the complexes [C24H35Nio02Cu]C104 and 
[C24H35Nio02Ni]C104 indicating noninvolvement of this group in coordination to metal 
ion. All the complexes displayed a strong peak at 1070-1086 cm'' and a medium intensity 
peak at 612-627 cm' assigned to uncoordinated CIO4" ions [216]. Complexes 
[C8H22N6Cu](C104)2 and [C8H22N6Ni](C104)2 exhibited broad stretching vibration at 
3220 cm'' attributed to i)(N-H) of coordinated amine and ligand showed ^(N-H) of 
imidazole moiety at 3180 cm"'. However, infrared spectra of complexes 
[C24H35Nio02Cu]C104 and [C24H35Nio02Ni]C104 revealed a very broad band at ca. 3203 
cm'' [217], which rendered the individual assignment of u(N-H) of ligand and 
macrocyciic moiety difficult. Far IR spectra of complexes exhibited absorptions at 480-
482 cm'' and 530-536 cm'' attributed to u(M-O) and u(M-N) bands (M = Cu, Ni), 
respectively, which further confirmed the bonding through oxygen atom of ligand to the 
metal ion in the chiral macrocyciic complexes [218] (Table 6). 
Electronic spectra 
The electronic spectra of all the complexes were recorded in the 200-800 nm region at 
room temperature (Figure 61 and 62). The electronic spectrum of complex 
107 
[C8H22N6Cu](C104)2 in aqueous solution displayed a strong high energy band at 268 nm 
attributed to n- n* transition and a low energy broad band at 594 nm assigned to ligand 
field ^B]g-^ ^Aig transition suggesting that Cu (II) ion is in square planar environment 
[219]. In contrast, new chiral macrocyclic complex [C24H35Nio02Cu]C104 exhibited three 
prominent bands. Ti)e broad band at ~ 678 nm corresponds to dxy, dyz—*dx^ -y^  transition 
[220] and two strong bands in UV region at 242 nm and 278 cm'' were due to IL n-n* 
transitions typical for square pyramidal Cu (II) complex [97, 221]. 
500 600 
' Wavelength (nm) 
Figure 61. Absorption spectra of complex [C8H22N6CU](€104)2 (~) and complex 
[C8H22N6Ni](Cm2 (-) 
The absorption spectrum of complex [C8H22N6Ni](C104)2 revealed one intense band at 
258 nm and a broad band at 444 cm'' due to square planar geometry around Ni (II) metal 
ion [222]. On the other hand, chiral macrocyclic complex [C24H35Nio02Ni]C104 
displayed bands at 687 nm and 348 nm which were assigned to ^Bi(F) —* 'E(F) and 
108 
''Bi(F) -^ ^Ai, ' 'E(P) transitions, respectively. [C24H35Nio02Ni]C104 complex also 
exhibited strong bands in UV region at 288 nm attributed to IL n-n* transitions. These 
results are consistent with pentacoordinate environment around Ni (II) ion [197, 223]. 
400 500 600 
WavBlenjitti{ra?i) 
TOO 
Figure 62. Absorption spectra of complex [C24Hs5NioOiCu]Cl04 (—) and 
[C24Hs5N,o02Ni]Cl04 (-) 
EPR spectra 
The X-band EPR spectra of complexes [C8H22N6Cu](C104)2 and [C24H35N,o02Cu]C104 
were recorded at a frequency of 9.1GHz under the magnetic field strength 3000 ± 1000 
gauss using TCNE as field marker (g = 2.0027) at LNT. The complexes 
[C8H22N6Cu](CI04)2 and [C24H35Nio02Cu]C104 showed anisotropic spectra with 
different g\\ and gi values. The EPR spectrum of complex [C8H22N6Cu](CI04)2 consists 
of a very broad axial symmetrical line shape with g|| = 2.18, gi= 2.07 values and gav = 
2.10 computed from the formula ga\'= gi|V2gx /^3 suggesting the square planer geometry 
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[224]. However, complex [C24H35Nio02Cu]Ci04 exhibited g||= 2.20, gx = 1.98 and gav = 
2.06 [225]. The values g)|andgi were in good agreement with an essentially dx -y copper 
(11) ground state and were anticipated for square pyramidal geometry [191, 226]. The 
order gy >gi> ge (2.0023) further confirm that the ground state of copper (II) is 
predominantly dx -y". 
NMR spectra 
In order to confirm the formation of new chiral macrocyclic complexes, 'H and '^ C NMR 
spectra of complex [C8H22N6Ni](CI04)2 were compared with complex 
[C24H35N|()02Ni]C104. The 'H NMR spectrum of ligand L revealed OH protons, aromatic 
protons and NH protons of imidazole ring at 5.4, 7.2-7.5 and 8.2 ppm, respectively [227]. 
The 'H NMR spectrum of complex [C8H22N6Ni](C104)2 exhibited the characteristic 
resonances at 2.6-3.3 ppm due to the NH-CH2-CH2-NH of macrocyclic framework 
[228]. In complex [C24H35N)o02Ni]CI04, peak at 5.4 ppm ascribed to the free OH groups 
of the ligand, disappeared suggesting that OH group is coordinated to metal center 
through deprotonation (Figure 63). The deprotonation at the alcohol function is quite 
feasible in these ligands as the conformation of ligand revealed two benzimidazoles 
inclined at about 100° to each other and with the one alcohol group directed towards the 
metal and second directed away. We have observed another less intensified signal at 5.3 
ppm in complex [C24H35N;o02Ni]C104, which revealed that one of the OH group is 
uncoordinated and is involved in hydrogen bonding with the anions and solvent. Other 
no 
resonances in complex [C24H35Nio02Ni]C104 appeared with sligiit sliifts at 4.8, 2.4-3.3, 
7.1-7.5, and 8.2 ppm for C-H, NH-CH2-CH2-NH, Ar-H and N-H proton of imidazole 
ring, respectively (Table 7). 
'^ C NMR spectrum of ligand exhibited (C-N), (C-0) and Ar-C at 154, 72.0, and 129-
134 ppm, respectively. However, '^ C NMR spectrum of complex [C24H35Nio02Ni]CI04 
in comparison to ligand L showed shift in the C-0 carbon at 69.4 ppm [229]. This 
considerable shift in the position of carbon atom adjacent to the oxygen atom clearly 
indicated the coordination of oxygen to metal center. In addition, signals at 153.8, 50.0 
and 115-133 ppm were observed due to C=N, macrocyclic carbons N-C-C-N and Ar-C, 
respectively [230] which also support the authenticity of the proposed structure (Table 8). 
Figure 63. 'HNMR Spectrum of complex [C^MjsNjoOiNiJCIO^ 
0 ppm 
DNA binding studies 
It is necessary to understand the DNA binding modes of these complexes in a hope to 
develop chiral antitumour agents as chirality manifests itself in the distinction between 
left and right handed versions. The nucleic acids DNA and RNA are polymers that exist 
in nature in only one chiral form, therefore pharmaceuticals for chemotherapy are highly 
sensitive to enantiomeric differences [231]. Binding properties of metal complexes to 
DNA can be detected by various techniques, however, absorption titration, fluorescence 
spectroscopy, cyclic voltammetry and viscosity measurements are best suited for 
studying the interaction mode of the copper complexes while CD studies provides further 
information about the mode of binding of complex [C24H35Nio02Cu]C104. 
Absorption titrations 
Electronic absorption spectroscopy is often employed to ascertain the binding of 
complexes with DNA. The extent of spectral changes were related to the strength of 
binding of complexes [232]. The hyperchromic and hypochromic effect are the spectral 
features of DNA concerning its double helix structure [233, 234J. Titration curves 
constructed from the fractional changes in absorbance of complex [CsH22N6Cu](C104)2 
and [C24Hl35Nio02Cu]C104 as a function of CT DNA concentration are shown in Figure 
64 and 65. Complex [C8H22N6Cu](CI04)2 showed broad band at 268 nm attributed to 
n-^n* transition. 
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300 400 
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Figure 64. Absorption spectral traces of complex [C8H22N6CV](€10^)2 in TrisHCl 
buffer upon addition ofCTDNA. Inset: Plots of [DNAJ/Sa-s/ vs. [DNA] for the titration 
of CT DNA with complexes; •, experimental data points; full lines, linear fitting of the 
data, [complex] = 1.5 x W M. 
The association of complex [C8H22N6Cu](Ci04)2 with CT DNA results small 
perturbalion in %—>•%* transitions and absorption spectrum indicates hyperchromism with 
a slight shift, which is indicative of weak binding of the complex [CsH22N6Cu](C104)2 to 
CT DNA through electrostatic interaction [161, 235] (Figure 64). 
Both covalent bond formation with the DNA bases and hydrogen bonding can be 
involved in binding as DNA possesses several hydrogen bond acceptor sites, which are 
accessible, both in the minor and major grooves and the complex [C8H22N6Cu](CI04)2 
contains four coordinated amine -NH- groups, which can favorably form hydrogen 
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bonds with base pairs in DNA [236]. On the other hand, complex [C24H35Nio02Cu]C104 
displayed two well resolved bands at 242 and 278 nm attributed to IL bands. Upon the 
200 3 0 0 
Wavelength (nm 
400 
Figure 65. Absorption spectral traces of complex [CoMssl^inO^CiiJClO^ in Tris-HCl 
bujfer upon addition of CT DNA. Inset: Plots of [DNA]/Sa-Cfvs. [DNA] for the titration 
ofCTDNA with complexes, experimental data points; full lines, linear fitting of the data., 
[complex] = 4 0x10'^ M 
addition of CT DNA, complex [C24H35Nio02Cu]C104 exhibited large hyperchromicity in 
both IL bands (Figure 65). There is also an appreciable bathochromic shift of one of the 
IL bands, from 242 to 249 nm. The increase in absorbance (hyperchromism) and red shift 
of 7 nm in this region suggest that [C24H35Niu02Cu]C104 complex strongly binds to CT 
DNA due to the presence of chiral ligand L at the axial trans directing position in the 
macrocycle. Structurally, this chiral ligand also provides aromatic rings of imidazole 
14 
moiety, which can bind to CT DMA by insertion into the adjacent base pairs on the DNA 
duplex i.e. partial intercalation [203, 237,238]. The capping of the ligand L is not only 
responsible for a chiral stereogenic center but also makes the molecule coordinately 
saturated (square pyramidal geometry) at the metal center and modulates the reactivity of 
complex by recognizing specific binding site of the molecular target [239]. 
To compare binding strength of complexes quantitatively, the intrinsic binding constant 
(Kb) of complexes [C8H22l^ 6Cu](C104)2 and [C24H35Nio02Cu]C104 were also determined 
to be 2.7 X 10"^  M"' and 6.6 x lO'^  M"', respectively. The Kb value of complex 
[C24H35Nio02Cu]C104 has increased two fold in comparison to achiral complex 
[C8H22N608Cu](C104)2 but is lower than that observed for a typical classical intercalator 
(ethidium-DNA, 1.4 x 10^  M"'). This is an indicative of strong binding affinity of 
complex [C24H35Nio02Cu]C104 for CT DNA. 
Fluorescence spectroscopic studies 
No luminescence was observed for both the copper complexes upon excitation at %—*%* 
transitions either in DMSO or in presence of CT DNA. Hence, competitive binding 
studies of the complexes [C8H22N6Cu](C104)2 and [C24H35Nio02Cu]C104 to the CT DNA 
have been carried out by fluorescence spectral method using the emission intensity of 
EthBr as a probe. The quenching extent of fluorescence of EthBr bound to DNA is used 
to determine the binding of complex and DNA. 
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Figure 66. Emission spectra of EthBr bound to DNA in the presence of complex 
[CsHyoNcCuJfClO^) in Tris HCl buffer. [EthBr] =2 x Iff^M. [DNA] = 1 x 10'^M, 
[complex] = 0 - 1.0 X 10' M. Arrows show the intensity changes upon increasing -
concentration of the complexes 
500 550 600 
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Figure 67. Emission .spectra of EthBr hound to DNA in the presence of complex 
[CsH22N60sCu](ClO^) in Tris HCl buffer [EthBr] =2 x 10''M, [DNA] = 1 x W'M, 
/complex/ = 0 - 1.0 X 10' M. ArroM's show the intensity changes upon increasing 
concentration of the complexes 
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Binding of the complex results in the displacement of bound EthBr molecule with a 
reduction of emission intensity due to fluorescence quenching of free EthBr by water 
[118, 240]. The emission spectra of EthBr bound DNA in the absence and presence of 
complex [C8H22N6Cu](C104)2 and [C24H35Nio02Cu]CI04 are given in Figure 66 and 67. 
The addition of the complex [C24H35Nio02Cu]C104 to CT DNA pretreated with EthBr 
causes appreciable reduction in the emission intensity indicating that the displacement of 
the EthBr fluorophore by the chiral complex results in a decrease of the binding of the 
ethidium to the DNA. However, as the concentration of complex [CgH22N6Cu](C104)2 
increased, very small decrease in emission intensity was observed indicating weak 
binding affinity of the achiral complex with CT DNA. 
The fluorescence quenching curve of EthBr bound to DNA by the complex 
[C8H22N6Cu](C104)2 and [C24H35Nio02Cu]C104 are depicted in Figure 68. 
0.4 
0.0 0.2 0.4 0.6 0.8 
[Complex] / [DNA] 
1.0 
Figure 68. Fluorescence quenching curve of DNA bound EthBr by [CsH22N6Cu](€104)2 
(•) and [C24H35N10O2CUJCIO4 (a). [EthBr] = 2 xlO'^M, [DNA] = 1 x 10'^M, [complex] 
= 0-1.0x10'' M 
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The quenching curve illustrates that the quenching of EthBr bound to DNA by the 
complexes are in good agreement with the linear Stern-Volmer equation. The Stern-
Volmer quenching constant Ksv values for complexes [C8H2:N6Cu](C104)2 and 
[C24H35Nio02Cu]CI04 estimated using Eqn. (2) are 0.10 and 0.60, respectively 
[161,118], and suggest that the interaction of the chiral complex [C24H3sNio02Cu]CI04 
with CT DNA is strong in comparison to the achiral complex [C8H22N6Cu](C104)2 which 
is consistent with the above absorption spectral results. 
Cyclic voltammetric studies 
Voltammetric techniques are most suitable for investigating the redox properties of new 
metal complexes due to the resemblance between electrochemical and biological 
reactions. The comparative redox behaviour of complex [C8H22N6Cu](CI04)2 and 
(C24K35Nio02Cu]Ci04 and their interaction with CT DNA were studied by CV. The 
cyclic voltammogram of complex [C8H22N6Cu](CI04)2 exhibited one quasireversible 
redox couple corresponding to the Cu(ll)/(I) [241] with Ep value 0.290 V and 0.390 V at 
scan rate 0.2 Vs'' and Ipa/Ipe ratio is 0.44 (Figure 69 curve a). For this couple, the 
difference between cathodic and anodic peak potential AEp and formal peak potential E° 
are 0.1 OOV and 0.336V, respectively. 
< 
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Figure 69. Cyclic votammogram at a scan rate 0 2 Vs ' w 5 95 DMSO/H2O of unbound 
complex [CsH22N6Cu](ClOi) (curve a) and complex in presence oj CT DNA (curve b) 
[complex] = IxlO^ M, [DNA] - 6 \ W' M 
I'c tcniial / V 
Figure 70 Cyclic votammogram at a scan rate 0 2 Vs in 5 95 DMSO/H2O of unbound 
complex [C24Ni(jH}s02Cu]Cl04 (curve a) and complex in presence ofCTDNA (curve b) 
[complex] = 1x10^ M, [DNA] = 6x10^ M 
On interaction of complex [CgH22N6Cu](C104)2 with CT DNA there is a shift in AEp 
value (0.110 V) as well as in E° value (0.355) suggesting that the complex 
[C8H22N6Cu](C104)2 binds with CT DNA (Figure 69 curve b). The cyclic voltammetric 
behaviour of complex [C24H35Nio02Cu]C104 and its interaction with CT DNA was 
studied at scan rate 0.2 Vs"' over the potential range +1.6 to -1.2 V (Figure 70). In 
absence of CT DNA, CV of complex [C24H35Nio02Cu]CI04 reveals one electron 
quasireversible redox couple at E°= -0.291 V and AEp = -0.235 V (Epc = - 0.409 V, Epa= -
0.174 V). The ratio of anodic to cathodic peak currents is 0.27. At different scan rates, the 
voltammogram does not show any major change [232]. On addition of CT DNA, 
complex [C24H35Nio02Cu]CI04 experiences a significant shift in AEp value (-0.221 V) as 
well as in E^value (-0.335 V) at constant parameters. The ratio of anodic to cathodic peak 
current Ipa/lpc increases to 0.31 implying quasi-reversible electron transfers [242]. The 
large shift in AEp value in comparison to complex [C8H22N6Cu](CI04)2 and increase in 
Ipa/lpc ratio indicate that complex [C24H35N|o02Cu]CI04 is strongly bound to CT DNA 
[199,243]. 
Circular dichoric studies 
The CD spectrum of complex [C24H35Nio02Cu]C104 was recorded in DMSO in the 
range 220 nm to 320 nm. The complex [C24lhsNin02Cu]C104 showed two sharp bands at 
270 nm and 282 nm in positive region (Figure 71). 
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Figure 11. CD Spectrum of complex [C24HssNin07Cu]Cl04 in DMSO 
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Figure 72. CD Spectra ofCTDNA alone in Tris HCl buffer (curve a) and CT DNA in 
presence of complex fCjMjsN/oOjCuJClO^ (curve b) [DNA] = / x W^ M, [complex] =1 
xlO'^M 
CD has been performed to llirther evaluate the structural modification of DNA caused by 
an interaction with complex [C24H3iNio02Cu]C104. The CT DNA exhibited two 
consecutive bands, a positive band at 275 nm due to siacising and a negative band at 245 
nm due to heiicity in the UV region [244]. Changes in the CD spectrum of CT DNA in 
the presence of complex [C24H35Nio02Cu]Ci04 are depicted in Figure 72. 
On addition of complex to CT DNA, it is observed that positive band position shifted to 
277 nm with slight increase in molar ellipticity while the intensity of negative band in the 
CD spectrum of DNA was perturbed remarkably with no shift. These observations 
suggest that the binding of complex increases the stacking and decreases the heiicity of 
DNA, attributed to strong conformational change in DNA helix [245]. 
Viscosity measurements 
As a means for further clarifying the binding oi'the achiral and chiral copper complexes, 
viscosity measurements were carried out on CT DNA by varying the concentration of the 
added complexes. Hydrodynamic measurements, which arc sensitive to length change, 
are regarded as the least ambiguous and most critical tests of binding in solution 
[210, 211, 246J. A classical intercalator causes a significant increase in viscosity of the 
DNA solution due to an increase in the separation of base pairs at the interaction sites and 
hence an increase in overall DNA length. In contrast, complexes that bind exclusively in 
the DNA groove by partial and/or non-classical intercalation typically cause less 
pronounced (positive or negative) or no change in the viscosity of DNA [247, 248]. 
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Figure 73 shows the relative changes in viscosity upon addition of complex 
fC8H22N6Cu|(C104)2 and [C24H35N,o02Cu]CI04. For complex [C8H22N6Cu](C104)2, the 
relative specific viscosity of CT DNA decreases with increasing concentration of 
complex which imply that complex |"C,sH22N6Cul(C104)2 binds to CT DNA by non-
classical intercalation i.e. partial intercalation or perhaps simple electrostatic binding 
1242]. 
0.01 0.03 0.05 
1/R (=[Cu]/[DNA] ) 
0.07 
Figure 73. Effects of increasing amount of complex [CsHiiNdCu] (€104)2, (•), complex 
[C24H3sNio02CuJci04 (m), and EthBr (k) on the relative viscosit)> of CT DNA at 29 ± 
().]"€. [DNA] = 5x 10'^M 
In contrast, with the increment of the concentration of complex [C24H35Nio02Cu]C104, 
the viscosity of DNA increases supporting that the complex interacts through a mode that 
involves a stacking interaction between aromatic chromophore and the base pair of DNA 
12: 
[249]. These results reveal different interaction mode involving both achiral and chiral 
complexes. 
Conclusions 
The synthesis and characterization of chiral and achiral complexes have been described. 
The comparative DNA binding studies of complex [CsH22N6Cu](C104)2, and 
[024^ 3^5^ 1 io02Cu]C104 by various spectroscopic studies along with CV and viscosity 
measurements indicate that mode of interaction of chiral and an achiral macrocyclic 
complex with DNA is markedly different. The value of intrinsic binding constant Kb 
suggests that chiral complex binds to CT DNA more strongly in comparison to achiral 
complex. Hence, the introduction of chirality has pronounced effect on the DNA binding 
event of the macrocyclic metal complexes. Chirality enhances percent inhibition at the 
target site (DNA) in a stereoselective manner at the molecular level. It tunes the reactivity 
and facilitates the modulation of macrocycle by exhibiting unique electronic and kinetic 
effects. Thus, molecular structure is directly related to biological activity. 
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CHAPTER V 
Synthesis, Characterization and Interaction of New 
Chlral Trinuclear Complexes 
[Bis(aquodlamlnotryptophanato) Cu"-Sn2'^ ] chloride 
with Guanine and Calf-Thymus DNA 
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CHAPTER V 
Experimental 
Nickel chloride hexaiiydrate, copper chloride dihydrate, ethylenediamine, 
propanediamine, tris-base (E. Merck), L-tryptophan (Loba Chemei), SnCU (Lancaster) 
and guanine (Sigma chemical Co.) were used as received. All reagent grade compounds 
were used without further purification. Microanalyses were performed on a Carlo Erba 
analyzer model 1108. IR spectra were recorded on an Interspec 2020 FTIR spectrometer 
in Nujol mull. Data were reported as Xmax/nm. 'H and ''C NMR spectra were obtained on 
a Bruker DRX-300 spectrometer in CDjOD. Chemical shifts were reported in ppm. 
Optical rotations of chiral complexes were determined on a Polarimeter Rudolf Autopol 
inat25'^C using the sodium D line in MeOH and DMSO. EPR spectra of the copper (II) 
complexes were recorded on a Varian E-112 spectrometer at the X-band frequency 
(9.1 Gil/) at LNT. All voltammetric experiments were performed in a single 
compartmental cell at 25° C with H2O/DMSO (95:5). The supporting electrolyte was 
0.4M KNO3 in distilled water and solvent was deaerated by purging with nitrogen. Molar 
conductances were measured at room temperature on a Digisun electronic conductivity 
bridge. The stock solution of guanine was prepared in phosphate buffer (pH 2). The 
kinetic experiments were performed under pseudo-first order condition and spectral 
changes were recorded at 260 nm (DNA) 273 nm (guanine), respectively. 
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Synthesis of [Bis(ethylenediamine/propanediamine) metal(II)]chloride, 
[C4Hi6N4M]Cl2 [M= Cu(n), Ni(n)] 
These compounds were synthesized by the methods reported earlier [250]. 
To a solution of CUCI2.2I-I2O (1.71 g, 10 mmol) in MeOH (50 ml) was added 
ethylenediamine (1.34 ml, 20 mmo!) / propanediamine (1.66 ml, 20 mmol) in a 1:2 molar 
ratio. The dark blue product obtained was washed with EtaO and dried in vacuo. 
[Bis(ethylenediamine / propanediamine) nickel (II)]chloride were also synthesized by a 
similar procedure with NiCl2.6H20 (2.37 g, 10 mmol). 
Synthesis of [Bis (aquodiaminotryptophanato) Cu(II)-Sn2(IV)]chloride 
[C26H36N806CuSn2]Cl2 
A solution of SnCU (2.34 ml, 20 mmol) in CCI4 (50 ml) was added to a hot solution of 
L-tryptophan (4,08 g, 20 mmol) in MeOH (50 ml) in a 1:1 molar ratio. The solution was 
refluxed for ca,36 hours and rotary evaporated to half the volume (50 ml). The above 
solution was further refluxed with [Bis(ethylenediamine)copper(II)]chloride (2.54 g, 10 
mmol) dissolved in MeOH (25 ml) for ca 1 hour and concentrated on a rotary evaporator 
to 20 ml. The yellowish brown solution was allowed to cool to room temperature and 
then left overnight in a refrigerator. A yellowish brown complex was obtained, filtered 
under anhydrous conditions, washed with hexane, and dried in vacuo. (Scheme 7) 
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[C28H40N8O6CuSn2]Cl2 
A mixture of SnCU (2.34 ml, 20 mmo!) in CCU (50 ml) and L-tryptophan (4.08 g, 20 
mmol) in MeOH (50 ml) was heated at reflux for 40 hours. The solution was 
concentrated by rotary evaporator to 50 ml. The above reaction mixture was further 
retluxed with [Bis(propanediamine)copper(ll)]chloride (2.82 g, 10 mmol) dissolved in 
MeOH for 2 hours and rotary evaporated to 20 ml. The solution was allowed to cool at 
room temperature and left overnight in a refrigerator. A yellowish brown precipitate was 
filtered off, washed with hexane and dried in vacuo (Scheme 7). 
Synthesis of [bis (aquodiaminotryptophanato) Ni(II)-Sn2(IV)]chIoride 
[C26H32N804NiSn2]Cl2 
To a hot solution of L-tryptophan (4.08 g, 20 mmol) in MeOH (50 ml) was added the 
solution of SnCU (2.34 ml, 20 mmol) in carbon tetrachloride (50 ml) in a 1:1 molar ratio. 
The solution was heated under reflux for ca 38 hours and the volume reduced up to 50 
ml. The above solution was further retluxed with 
[bis(ethylenediamine)nickel(lI)]chloride (2.49 g, 10 mmol) dissolved in MeOH (25 ml) 
for ca.l hour and concentrated by rotary evaporator to 20 ml. The solution was allowed to 
cool to room temperature and then left overnight in a refrigerator. A light brown complex 
was obtained, filtered under anhydrous conditions, washed with hexane, and dried in 
vacuo (Scheme 7). 
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ICisHjcNsO^NiSnzJCb 
A solution of SnCU (2.34 ml, 20 mmol) and L-tryptophan (4.08 g, 20 mmol) in MeOH 
(50 ml) was refluxed and stirred for ca 42 hour. A brown coloured solution was obtained 
which was concentrated by rotary evaporator. A solution of [Bis (propanediamine) 
nickel(II)]chloride (2.77 g, 10 mmol) dissolved in MeOH was added to the above 
reaction mixture and subjected to reflux for 2 hours The solution mixture was further 
concentrated by rotary evaporator and left overnight in a refrigerator. Light brown 
compound was isolated, washed with hexane and dried over fused CaCb (Scheme 7). 
Results and discussion 
New chiral trinuclear complexes were synthesized by the reaction of L-tryptophan, tin 
tetrachloride and [Bis(ethylenediamine/propanediamine)metal (II)]chloride [M = Cu(II), 
Ni(II)] (Scheme 7) and characterized by analytical and physicochemical techniques. The 
complexes were stable at room temperature and soluble in DMSO. The molar 
conductance measurements in DMSO show that complexes are 1:2 electrolytes. The [ajo 
values of the complexes indicate that the complexes are chiral in nature. The important 
properties and physical data of the complexes are shown in Table-9. DNA binding studies 
of copper complexes were investigated by absorption spectroscopy. 
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cyclic voltammetry and viscosity measurements wiiich exhibited that complexes bind to 
CT DNA through N7 position of guanine which was further confirmed by the interaction 
studies of copper complexes with guanine. 
IR spectra 
The IR spectra of chiral trinuclear complexes show characteristic band shifts, band 
positions and band intensities in comparison with the free amino acid, which shows the 
amino acid chelation in bidentate manner. The IR spectra of amino acids exhibit 
significant features in \)(NH2) and u(COO) regions. It is important to note that amino 
acids exist as zwitter ions (^Ha-AA-COO") and can form metal complexes in a 
bidentate manner only by deprotonation. In our complexes, L-tryptophan binds to tin 
covalently by the elimination of two molecules of HCI. The transformation of ^Ha to 
NH must undergo a shift in uCNH )^ of the free amino acid. The IR spectra of the 
complexes show characteristic bands in the 3250-3185 cm"' region [251] which is lower 
in comparison with D(NH2). Hence, it indicates the involvement of nitrogen of the amino 
group in coordination. The free amino acid displays two absorption bands corresponding 
to asymmetric and symmetric vibrations of the carboxylate group in the 1610-1660 cm' 
and 1395-1430 cm'' regions, respectively. The trinuclear complexes also show strong 
bands at 1570-1577 cm"' and 1342-1345 cm"' for asymmetric and symmetric -COO 
vibrations, respectively. These shifts further authenticate the coordination of amino acid 
to the tin(IV) metal center [252]. The absence of ^(NHiJ band at 3300-3400 cm'' in the 
133 
IR spectra of trinuclear complexes indicates tiiat NH2 group of 
ethyienediamine/propanediamine were coordinated to copper (Il)/nickel(II) and, 
simultaneously, to tin metal by the elimination of two HCI molecules. A broad band at 
3450-3500 cm" can be ascribed to the stretching vibration of water molecules present in 
the lattice or coordinated to the metal ion in copper complexes. Other medium intensity 
bands at 1300-1400 cm'' have been assigned to u(C-C), u(C-N) and uAr(N--H). Far IR 
spectra of complexes exhibit absorptions at -449 cm"', -493 cm'' and -418 cm'' assigned 
to -oCM-N), \)(Sn-0) and i)(Sn-N) [253], respectively (Table 10). 
Electronic absorption spectra 
The UV/vis spectra of the complexes [C26H36N806CuSn2]Cl2and [C28H4oN806CuSn2]Cl2 
in methanol exhibit a strong intense charge transfer band at ca. 276 nm and broad band at 
ca. 862 nm and 869 nm, respectively which can be assigned to the Eg-^ T2g transition. 
These spectral features suggested an octahedral geometry around the Cu(II) ion [254]. 
Complex [C26H32N804NiSn2]Cl2 and [C28H36N804NiSn2]Cl2 are diamagnetic and bands 
observed in the -505 nm and - 500 nm regions are assigned to 'Aig(F) —> 'BI(G) and 
'Aig ^- 'A2g transitions, respectively consistent with a square planar Ni(II) complex 
[255]. In addition, electronic spectra of both complexes display characteristic absorption 
bands at 279-287nm attributed to intraligand 7r-» 71* transitions as well as ligand-to-metal 
charge transfer bands. 
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EPR spectra 
The X-band EPR spectra of complexes |C2(,I l!6N}j06CLiSn2]Cl2 and 
[C28H4oN806CuSn2]Cl2 were recorded at a frequency of 9.1GHz under a magnetic field 
strength of 3000±1000 gauss with TCNE as 'g' marker at 77 K. The complex 
[C26H36N806CuSn2]Cl2 shows an anisotropic spectrum with gir2,12 and gi = 2.03 and 
gav= 2.06 while complex [C28H4oN806CuSn2]Cl2 exhibits ,i,'||=2.10 and gi = 2.02 and 
gav= 2.04 computed from the formula gj = g||'^ -f2gx /^3. The values of gn and g± are in 
good agreement with an essentially d l^y" copper (II) ground state and were anticipated 
for an octahedral geometry [253]. The G factor (defined as G = (g||-2)/(gx-2) indicative of 
exchange interactions between the Cu(II) sites in polycrystalline solids) close to 4 
suggests the negligible exchange interaction. The order g|| >gi>ge (2.0023) further 
confirm that the ground state of Cu(ll) is predominantly d\2-y2-
NMR spectra 
The 'H NMR spectra of the chiral complexes [C26H32N804NiSn2]Cl2 
[C28H36N804NiSn2]Cl2 are informative due to the protons present in different 
environments. The relative intensities are in agreement with the formulation of nickel 
complexes as depicted in Scheme-7. The signals due to NH2 and COOH functional 
groups appearing at 5.3-5.4ppm and 10.0-12.0 ppm, respectively in free L-tryptophan are 
missing in the complexes, which is a consequence of coordination of the L-tryptophan in 
a bidentate manner to the tin atom. The 'H NMR spectrum of nickel complexes show a 
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NH proton signal at 7.0 ppm which further supports the coordination of the NH2 group of 
the amino acid to the tin atom by the elimination of HCI. 
The NH proton signal of coordinated ethylenediamine and propanediamine were 
considered to be downfield in comparison to the coordinated NH proton of L-tryptophan, 
which commensurates with the fact that the prior NH proton is coordinated to nickel and 
to the tin metal atom simultaneously [251]. This is also evidenced by the absence of the 
NH2 proton (7.2 ppm) of the coordinated ethylenediamine and propanediamine in the 'H 
NMR spectrum of the trinuclear complex. The other resonances are at 7.5-7.7, 7.3-7.4, 
7.1 and 3.7 ppm which corresponds to Ar-H, NH-C=C, CH=C and CH2 group, 
respectively. These findings are consistent with the formation of new chiral trinuclear 
complexes. The assignment of the proton signals were further confirmed by the 
2D-correlation spectroscopy, (Table 11). which exhibits relatively the same resonances in 
'H NMR spectra of nickel complex (Figure 74). 
The '^ C NMR spectrum of complexes [C26H32N80,NiSn2]Cl2and [C28H36N804NiSn2]Cl2 
exhibits seven signals in CD3OD, depicted in Table 12. Among these seven signals, the 
peaks at ca. 170.9, 123.1, 112.8, 107.6, 54.8 and 38.0 ppm are attributed to 0-C=0, Ar-
C, - N H - C H = , Ar-C=, -CH- and CH2 groups, respectively of coordinated L-tryptophan. 
On the other hand, the '^ C NMR spectra of the complexes reveal characteristic N-CH2-
CH2-N and N-CH2-CH2-CH2-N carbons at -27.3 ppm. Thus, the '^ C NMR is in good 
agreement with the proton NMR spectrum confirming the proposed structure. 
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Electrochemical behaviour 
Cyclic voltammetry is a useful technique for studying the inteiaction of metal complexes 
with CT DNA and understanding the nature of DNA binding [241, 256]. The cyclic 
voltammogram of complexes [C26H36N806CuSn2]Cl2 and [C28H4oN806CuSn2]Cl2 were 
recorded in H2O/DMSO (95.5) at a scan rate of 0.3 Vs' over a potential range from 1.6 to 
-1.2 V. The CV of complex [C26H36N806CuSn2]Cl2 reveals a one electron 
quasireversible wave attributed to the redox couple Cu(II)/Cu(l) [257] with the formal 
electrode potential E° = -0.530 V, the ratio of anodic peak current and cathodic peak 
current Ip^ /lpc value ~ 0.6 and AEp=0 182V, which is larger than theNernstian value 
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- 1 I 
•0.4 -0.8 - U 
Potential/V 
Figure 75. Cyclic voltammogram of complex [CjdHseNsOeCuSniJCh alone (curve a) and 
CTDNA hound [C^eHssNgOsCuSnyJCh (curve b) at scan rate 0.3 Vs' 
> 
Potential / V 
Figure76. Cyclic voltammogram of [C26H36N806CuSnj]Cl2 at different scan rates in 
H20/DMSO(95:5) 
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observed for one electron transfer (Figure 75). Complex [C28H4oN806CuSn2]Cl2 also 
exhibits the similar behaviour with E°= -0.350 V, AEp= 0.200 V and Ipa/Ipc value ~ 0.5. 
Large peak to peak separation is commonly observed in copper complexes and has been 
attributed to structural reorganization [258]. The profile of the voltammogram obtained at 
various scan rates does not show any major change (Figure 76). However, at various scan 
rates the peak height increases indicating the reversibility of the process. 
On the addition of CT DNA, the complex [C26H36Ng06CuSn2]Cl2 experiences a shift in 
formal potential E°, the cathodic peak potential shifts to negative side (-0.602 V) while 
the anodic peak potential (-0.459 V) experiences a positive shift and a decrease in the AEp 
value (143 mV). Complex lC2gH4oN806CuSn2]Cl2 also shows decrease in AEp (0.150 V) 
and E" (-0.320 V) values (Figure 77) 
I ' • • I ' ' ' I ' • • I — • • I • • ' I ' • ' I — • ^ ' - n 
16 14 \2 10 08 06 04 02 0 -02 -04 -06 -OS 
Polenlal/V 
Figure 77. Cyclic voltammogram of complex [C28H4oN806CuSn2]Cl2 alone (curve a) and 
CTDNA bound [C28H4nNs06CuSn2jCl2 (curve b) at scan rate 0 3 Vs' 
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In addition, tiie change in formal potential E", the ratio of voltammetric peak currents 
Ipa/lpc decrease upon the addition of CT DNA to the complexes suggesting that both the 
complex bind strongly to CT DNA [199, 259]. The E° formal potential, Epc cathodic peak 
potential Epa anodic peak potential and Ipa/lpc in the presence of CT DNA also 
demonstrate a fairly quasi-reversible one electron transfer further suggesting that both 
copper(Il) and copper(I) forms of the present complex bind to CT DNA with the same 
affinity. 
To elucidate the binding mechanism involving the copper(ll) or copper(I) forms of 
complexes to CT DNA, the net shift in E°can be used to estimate the ratio of equilibrium 
constants by the following equation (Scheme 8). 
Eb"-E,-°= 0.059 log (KK/K2+) 
The ratio of binding constants of Cu^ and Cu^ ^ species were (-0.82) close to 1, 
suggesting that both copper(ll) and copper(l) forms interact with CT DNA to the same 
extent [241, 256]. 
Cu f e 
K., 
II 
V 
Cu - CT DNA + e 
-^ Cu 
I<K 
y 
Cu - CTDNA 
Scheme 8 
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Kinetic studies 
The interaction of complexes [C26H36N806CuSn2]Cl2 and [C28H4oN806CuSn2]Cl2 with 
CT DNA and guanine were investigated by absorption spectroscopy under psuedo-first 
order conditions (DNA / guanine » complex) at 25±01 '^  C. Kinetics of CT DNA binding 
to complexes were carried out at 260 nm (kma^ for DNA) by keeping the concentration of 
complexes constant (c = 0.4 x 10"^  M) and varying the concentration of CT DNA (4.0-6.4 
x 10" M) at different time intervals (Figure 78). The spectral traces showed that on 
addition of CT DNA to the complexes, there is an increase in absorbance intensities, 
which is attributed to hyperchromism [203, 260] and a red shift of 2-4 nm suggesting 
strong binding of the two complexes with CT DNA. In view of earlier reports, such 
strong interaction of [C26H36N806CuSn2]Cl2and [C28H4oN806CuSn2]Cl2 complexes with 
CT DNA indicate that the tin(IV) atom binds to the phosphate backbone of the DNA 
helix while the copper(ll) center preferentially attacks at the N7 position of guanine, and 
shows structural and conformational changes in DNA [161,261, 262]. 
Furthermore, the interaction of the copper complexes [C26H36N806CuSn2]Ci2 and 
[C28H4oN806CuSn2]Cl2 with guanine were also carried out to obtain detailed information 
concerning the binding mode of the two complexes as a function of N7 position of 
guanine within CT DNA. The absorption spectrum of free guanine exhibits two 
characteristic bands at 244 nm and 273 nm [263]. On addition of complexes to guanine, a 
red shift of 2-4 nm was observed with significant hyperchromism (Figure 79). 
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Figure 78. Absorption spectral traces of (a) [C26H36Ns06CuSn2]Cl2 (b) 
[C28H4oNs06CuSn2]Cl2 in tris HCl buffer upon addition ofCTDNA. Inset: Plot of log A 
versus time at varying concentration ofDNA (c - 4.0-6.4x10'^M) 
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Figure 79. Absorption spectral traces of (a) [C26Hi6NsO(,CuSn2]Ch (b) 
[C2sH4f)Ns06CuSn2jCh in phosphate buffer upon addition of guanine. Inset: Plot of log 
A versus time at varying concentration of guanine (c = 4.0-6.4x10'^M) 
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The spectral changes support the binding mode of copper complexes with N7 position of 
guanine base. Thus, the two complexes [C26H36N806CuSn2]Cl2 and 
[C28H4oNs06CuSn2]Cl2 may first bind to phosphate group of CT DMA, neutralizing the 
negative charge of CT DNA phosphate group and then bind covalently with guanine 
nucleobase which is clearly evidenced by the overall hyperchromism effect observed in 
the kinetic studies with guanine [164], 
The pseudo-first order rate constants kobs were derived by a fit of a single exponential 
function, log (Aoo-At) to the time dependent increase of peak areas corresponding to 
binding of CT DNA and guanine. The following rate law has been derived 
kobs =kik2[DNA]or[Guanine]/k.i+k2 (3) 
where ki k2 and k.i are respective rate constants, the subscript describes the direction in 
which the rate constant is acting. k2 is the rate determining step for DNA/guanine-
complex formation, and l<obs are depicted graphically in Figure 80 and 81. The rate law 
(3) holds good only if the plot of kobs versus [DNA]/[Guanine] is linear. Thus, the 
suggested mechanism derived from the kinetic data for binding of copper complexes with 
CT DNA is correct as shown in Scheme 9. The plots of kobs versus [DNA] and [Guanine] 
gave a straight line, which provides a supporting evidence for the proposed mechanism. 
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Figure 80. Plot of kobs versus [DNA] [C26H36Ns06CuSn2]Cl2 (•) 
[C2sH4oNs06CuSn2]Cl2(w) ([DNA] = 4.0-6.4x10'^ M) 
0.0045 
r^ 0.0035 
do 
4.8 5.6 6.4 
[Guanine] X10-'M 
Figure 81. Plot of hots versus [Guanine] [C26H36Ns06CuSn2]Cl2 (^) 
[C2sH4oNs06CuSn2]Cl2(*) ([Guanine] = 4.0-6.4x 10'^M) 
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Viscosity measurements 
As supporting evidence for exploring the binding mode of tiie complexes witii CT DNA, 
viscosity measurements were performed, which are the most critical tests of binding in 
solution [210, 211, 264]. Viscosity of CT DNA was measured at a fixed concentration of 
DNA by varying the concentration of added complexes [C:6H.i6Ns06CuSn2]Cl2 and 
[C28H4oN806CuSn2]Cl2, as depicted graphically in Figure 82. 
aoe ai5 a25 
|Complex]/[DNAl 
Figure 82. Effect of increasing amount of complexes [C26H3(N806CuSn2]Cl2(M) and 
[C2&H4(iN&06CuSn2]Cl2(*) on the relative viscosity of CT DNA at 29±0.f C. [DNA] = 
5x10-' 
On addition of complexes [C26H36N806CuSn2]Cl2 and [C28H4oN806CuSn2]Cl2, the 
relative viscosity of CT DNA decreases [265]. These experimental results suggest that 
the complexes fail to significantly alter the length of DNA, which imply that both the 
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complexes bind to CT DNA covalently [206]. The conformational structure of the chiral 
complexes brings about significant changes in the DNA helix by inducing static bends 
and concomitantly decreases the viscosity of DNA [266]. Thus, viscosity measurements 
are consistent with the observed hyperchromic effect and a red shift of copper complexes 
bound to CT DNA. 
Conclusions 
The present studies show that amino acids in combination with ligands such as 
ethylenediamine and propanediamine, can form stable trinuclear complexes with tin(IV) 
and copper/nickel(II) metal ions. The chiral auxiliary such as tryptophan incorporated in 
the metal complexes can generate more selective and active metal center, which is well 
tuned to adopt a different stereochemistry. The interaction studies of 
[C26H36N806CuSn2]C!2 and [C28H4oN806CuSn2]Cl2 complexes with CT DNA suggest 
that the complexes are strong stereoselective inhibitor of DNA as Cu(ll) center 
preferentially attacks at the N? position of guanine while Sn(lV) atom binds to the 
phosphate backbone of DNA helix, which was further supported by the kinetic studies of 
copper complexes with guanine base. Thus, the complexes [C26H36N806CuSn2]Cl2 and 
[C28H4oN806CuSn2]Cl2 are the promising candidates for cancer chemotherapy. 
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CHAPTER VI 
DNA Binding Studies of Novel Copper (II) 
Complexes Containing L-Tryptophan as Chiral Auxiliary: 
In Vitro Antitumour Activity of Cu-Sn2 Complex 
in Human Neuroblastoma Cells 
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CHAPTER VI 
Experimental 
All reagents were of the best commercial grade and were used without further 
purification. 1,2-diaminobenzene, CUCI2.2H2O, Tris-base, adenine (E. Merck), ZnCb 
(Ranbaxy), SnC^ (Lancaster), ZrCU (Lancaster), thymine, guanine (Sigma Chemical 
Co.) and L-tryptophan (Loba Chemie) were used as received. Carbon, hydrogen and 
nitrogen contents were determined using Carlo Erba Analyzer Model 1108. Molar 
conductance were measured at room temperature on a Digsun Electronic conductivity 
Bridge. Fourier-transform IR (FTIR) spectra were recorded on an Interspec 2020 FTIR 
spectrometer, in nujol mull. UV/vis spectra were recorded on a USB 2000 Ocean Optics 
spectrometer in DMSO and the data were reported as A,max/nm. The EPR spectrum of the 
copper complex was acquired on a Varian E 112 spectrometer using X-band frequency 
(9.1GHz) at liquid nitrogen temperature in solid and solution state. The 'H and '^ C NMR 
spectra were obtained on a Bruker DRX-300 spectrometer and "'^ Sn NMR was recorded 
on a VXR-300 Varian spectrometer operating at room temperature. Optical rotations of 
chiral complexes were determined on a Polarimeter Rudolf Autopol 111 at 25*^0 using the 
sodium D line in EtOH. ESl-MS spectra were recorded on Micromass Quattro II triple 
quadrupole mass spectrometer. Copper and Zinc content were determined on GBC 932 
Plus atomic absorption spectrophotometer. 
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Concentrated stock solutions of the copper complexes were prepared by dissolving the 
complex [C23H3iN606CuSn2Cl4]Cl and [C23H3iN606CuZr2Cl4]Cl in EtOH and diluting 
suitably with the corresponding buffer to the required concentrations for all the 
experiments. 
Evaluation of in vitro antitumour activity 
Stock solution of complex [C23H3iN606CuSn2Cl4]CI (Img/ml) was prepared in EtOH, 
stored at room temperature and diluted suitably with corresponding medium to required 
concentrations for all the experiments. 
Cell Culture 
SH-SY5Y cells were obtained from the American Type Culture, collection was 
maintained in DMEM medium with high glucose, supplemented with 10% freshly 
inactivated FBS, 1% antibiotic-antimycotics, 1% non essential amino acid and 2.5% L-
glutamine (all from Life Technologies, Inc.). PC-12 cells were cultured in DMEM with 
high glucose, supplemented with \0% FHS, 5% PCS and \% antibiotic-antimycotics. 
Both the cell cultures were grown in a humidified incubator at 37"C with 5% CO2. The 
medium was replaced after 3 days and cells were split before they reached confluence. 
Cells were discarded after about 15 passages. 
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Cell counting 
The cells (SY5Y, PC-12,) were plated in a 24 well plate at a density of 2.5 x 10^  cells per 
well in ca. 800 )J,I of medium and was kept in the incubator for 24 hours. The cells were 
then serum starved for ca. 12 hours and treated with various doses (2 |.d, 4 \i\, 6 |al and 8 
|j.l) of complex [C23H3iN606CuSn2Cl4]CI in duplicates. No treatment was given to the 
control sets. After 24 hours of treatment, the medium was removed and the cells were 
washed with PBS (400|a,l). In order to detach cells, the wells were trypsinised with 50fxl 
of trypsin in case of SY5Y cells. The cell mortality was evaluated by counting the cells 
using a haemocytometer. The data were presented by plotting a graph between the 
percentage of live cells and compound concentration. 
MIT assay 
The cytotoxicity exerted by complex [C23H3iN606CuSn2Cl4]Cl was assessed by the MTT 
assay. The assay is based on the fact that only live cells reduce yellow 3-(4,5-
dimethylthiazo]-2-yl-)-2,5-diphenyltetrazolium bromide (MTT) but not dead cells to blue 
formazan products. Briefly, 7x10'* tumor cells (SY5Y) were plated in a 96-well flat 
bottom microliter plates, in 150|j,l of corresponding medium. Cells were incubated for 24 
hours to adhere properly. The cells were treated with complex [C23H3iN606CuSn2Cl4]CI 
in different concentrations (0.1-0.4 x 10'^  |.iM, final concentration), and incubated for 24 
hours. Untreated cells were used as negative control, since complex 
[C23H3iN606CuSn2Cl4]Cl is ethanol soluble so the cells treated with EtOH without 
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complex [C23H3iN606CLiSn2CLi]CI were used as controls. MTT (15 ).il) was added to each 
well to a final concentration of 5mg/ml and incubated additionally for 3 hour at 37^ C. 
The reaction was terminated by removing the medium, the formazan dye was dissolved 
by adding 50 1^ of 0.1 N HCI in isopropanol. The plates were read at 570 and 655 nm on 
Bio-Rad 680-microplate reader. The assay was performed in triplicate and the arithmetic 
means were determined by using Excel Software. The results were expressed as the 
percentage of alive cells vs [C23H3|N606CuSn2Cl4]Cl as calculated from MTT reduction, 
assuming that the absorbance of the negative controls was 100%. 
Preparation of whole cell lysates 
To prepare the whole cell lysates, cells were first grown in 6 cm dishes, after treatment 
with complex [C23H3iN606CuSn2Cl4]CI, cells were harvested at different time points. 
Cells were washed with PBS, pH 7.2, and lysed with 500 |j.l of lysis buffer (10 mM Tris, 
150 mM NaCI, 1% Triton X-100, 5 mM EDTA, 25mM glycerophosphate, 1 mM PMSF, 
2mM, benzamidine, 10 mg/ml aprotinin, 10 mg/ml leupeptin, and ImM sodium 
orthovanadate) and incubated on ice for 15 minutes. The lysed cells were transferred to 
1.5 ml Eppendorf tubes, and were centrifuged at 16,000 rpm for 20 min at 4 C. 
Supernatant was collected, and Pierce BCA protein assay reagent was used to determine 
the protein concentration. The aliquots of cell lysates were boiled with SDS sample 
buffer and analyzed by Western blot using the indicated antibodies. 
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Preparation of mitochondrial lysates 
To prepare the mitochondrial lysates, cells were first grown in 6 cm dishes, after 
treatment with complex |"C2iH3iN606CuSn2Cl4]CI, cells were harvested at different time 
points. Cells were washed twice with ice cold sterile PBS (pH 7.2) and cell pellets were 
resuspended in RSB buffer (a hypotonic buffer) (10 mM NaCl, 1.5 mM MgCl2, 10 mM 
Tris-HCl, pH 7.5) for 10 minutes to allow cells to swell. The swollen cells break opened 
by several strokes of pestle of Dounce homogenizer. 2.5 X MS buffer (an iso-osmotic 
buffer) (525 mM mannitol, 175 mM sucrose, 12.5 mM Tris-HCI, pH 7.5, 2.5 mM EDTA, 
pH 7.5) was added immediately to it and mixed well by inverting the homogenizer a 
couple of times. The homogenate was transferred to a centrifuge tube for differential 
centrifugation and then 1 X MS buffer (210 mM mannitol, 70 mM sucrose, 5 mM Tris-
HCl, pH 7.5, I mM EDTA, pH 7.5) was added. The mitochondrial extracts for the 
detection of Bcl-2 family proteins (Bad, and Bak) were fractionated onto 12% 
polyacrylamide gel. Proteins were visualized by ECL. 
Western blot analysis 
Cell lysates containing a total protein of 20-30 |xg were loaded onto 12% SDS-
polyacrylamide gels. Resolved proteins were then electrophoretically transferred onto 
PVDF membrane. The blot was blocked with 5% skim milk, in 0.1% Tween 20 TBS 
solution for 2 hours at room temperature; all antibody binding reactions were performed 
in the same buffer. The membrane was incubated at 4° C overnight with primary 
157 
antibodies, after washing, the membrane was then incubated with activator protein-
conjugated secondary antibody for Ihour at room temperature and washed again in 
TBS/Tween 20. The signal was detected by the ECL Western blot system (Pierce). 
Caspase activation and activity assay 
The caspase activity assay was based on spectrophotometric detection of the 
chromatophore pNA after cleavage from the labeled substrate DEVD-/?NA by caspase-3 
like proteases. Cultured SY5Y cells were treated with and without complex 
rC23H3iN606CuSn2Cl4]CI (2.0 )il/ml) for 0 to 18 hours at 3?" C. Cells were lysed and 
assay was performed with the Caspasc-3/CPP32 colorimetric kit (BioVision) according to 
the manufacturer's protocol. 
Synthesis of [Bis(l,2 diaminobenzene) copper/zinc(II)] chloride 
To a solution of CUCI2.2H2O (1.71 g, 10 mmol) in 30 ml MeOH, was added a methanolic 
solution of 1,2-diaminobenzene (2.16 g, 20 mmol) in 1:2 molar ratio. The mixture was 
stirred for 1 hour. The dark green product obtained was washed with Et20 and dried in 
vacuo. 
[Bis (1,2-diaminobenzene) zinc (II)] chloride was also synthesized by a similar procedure 
with ZnCl2 (1.36 g, 10 mmol). 
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Synthesis of [C23H3iN606CuSn2Cl4]CI 
[Bis(l,2-diaminobenzene) copper (II)] chloride (3.49 g, 10 mmol) dissolved in 20 ml 
MeOH was treated with SnCU (2.34 ml in CCU, 20 mmol) in 1:2 molar ratio. The green 
coloured solution turned to red and the volume of the resulting solution was reduced to 
10 ml by rotary evaporator. A methanolic solution of L-tryptophan (2.04 g, 10 mmol) 
was added to above reaction mixture and refluxed for 72 hours. The solvent was further 
removed by rotary evaporator to give a dark brown coloured solid product, which was 
filtered, washed with hexane and dried in vacuo (Scheme I). 
Synthesis of [C23H3iN606CuZr2Cl4]Cl 
[Bis(],2-diaminobenzene) copper (II)] chloride (3.49 g, 10 mmol) was dissolved in 20 ml 
MeOH and added to a solution of ZrCU (4.66 gm, 20 mmol) in 20 ml MeOH with 
stirring. The green coloured solution changed to red, which was concentrated up to half 
of the volume. To this solution L-tryptophan dissolved in MeOH was added slowly and 
• subjected to reflux for 75 hours. The volume of the resulting solution was reduced by 
rotary evaporator to give red brown coloured amorphous product, which was filtered, 
washed with hexane and dried in vacuo. 
Synthesis of [C23H3iN606ZnSn2Cl4]Cl 
[Bis (1,2 diaminobenzene) zinc] chloride (3.51 gm, 10 mmol) dissolved in 20 ml MeOH 
was added to a solution of SnCl4 (2.34 ml in CCI4, 20 mmol) in 1:2 molar ratio. 
159 
SnCl4/ZrCl4 + H2N—(^ COOH 
R 
L-Tryptophan 
1 
HpN-C-R 
NHT H-^N-
H,N' 
.CI 
•CI-
R = 
— CH2 
- ^ 
M = Cu (II), Zn(ll) M' = Sn (IV), Zr(IV) 
Scheme 10 
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The green coloured solution turned to red and the volume of the resulting solution was 
reduced to 10 ml by rotary evaporator. L-tryptophan (2.04 g, 10 mmol) dissolved in 
methanol was added to above reaction mixture and allowed to reflux for 76 hours. The 
solvent was gradually removed by evaporation under vacuum until a blackish brown solid 
product was obtained which was filtered, washed with hexane and dried in vacuo 
(Scheme 10). 
Synthesis of [CjaHaiNcOfiZnZrzCUlCl 
[Bis (1,2-diaminobenzene) zinc] chloride (3.51 gm, 10 mmol) was dissolved in 20ml 
MeOH and a solution of ZrCU (4.66 gm, 20mmol) in 20 ml MeOH was added to it with 
stirring. The solution was concentrated up to half of the volume. To this solution 
L-tryptophan dissolved in MeOH was added slowly and subjected to reflux for 73 hours. 
The resulting solution was concentrated by rotary evaporator to give red brown coloured 
amorphous product, which was filtered, washed with hexane and dried in vacuo. 
Results and discussion 
Synthesis of trinuclear complexes were achieved by mixing stoichiometric amounts of 
[Bis(l,2-diaminobenzene)copper(II)/zinc(II)] chloride and SnCU/ZrCU followed by 
reaction with L-tryptophan as chiral auxiliary (Scheme 10). The complexes have been 
characterized using elemental analysis and various spectral methods. All the analytical 
data are in good agreement with theoretical requirements. The complexes are red brown 
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in colour, stable towards air and moisture and soluble in EtOH, DMSO and DMF. Molar 
conductance values of complexes in EtOH (1x10'^  M) at 25 °C suggest their 1:1 
electrolytic nature (40-45 Q.' cm" mol" ). Due to the presence of chiral auxiliary L-
tryptophan, complexes exhibited optical rotation [ajo values +26, +12, +17 and +72, 
respectively which indicate that all the complexes are optically active (Table 13). In 
complexes the coordination geometry of central metal ion Cu(ll)/Zn(ll) are square 
pyramidal; Sn(lV)/Zr(IV) is present in hexacoordinate environment, which is proposed 
on the basis of spectroscopic studies. DNA binding studies were carried out with copper 
complexes and their analogous zinc complexes were synthesized only for NMR studies. 
The interaction studies of copper complexes with CT DNA indicate that complex 
[C23H3iN606CuSn2Cl4]CI binds to DNA with a strong affmity. Thus, the in vitro 
antitumour activity was performed with complex [C^sHsiNeOeCuSniCUJCl. 
IR spectroscopy 
The infrared spectra of the complexes under investigation were recorded in the 4000 to 
250 cm"' range (Table 14). The bands around 1660 cm'' and 1430 cm"' observed in the 
free amino acid assigned to antisymmetric and symmetric 0-C=0 stretching vibrations 
were shifted to lower frequencies suggesting the terminal coordination mode of 
carboxylate group of the L-tryptophan to the transition metal ion via deprotonation [53]. 
The bands at 3185 to 3190 cm"' region and 1528 to 1539 cm"' region were assigned to 
x)(NH) and 8(NH), respectively suggesting that NH2 groups of 1,2-diaminobenzene is 
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coordinated to copper/ zinc and simultaneously to tin/zirconium metal ions by the 
elimination of HCl molecules [267]. The IR spectra of the all the complexes exhibited a 
very broad band at -3386 cm"' corresponding to the uncoordinated amino group of L-
tryptophan suggesting that the amino acid binds to the metal ion in monodentate fashion. 
As a consequence of presence of water molecule coordinated to tin/zirconium metal ion 
the IR spectra of the complexes also displays a band in 3300-3400 cm"' region [268]. 
Thus, the individual assignment of the coordinated water molecule and free NH2 group of 
L-tryptophan was difficult. However, the presence of free NH2 group of tryptophan 
moiety was further substantiated by 'H N M R spectra of zinc complexes. The 
coordination of water molecules to the Sn/Zr metal ion was supported by the appearance 
of non-ligand band in the region 840-851 cm"' attributed to rocking mode of water [39]. 
Other medium intensity bands at 749-755 cm"'signature of aromatic ring vibrations and at 
1239-1245 cm"' due to imidazole-NH were also observed. The coordination of L-
tryptophan and complex formation were also revealed by the presence of medium 
intensity (Cu/Zn-N), (Cu/Zn-0), (Sn/Zr-N) and (Sn/Zr-CI) bands around -460, -520, 
-448 and -330 cm"', respectively in far IR region. All these values are consistent with the 
reported values for a number of copper-tin complexes [269]. 
NMR spectroscopy 
The complexes [C23H3iN606ZnSn2Cl4]CI and [C23H3iN606ZnZr2Cl4]Cl were 
characterized by 'H, '^C, 2D cosy and "^Sn NMR spectra recorded in DMSO-de solution 
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and showed signals for aliphatic and aromatic protons with chemical shift values in 
accordance with the proposed structure. Apart from the absence of signal at 10.0-12.0 
ppm due to the deprotonation of carboxylic acid group of L-tryptophan, the 'H N M R 
spectra of complexes also exhibited the signals of NH2 group of amino acid at ~ 5.3 ppm 
indicating the coordination of amino acid in a unidentate manner to the zinc atom [270]. 
Coupled with these observations the characteristic signals at 4.3, 3.3, 6.9 and 7.1 ppm 
corresponding to asymmetric CH, CH2, imidazole NH and CH=C groups, respectively 
further confirmed the presence of L-tryptophan moiety in chiral metal complexes 
[C23H3iN606ZnSn2Cl4]CI and [C23H3iN606ZnZr2Ci4]CI [270, 271]. The resonance at ~ 
7.3 ppm arise due to -NH proton of 1,2-diaminobenzene [272]. This feature 
commensurate with the fact that the amino group of 1,2-diaminobenzene was coordinated 
to Sn/Zr metal ion through monodeprotonation and simultaneously to zinc metal atom. 
The multiplets due to aromatic protons appeared in the 7.4-7.7 ppm region. The 
assignments of the proton signals were also obtained from 2D cosy NMR, which exhibits 
relatively the same resonance (Figure 83) observed in 'H NMR spectra of complexes 
[C23H3iN606ZnSn2Cl4]Cl and [C23H3iN606ZnZr2Cl4]Cl (Table 15). 
The '^ C NMR spectra of complexes [C23H3iN606ZnSn2Cl4]Cl and 
[C23H3)N606ZnZr2Cl4]Cl were characterized by various resonances due to 0—C=0, 
N—CH, chiral CH and CH2, and carbons at 173, 114, 56 and 38.0 ppm, respectively of 
the coordinated L-tryptophan. In addition C NMR spectra of the zinc complexes reveal 
aromatic carbons at 120-132 ppm (Table 16). 
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119 Sn NMR spectroscopy has been found to be a useful technique for structure elucidation 
and the nature of coordination of tin atom in complexes. The"'Sn chemical shift, S 
("^Sn) is sensitive to the chemical environments of the tin atom. "^Sn NMR spectrum of 
the complex [C23H3iN606ZnSn2Cl4]Cl displayed two signals at -625 and -668 ppm, 
(Table 3) which is due to the presence of two tin metal centers. These chemical shift 
values are consistent with those reported for complexes with hexacoordinate geometry of 
tin metal atom [273] (Figure 84). 
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119 Figure 84. '"Sn NMR spectrum of complex [C23H3iN606ZnSn2Ck]Cl. 
Absorption spectroscopy 
The electronic spectra of all the complexes were recorded in the 200-800 nm region at 
room temperature in DMSO. A broad band at 410 and 420 nm assigned to metal to ligand 
charge transfer transition were observed for complexes [C23H3iNt,06CuSn2Cl4]Cl and 
[C23H3iN606CuZr2Cl4]Cl, respectively [274]. The UV/vis spectra of complexes 
[C23H3iN606CuSn2Cl4]Cl and [C23H3iN606CuZr2Cl4]CI also showed broad and intense 
absorption maxima centered at 620 and 630 nm, respectively [238, 275]. This spectral 
feature is typical of pentacoordinated copper complexes with distorted square pyramidal 
geometry, which generally exhibited a band in the 550-660 nm region (dxz, dyz -* dx% )^ 
[276]. The absorption spectra of the complexes [C23H3iN606ZnSn2Cl4]Cl and 
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[C23H3iN606ZnZr2Cl4]CI revealed one intense band around 400 nm, which corresponds 
to the metal to ligand charge transfer transitions [277]. All the complexes displayed 
strong band in UV region at 257-277 nm attributed t0 7r-7r* transition [103]. 
EPR spectra 
The X-band EPR spectra of complexes [C23H3iN606CuSn2Cl4]CI and 
[C23H3iN606CLiZr2Cl4]CI, were acquired at liquid nitrogen temperature under the 
magnetic field strength 3000 ± 1000 gauss using TCNE as field marker. In solid state, 
both the complexes show only an isotropic band centered at g = 2.04 [278] (Figure 85a & 
86a). The value was in good agreement with the unpaired electron mainly located in d^ 
orbital. This pattern is typical for copper complexes with square pyramidal environment. 
H/0 
Figure 85. EPR spectra of complex [C23H3iN606CuSn2Cl4jCl in solid state (curve a) 
in DMSO at LNT(curve b) 
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The geometry of the complexes in solution state was confirmed by running tiie spectra in 
DMSO. The solution EPR spectra of complexes [C23H3iN606CuSn2Cl4]Cl and 
[Ci^ H i^iN^Or.CuZraCUlCl, at I.NT were also well reproduced and exhibited only a single 
isotropic signal at g = 2.09 and 2.07, respectively [279] (Figure 85b & 86b). This is 
consistent with the square pyramidal geometry of copper ion as well as with the results of 
solid-state RPR spectra. 
JDOO 
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Figure 86. EPR spectra of complex [CisHsiNcOoCuZriCUJCl in solid state (curve a) 
in DMSO at LNT(curve b) 
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DNA binding studies 
Since DNA is the primary pharmacological target of many antiliimour compounds [280] 
DNA-mctal complex interaction has paramount importance in understanding mechanism 
of tumour inhibtion for the treatment of cancer (The cancer spreads when affected cells 
multiply rapidly, forming tumors of varying degrees.), as the binding of complexes to 
DNA causes significant distortion of its helical structure and results in inhibition of DNA 
replication and transcription [281]. The interaction of complexes 
[C23H3iN606CuSn2Cl4]Cl and [C23H3iN606CuZr2Cl4]Cl, with DNA were analyzed by a 
number of techniques, such as absorption titration, cyclic voltammetry, fluorescence 
spectroscopy, circular dichroism and viscosity measurements. 
Absorption titration 
Electronic absorption spectroscopy is utilized to determine the relative binding propensity 
of the complexes to DNA as the absorption spectra of complexes arc sensitive to changes 
in their environment and are thus able to give an indication of their association with 
nucleic acid. The extents of spectral changes were related to the strength of binding of 
complexes and the spectra for intercalator are more perturbed than those for groove 
binders [282]. The absorption spectra of two complexes [C23H3iN606CuSn2Cl4]Cl and 
[C23H3iN606CuZr2Cl4]CI. in the absence and presence of CT DNA (at a constant 
concentration of complexes, 0.16 x 10" M) are shown in Figure 87. In the ultraviolet 
region, the complexes [C23H3iN606CuSn2Cl4]CI and [C23H3iN606CuZr2Cl4]CI exhibited 
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intense absorption bands at 257 and 262 nm, respectively, which were assigned to 7i - TI* 
transition of aromatic chromophore and other at ~ 420 nm in visible region which is 
attributed to metal to Hgand charge transfer (MLCT) bands. The intense n-n* bands and 
MLCT bands were measured as a function of the concentration of added CT DNA (0-0.4 
X lO""* M). With increasing CT DNA the absorption bands of the complexes 
[C23H3iN606CuSn2Cl4]CI and [C23H3iN606CuZr2Cl4]CI, are affected, exhibiting 
hyperchromism of 26% and 24% and red shift of 6 and 4 nm in TI - 7t* transitions of 
complex [C23H3iN606CuSn2Cl4]CI and [C23H3iN606CuZr2Cl4]CI, respectively when 
saturated around [DNA]/[Complex] = 25. hi addition, the spectral changes in MLCT 
bands at 410 and 420 nm also reveal hyperchromism, although the extent of 
hyperchromism is lower than that observed in case of TT - n*. A strong hyperchromic 
effect with a significant red shift in TT - n* transition was observed for complex 
[C23H3iN606CuSn2Cl4]CI suggesting that this complex posses higher propensity for DNA 
binding. The extent of hyperchromism was different for complexes 
[C23H3iN606CuSn2Cl4]CI and [C23H3iN606CuZr7Cl4]CI, which could be due to the 
presence of second metal ion (less reactive Zr(lV) ion is present in complex 
[C23H3iN606CuZr2Cl4]CI in comparison to Sn(IV) metal ion in complex 
[C23H3iNo06CuSn2Cl4]Cl) [283]. The experimental results suggest that in both the 
complexes Sn(IV)/Zr(IV) metal ion binds to the phosphate backbone of the DNA helix 
[284] while the copper (II) ion preferentially attacks at the Ny position of guanine and 
shows structural and conformational changes in DNA [285]. 
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Figure 87. Absorption spectral traces of (a) Complex [C23HsiN606CuSn2Cl4jCl and 
(b) complex [C23HS1N606CuZr2Cl4]CI in Tris HCl buffer upon addition of CT DMA. 
Inset: Plots of [DNAJ / Sa-C/vs [DMA] for the titration ofCT DNA with complexes u, 
experimental data points; full lines, linear fitting of the data, [complex] 0.16x10' M, 
[DNA] 0-0.4 xia^M 
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In order to compare quantitatively the binding strength of complex 
[C23H3iN606CuSn2Cl4]Cl and [C23H3iN60(,CuZr2Cl4]CI with CT DNA, the intrinsic 
binding constants Kb of the complexes were determined with eq. (1) by monitoring the 
changes in absorbance of the % - n* bands with increasing concentration of CT DNA. 
The binding constants obtained for the complexes [C23H3iN606CuSn2Cl4]Cl and 
[C23H3iN606CuZr2Cl4]CI are 3.0 x lO'' M"' and 2.7 x 10^  M"', respectively. These Kb 
values suggest that complex [C23H3iN606CuSn2Cl4]Cl has strong binding affinity for CT 
DNA. 
To confirm the mode of binding the interaction of complexes [C23H3iN606CuSn2Cl4]Cl 
and [C23H3iN606CuZr2Cl4]Cl have also been carried out with guanine, adenine and 
thymine. The complexes [C23H3iN606CuSn2Cl4]CI and [C23H3iN606CuZr2Cl4]Cl exhibit 
d-d band at 620 nm and 630 nm. 
700 
Wavelength Inm 
Figure 88. Absorption spectra of complex [CjsHsiNoOoCuSnjCUjCl (6 x 10' M) (curve 
a), on interaction with adenine (cur\>e b), thymine (curve c), guanine (curve d) and CT 
DNA (curve e). 
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Upon addition of adenine and thymine to tiie copper complexes small changes were 
observed with no shift. On the other hand, copper complexes bound to guanine showed 
hyperchromism with a red shift of 10 nm (Figure 88). Thus, the experimental results 
suggest that copper complexes bind preferably to Ny position of guanine [206, 262]. 
Steady-state emission titration 
Complexes [C23H3i>J606CuSn2Cl4]Cl and [CjsHjiNoOftCuZr.CUlCl exhibit strong 
emmission either alone in DMSO or in the presence of DNA. At room temperature 
complex [C23H3iN606CuZr2Cl4]Cl exhibits strong emission bands around 350 nm with a 
shoulder when excited at 262 nm while for complex [C23H3iN606CuSn2Cl4]Cl an 
excitation wavelength of 257 nm was used and total emission intensity was monitored at 
550 nm. Fixed amount of complexes [C23H3iN606CuSn2Cl4]Cl and 
fC23H3|N606CuZr2Cl4]Ci were titrated with increasing amounts of DNA, over a range of 
DNA concentration from 0-13 x 10"^  M. Titration of CT DNA led to a remarkable 
decrease in the emission intensity of complex [C23H3iN606CuSn2Cl4]Cl and 
[C23H3iN606CuZr2Cl4]Cl, as illustrated in Figure 89 a, b respectively. 
The relative fluorescence intensity as a function of calf thymus DNA concentration (in 
terms of [DNA]/[complex]) was plotted in inset of Figure 90 a, b. Complex 
[C23H3iN606CuSn2Cl4]CI produced a large reduction in emission intensity in the presence 
of DNA in comparison to complex [C23H3iN606CuZr2Cl4]Cl. 
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Figure 89. Emission spectra of (a) complex [C23H3jN606CuSn2Cl4]Cl (b) complex 
[C2iH3iN606CuZr2Cl4]Cl in Tris HCl buffer DNA in the presence ofDNA. [DNA] 0-13 x 
10'^ M. Arrows shows the intensity changes upon increasing concentration of the 
complexes. Inset: Plot of relative emission intensity versus [DNA]/[complex] 
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The quenching of the luminescent excited state of the complexes was due to the 
energy/electron transfer from the guanine base of DNA to the MLCT of the complexes 
178,286]. 
To further demonstrate the interaction pattern of the (luorescence probe complex 
[C23ll3iN60(,CuSn2Cl4jCl and [Cajl IjiNfaO i^CuZriCUJCI with DNA, we performed the 
[Fe(CN)6j' quenching experiments. Multianionic [Fe(CN)6]''' ion is known to be a 
dynamic fluorescence quencher and provides a sensitive tool to examine the nature of the 
interaction of the probe with the DNA[287]. The binding of complexes to the helix 
should protect the fluorophore from quenching due to the repulsion between negatively 
charged |Fe(CN)6]''' and negative charge of the DNA phosphate backbone [288]. The 
quenching efficiency is evaluated by Stern-Volmer constant Ksv, which varies with the 
experimental conditions. A large value of binding constant corresponds to poorer 
protection and weaker binding to DNA and vice versa. 
33 6.6 10 
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Figure 90. Emission quenching curve of complex [Ci^lhiN(,0(>CuSn2Cl4]Cl with 
increasing concentration of quencher [Fe(CN)(,] ' in absence of DNA (m) in presence of 
DNA (k). fComplex] = 3.3x 10'^M, [DNA] ^6.6x10"^ M 
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Figure 91. Emission quenching curve of complex [C23H3iN606CuZr2Cl4jCl with 
increasing concentration of quencher [Fe(CN)6]^' in absence of DMA (m) in presence of 
DMA (k). [Complex] = 3.3 x 10'^M. [DMA] = 6.6 x 10"' M 
Figure 90, 91 showed the Stern-Volmer plots with ferrocyanide anion as quencher for 
complex [C23H3iN606CuSn2Cl4lCI and [C23H3iN606CuZr2Cl4]CI, respectively. The plot 
in case of free complexes gave Ksv = 14 x lO^M'' for [C23H3iN606CuSn2Cl4]Cl & 8 x 10^  
M" for [C23H3iN606CuZr2Cl4]CI. In presence of DNA, the quenching curve was 
obviously depressed, reflecting the complexes were protected by the DNA helix. The Ksv 
values decreased to 5 x 10^  M"' and 4 x 1 0 ' M"' for complex [C23H3|N606CuSn2Cl4]Cl 
and [C23H3iN606CuZr2Cl4]CI, respectively. The greater decrease in K^v value of complex 
[C23H3iN606CuSn2Cl4]Cl in presence of DNA as compared to complex 
[C23H3iN606CuZr2Cl4]Cl indicates that complex [C23H3iN606CuSn2Cl4]Cl was bound 
more tightly to the DNA. This could be explained by the fact that complexes free in 
76 
solution or bound on the helix exterio'- are accessible to the quencher while those bound 
in the helix interior are much less accessible [78]. 
Circular dichoric spectral studies 
Circular dichoric studies are useful in diagnosing changes in the morphology of DNA 
during complex-DNA interactions [289]. Complex [C23H3|N606CuSn2Cl4]Cl and 
[C23H3iN606CuZr2Cl4]Cl were characterized by positive bands around 260 and 280 nm 
(Figure 92). 
The observed CD spectrum of CT DNA consists of a positive band at 275 nm due to base 
stacking and negative band at 245 nm due to helicity, which arc characteristics of DNA in 
right handed B form [290]. Simple groove binding and cicctroslatic interaction of the 
complexes with DNA show less or no perturbations on the base slacking and helicity 
hands while intercalator enhances the intensities of both bands [290|. 
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Figure 92. CD spednim of complex [C:sHsiNo06CiiSn2ClJCl (curve a) complex 
[C:;H,,y,0f,CuZr2CU]Cl (curve b) 
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The CD spectrum of CT DNA after addition of complex [C23H3iN606CuSn2Cl4]Cl show 
an increase in positive and decrease in negative ellipticity with red shift of 4 nm. 
Complex [C23H3iN606CiiZr2Cl4]Cl also display a decrease and increase in intensities, 
respectively of the negative and positive bands but interestingly, without shift in the band 
position. These alterations in the CD spectrum of DNA indicate strong conformational 
changes by the complexes [291]. We can see that CD spectral changes by the complex 
[C23H3iN606CuSn2Cl4]CI are larger than that of complex [C23H3iN606CuZr2Cl4]CI 
(Figure 93). Such results suggest that the CD spectra are closely correlated with DNA 
binding affinity. Further, the decrease in negative band is probably due to the unwinding 
of DNA helix upon interaction of comple.Kes then transformed into other A-like 
conformations. 
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Figure 93. CD spectra of CT DNA alone (curve a) CT-DNA in presence of complex 
[C23H3iN606CuZr2Cl4]Cl (curve b) CT DNA in presence of complex 
[C23H3iN606CuSn2Cl4]Cl (curve c) in Tris-HCl buffer at 25^C. [Complex] = 1 
xlO'^ M, [DNA] =1 xlQ-^ M 
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Viscosity studies 
To throw further Hght on the binding mode, viscosity measurements on complexes 
fC23H,iN(,06CuSn2Cl4]Cl and [C23H.,iNf,06CuZr2Cl4lCI bound to DNA were undertaken. 
Optical photophysicai probes generally provide necessary but insufficient evidences to 
support a binding mode of complexes with DNA. Measurements of DNA viscosity are 
regarded as the least ambiguous and most critical test of a DNA binding model in 
solution [292] and affords a stronger argument for DNA binding mode [293]. The 
increase in relative specific viscosity (TIMO, where r] and r\o are the specific viscosities of 
DNA in the presence and absence of complexes) reflects the increase in contour length 
associated with separation of DNA pairs caused by intercalation, [206] a classical 
inlercalator such as ethidium bromide cause a significant increase in viscosity of DNA 
solutions [294]. In contrast, electrostatic or covalent binding of molecules could bend or 
kink the DNA helix resulting in a decrease in its effective length and concomitant 
decrease in its viscosity [295]. The values of relative specific viscosities were plotted 
against 1/R (=[complex]/[DNA] 0.02-0.08) (Figure 94). When the complexes 
[C23H3iNft06CuSn2Cl4]Cl and [C23H3iN606CuZr2Cl4]Cl were treated with CT DNA and 
the complex concentration increased from 0.016-0.064 x 10" M, the relative specific 
viscosity decreases which is due to the strong covalent binding of complexes with DNA 
bases [295, 296]. 
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Figure 94. Effects of increasing amount of complex [C2iH}iN(,0(,CuSn2Cl4]Cl (m) and 
complex [C23H3iN606CuZr2Cl4]Cl (k) on the relative viscosity! of CT DNA at 29 ± 0.1 
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Cyclic Voitammetry 
The electro analytical techniques usually rely on the effect of macromolecules e.g. DNA 
on the redox behavior of the metal complexes or other redox active molecules [297]. 
These methods are the rich source of information about the binding and reactivity of 
metal complexes and provide a useful complement to the spectral and viscometric 
studies. The electrochemical profiles of the complexes [C23H3iN606CuSn2Cl4]CI and 
[C23H3iN606CuZr2Cl4]Cl were studied in H2O/DMSO (95:5) by cyclic voitammetry in 
the range from 2.0 to -0.8 V. Cyclic voltammograms of complexes 
[C23H3iN606CuSn2Cl4]CI and [C23l-l3iN606CuZr2Cl4]CI in the absence and presence of 
DNA are shown in Figure 95 and 96. Both the complexes displayed a well-defined 
cathodic wave but the corresponding anodic waves were drawn cut revealing that the 
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very unstable Cu(I) species are not discernible with the time scale of the CV experiments 
[293]. The cyclic voltammogram of complex [C23H3iN606CuSn2Cl4]Cl exhibited 
quasireversible one electron redox process involving the Cii(Il)/(l) couple with cathodic 
peak at Epc= - 0.45V and oxidation peak Ep,, - - 0.31V. For this couple, the difference 
between cathodic and anodic peak potential AEp and ratio of anodic and cathodic peak 
currents Ipa/Ipc are -0.140 V and ~1, respectively. The formal electrode potential E t^aken 
as an average of Epc and Epa was - 0.38 V in the absence of DNA. The CV of complex 
[CjiHii'NeOeCuZrjC^Cl featured reduction of Cu(I])/(I) form at a cathodic peak 
potential Epc of-0.42V. Reoxidation of the complex occurred at -0.32V. The separation 
of the anodic and cathodic peak potential AEp = - O.IOV and ipj/Ip^  ratio = 0.43 indicated 
a quasireversible redox process. 
On addition of CT DNA to the complex [C23H3iN606CuSn2Ci4]Cl and 
[C23H3iN606CuZr2Cl4]Cl results significant reduction in cathodic and anodic peak 
current is due to slow diffusion of an equilibrium mixture of the free and DNA bound 
complexes to the electrode surface [161]. The observed shifts in E values to less 
negative potentials suggest that Cu(Il) and Cu(I) forms of the complex 
[C23H3iN606CuSn2Cl4]CI and [C23H3iN606CuZr2Cl4]Cl bind to DNA. However, the 
larger shift in AEp, E°and Ipa/lpc values observed for [C23H3iN606CuSn2Cl4]Cl than that of 
[C23H3iN606CuZr2Cl4]Cl upon addition of CT DNA may suggest that the binding affinity 
of the former to DNA is stronger than that of the latter.[298] 
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Figure 95. Cyclic voltanimogram (5:95 DMSO/H2O) of imboimd complex 
[C23H3iN606CuSn2Cl4]Cl (curve a) complex [C23Hi,N606CuSn2CU]Cl in presence ofCT 
DMA (curve b). [Complex] 1 xlO'^ M, fDNAJ 6x10'' M 
Figure 96. Cyclic Voltammogram (5:95 DMSO/H2O) unbound complex 
[C23H3!N(,06CuZr2Cl4]Cl (curve a) complex [C23H3iN606CuZr2Cl4]Cl in presence of 
CTDNA (curve b). [Complex] 1 xlO'^ M, [DNA] xlO'^ M 
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In vitro arititumour studies 
The molecular design of novel chiral complex [C23H3iN606CuSn2Cl4]CI is very unique as 
it provides distinct recognition properties for biopolymer structure. Complex 
[C23H3iN606CuSn2Ci4]CI contains two metal centers, a Cu(Il) and Sn(IV) metal ion, 
which act in concord with each other to distort the DNA structure. Previous reports reveal 
that Sn(lV) cation interacts with phosphate backbone of DNA double helix and influence 
the growth of tumour cells. Thus, the mechanism of antitumour action of Sn(IV) 
complexes substantially differs from classical anticancer drugs (cisplatin) and modulatory 
activity of transition metal ions in presence of tin is a unique way to address resistance of 
the anticancer drugs. Complex [C23H3iN606CuSn2Cl4]CI was selected for antitumour 
activity in vitro because it exhibited higher activity than that of [C23H3iN606CuZr2Cl4]Cl 
in preliminary DNA binding studies by various spectroscopic methods and viscosity 
measurements. 
To investigate the antitumor activity of complex [C23H3iN606CuSn2Cl4]CI cell counting 
and MTT assay were performed. Furthermore, to analyze the apoptotic pathway of 
complex fC23H3iN606CuSn2Cl4]CI induced apoptosis in human neuroblastoma cells 
western blot analysis were carried out with Bcl-2 and p-53 family proteins. Caspases 
initiate apoptosis in mammalian cells. Thus, caspase -3 activation has also been checked 
to authenticate the induction of apoptosis by complex [C23H3|N606CuSn2Ci4]Ci. 
Effects on cell proliferation 
The growth-inhibitory effect of complex [C23H3iN606CuSn2Cl4]Cl was examined in 
SY5Y and PC-12 cells using untreated cells as negative controls. In both cases drug 
treatment in the concentration range between 2-8)j,M resulted in a dose dependent 
inhibition of cell survival. The results of these experiments are collected in Figure 97. 
As can be seen, complex [C23H3iN606CuSn2Cl4]Cl showed good antitumor activity 
towards both cell lines. In SY5Y and PC-12 cells a progressive decrease of cell survival 
was observed after 24 hours for complex [C23H3iN606CuSn2Cl4]Cl, when the drug 
concentration increased. Note that the relative number of live PC-12 cells was lower than 
those of SY5Y cell line [299]. Such differences in cell viability may be perhaps due to 
the different origin of the PC-12 cells, a pheochromocytoma cancer cells, which are 
undifferentiated cells in comparison to SY5Y cells, a human neuroblastoma cancer cell 
line. 
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Figure 97. Effect of complex [C23H3,N606CuSn2Cl4]Cl on (a) SY5Y and (b) PC-12 
proliferation after 24 hours of treatment 
Cytotoxicity of complex [C23H3iN(,06CuSn2Cl4]CI 
The in vitro cytotoxicity effect of complex [C23H3iN606CuSn2Cl4]Cl against SY5Y 
tumor cells was analyzed by MTT assay, which serves as an index of cell viability by 
measuring the reduction of tetrazolium salt to a blue formazan product by mitochondrial 
enzyme activity of succinate dehydrogenase in living cells [181]. Complex 
[C23H3iN606CuSn2Cl4]CI in the range of 2.Q\M to S.OJLIM caused dose dependent 
cytotoxicity with approximately 50% of the cells having lost viability after complex 
fC23H3iN606CuSn2Cl4]Cl treatment at a concentration of 4 ^M as shown in Figure 98. 
These results are in accordance with those of the counting experiments [299]. 
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Figure 98. Dose-dependent cytotoxic effect of complex [C2}HsiN606CuSn2Cl4]Cl towards 
SY5Y cells After 24 hours, cell viability was evaluated by MTT assay The data 
expressed as a percentage of the control MTT reduction Since complex 
[C23H3iN606CuSniCl4]Cl is EtOH soluble, cells treated with EtOH without complex 
[C23H3/N(,0(;CuSn2Cl4jChvere used as controls 
Complex [C23H3iN606CuSn2Cl4]CI induced apoptosis in SY5Y cells by intrinsic 
mitochondrial pathway 
The Bcl-2 family of proteins regulates apoptosis by controlling mitochondrial 
permeability and the lelease of cyto c. The anti-apoptosis proteins Bcl-2 and Bcl-xL 
reside in the outer mitochondrial wall and inhibit cyto c release The pro-apoptotic Bcl-2 
proteins are Bad, Bax and Bak iaside in the cytosol but translocate to mitochondria 
following death signaling, where they promote the release of cyto c [300] 
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Reduced Bcl-2 protein level in response to complex [C23H3iN606CuSn2Cl4]CI 
treatment in SY5Y cells 
To investigate the role of antiapoptotic members of the Bcl-2 family in the induction of 
apoptosis in SY5Y cells, we determined its expression in untreated and complex 
[C23H3iN„06CuSn2Cl4]CI -treated cells by Western blot analysis of total cell extracts. As 
shown in Figure 99 complex [C23H3iN606CuSn2Cl4]CI provoked a lower level of 
expression of Bcl-2 in SY5Y cells as measured at fixed dose of complex 
[C23H3iN606CuSn2Cl4]CI (2fil) with different time points. Decline in Bcl-2 level was 
time dependent and was maximum after 24 hour of treatment with complex 
[C23H3iN606CuSn2Cl4]CI. These results support that complex [C23H3iN606CuSn2Cl4]CI 
induced apoptosis associated with a reduced Bcl-2 protein level [301] 
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Figure 99. Protein levels of Bcl-2 determined through Western blotting using total cell 
lysates of SY5Y cells after treatment with 2fil of complex [C23H3iN(,Of,CuSn2ClJCl 
Controls were used to ensure equal protein loading. Protein after Lane 1: 0 hour, Lane 
2- Ihour Lane 3: 3 hour Lane 4: 6 hour Lane 5- 18 hour of treatment with complex 
[C23H3lN606CuSn2Cl4jCl 
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Bak expression in SY5Y cells after incubation with complex 
[C23H3|N606CuSn2Cl4]Cl 
The most intuitive link between p53-medialcd transactivation and apoptosis comes from 
the ability of p53 to control transcription of proapoptotic members of BcI-2 family. To 
determine whether p53 is involved in complex [CasHsiNeOeCuSnaCUJCI -induced 
apoptosis, we examined the expression of its direct downstream factor Bak. SY5Y cells 
were treated with 2.0fig/ml complex [C23H3iN606CuSn2Cl4]Cl, harvested at different 
time points and mitochondrial proteins were extracted which were then subjected to 
Western blot analysis with anti-Bak antibody as depicted in Figure 100 a. Expression 
level of the Bak in SY5Y cells were shown to increase as the incubation time proceeded 
after the treatment of complex [C23H3i'N606CuSn2Cl4]Cl [302]. Since it is well known 
that proapoptotic proteins promotes cell death induced by a variety of stimuli, so up 
regulation of Bak is evidence of complex [C23H3iN606CuSn2Cl4]Cl induced apoptosis. 
Bad regulation in apoptotic STiFcells 
The proapoptotic Bcl-2 family protein Bad resides in the cytosol but translocate to 
mitochondria following death signaling, where they promote the release of cyto c. Bad 
translocates to mitochondria and forms proapoptotic complex with Bcl-xL. This 
translocation is inhibited by survival factors that induce phosphorylation of Bad, leading 
to its cytosolic sequestration [303]. Phosphorylated Bad was seen only in control (Figure 
100 b). 
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Figure 101. The immunoblot analysis of (a) Bak, (b) phospho-bad and (c) total bad in 
mitochondrial lysates of SY5Y cells at indicated time treated with 2/ul of complex 
[C23H3iN606CuSn2ChJCl 
No Bad was seen even at earliest time point of 1 hour of complex 
[C23H3iN606CuSn2Cl4]Cl treatment indicating inhibition of phosphorylation of Bad. No 
difference was seen in the total levels of Bad in mitochondria (Figure 100 c). 
Role of p53 in the complex [C23H3iNo06CuSn2Cl4]CI induced apoptosis 
The p53 tumor suppressor gene is the most frequently mutated gene in human cancer. 
Activation of p53 can lead to either cell cycle arrest and DNA repair or apoptosis. p53 is 
phosphorylated at multiple sites in vivo and by several different protein kinases in vitro. 
DNA damage induces phosphorylation of p53 at Ser 15 and Ser 20 and leads to reduce 
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interaction of p53 with its negative regulator, oncoprotein MDM2. MDM2 inhibits the 
accumulation of p53 by targeting it for ubiquitination and proteasomai degradation. p53 
can apparently be phosphorylated by ATM, ATR and DNA-PK at Ser 15, this 
phosphorylation impairs the ability of MDM2 to bind p53, promoting both the 
accumulation and functional activation of p53 in response to DNA damage. 
This section examines whether p53 protein is involved in complex 
[C23H3iN606CuSn2Cl4]CI -induced apoptosis. The p53 activity was studied by extracting 
nuclear protein from complex [C23H3iN606CuSn2Cl4]CI -treated cells and monitoring the 
p53 protein by immunoblot analysis. The p53 protein was detectable in the nuclear 
extract of the untreated cells (Figure 101, lane 1). After an exposure to complex 
[C23H3iN606CuSn2Cl4]CI, the p53 (phospho-Serl5 and phospho-Ser20) protein level was 
elevated in a time-dependent manner. A complex [C23H3iN606CuSn2Cl4]CI -induced 
increase in phospho-Serl5 and phospho-Ser20 was not noticeable at 1,3 and 6 hour 
(Figure 101, lanes 2, 3, 4) and this increase reached its peak at 18 hour (Figure 101, lane 
5) during the period of complex [C23H3iN606CuSn2Cl4]Cl treatment. However, there was 
no change in the total p53 on treatment with complex [C23H3iN606CuSn2Cl4]Cl. 
Collectively, these results demonstrate that p53 was activated by complex 
fC23H3iN606CuSn2Cl4]CI because nuclear p53 level was increased. 
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Figure 101. Expression ofp53 proteins Western blot analysis of nuclear cell extracts of 
SY5Y cells at different time points after treatment M'ith 2/ul of complex 
[CosHsiN.OoCuSnjChJCl 
Complex [C23H3iN606CuSn2Cl4]CI induced cell death requires Caspase-3 activation 
Caspases have been reported to play vital roles in executing apoptosis [304]. To identify 
the role of caspase involved in the signaling of apoptosis induced by complex 
[C23H3iN606CuSn2Ci4]CI, we examined protein level of active caspase-3 (Figure 102). 
Incubation of 12 hourewith complex [C23H3iN606CuSn2Cl4]CI (2.0|al/ml) increased the 
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protein level of caspase-3 to 101% of the control. However, incubating SY5Y cells with 
complex [C23H3iN606CLiSn2Cl4]Cl for 24 hours resulted in an increase of caspase-3 to 
113% of the control while 48 hour incubation with complex |C23H3iN606CuSn2Cl4]Cl 
increased the protein level 118%o to that of control cells. 
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Figure 102. Caspase activity induced by complex [C23HsiN606CuSn2Cl4]Cl (2fil) in SY5Y 
cells at 0 to 48 hours was expressed as a percentage of the 0-hour time value 
Conclusions 
The synthesis and structural characterization of Sn(IV)/Zr(lV) modulated Cu(I])/Zn(II) 
trinuclear complexes were carried out with an aim to develop robust cancer 
chemotherapeutic agents. DNA binding experiments with complexes 
[C23H3iN606CuSn2Cl4]CI and [C23H3iN606CuZr2Cl4]CI were employed viz. electronic 
and emission spectral, viscometric and electrochemical studies. The results show that in 
both complexes copper binds to DNA through G-N? cross-linked intrastrand while 
Sn(IV)/Zr(IV) prefers to bind with phosphate backbone of DNA double helix. Thus, 
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complex [C23H3iN606CuSn2Cl4]Cl inhibits DNA more strongly than complex 
[C23H3iN606CuZr2Cl4]Cl, due to the presence of Sn(IV) metal ion, which has more Lewis 
acid character than zirconium metal ion. Complex [C23H3iN606CuSn2Cl4lCl has a potent 
antitumour effect capable of inhibiting the growth of SY5Y by 60 % at 8|a.l and of PC-12 
by 70% at 2|.d. In case of SY5Y neuroblastoma cell line, complex 
[C23H3iN606CuSn2Cl4]Cl exhibit significant antiploriferative activity indicative of 
apoptosis. The immunoblot analysis which clearly demonstrated the down regulation of 
Bcl-2 and up regulation of proapoptotic (Bad and Bax) and p53 (ser-15 & ser-20) 
proteins suggested that mitochondrion play a central role in governing the induction of 
apoptosis by complex [C23H3iN606CuSn2Cl4]Cl. This is further diagnosed by the 
activation of caspase-3. Indeed, complex [C23H3iN606CuSn2Cl4]Cl is one of the most 
effective therapeutic agents developed in terms of its selective antitumour activity, and it 
warrants further vigorous investigations. 
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